0000711404-19-000012.txt : 20190306 0000711404-19-000012.hdr.sgml : 20190306 20190306162256 ACCESSION NUMBER: 0000711404-19-000012 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 78 CONFORMED PERIOD OF REPORT: 20190131 FILED AS OF DATE: 20190306 DATE AS OF CHANGE: 20190306 FILER: COMPANY DATA: COMPANY CONFORMED NAME: COOPER COMPANIES INC CENTRAL INDEX KEY: 0000711404 STANDARD INDUSTRIAL CLASSIFICATION: OPHTHALMIC GOODS [3851] IRS NUMBER: 942657368 STATE OF INCORPORATION: DE FISCAL YEAR END: 1031 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-08597 FILM NUMBER: 19662792 BUSINESS ADDRESS: STREET 1: 6140 STONERIDGE MALL RD STREET 2: STE 590 CITY: PLEASANTON STATE: CA ZIP: 94588 BUSINESS PHONE: 9254603600 MAIL ADDRESS: STREET 1: 6140 STONERIDGE MALL ROAD STREET 2: SUITE 590 CITY: PLEASANTON STATE: CA ZIP: 94588 FORMER COMPANY: FORMER CONFORMED NAME: COOPERVISION INC DATE OF NAME CHANGE: 19870701 10-Q 1 coo_2019x01x31x10qq12019.htm 10-Q Document
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________________________________________________________
FORM 10-Q
_____________________________________________________________
ý
Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For Quarterly Period Ended January 31, 2019
o
Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the transition period from              to             
Commission File Number 1-8597
_____________________________________________________________
The Cooper Companies, Inc.
(Exact name of registrant as specified in its charter)
_____________________________________________________________
Delaware
94-2657368
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)
6140 Stoneridge Mall Road, Suite 590, Pleasanton, CA 94588
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code (925) 460-3600
_____________________________________________________________
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ý    No  o
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ý    No  o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer
ý
 
Accelerated filer
o
Non-accelerated filer
o
 
Smaller reporting company
o
Emerging growth company
o
 
 
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.):    Yes  o    No  ý
Indicate the number of shares outstanding of each of issuer’s classes of common stock, as of the latest practicable date.
Common Stock, $.10 par value
 
49,374,137
Class
 
Outstanding at February 26, 2019



 
 
 


INDEX
 
 
 
Page No.
PART I.
 
 
 
 
Item 1.
 
 
 
 
 
Consolidated Statements of Income - Three Months Ended January 31, 2019 and 2018
 
 
 
 
Consolidated Statements of Comprehensive Income (Loss) - Three Months Ended January 31, 2019 and 2018
 
 
 
 
Consolidated Condensed Balance Sheets - January 31, 2019 and October 31, 2018
 
 
 
 
Consolidated Statements of Stockholders' Equity - January 31, 2019 and January 31, 2018
 
 
 
 
Consolidated Condensed Statements of Cash Flows - Three Months Ended January 31, 2019 and 2018
 
 
 
 
 
 
 
Item 2.
 
 
 
Item 3.
 
 
 
Item 4.
 
 
 
PART II.
 
 
 
 
Item 1.
 
 
 
Item 1A.
 
 
 
Item 2.
 
 
 
Item 6.
 
 

2


 
 
 

PART I. FINANCIAL INFORMATION
Item 1. Unaudited Financial Statements
THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Consolidated Statements of Income (Loss)
Three Months Ended January 31,
(In millions, except for earnings per share)
(Unaudited)
 
 
  
2019
 
2018
Net sales
$
628.1

 
$
590.0

Cost of sales
209.6

 
219.1

Gross profit
418.5

 
370.9

Selling, general and administrative expense
250.0

 
225.9

Research and development expense
21.0

 
18.8

Amortization of intangibles
36.6

 
36.0

Operating income
110.9

 
90.2

Interest expense
18.2

 
18.4

Other income, net
1.1

 
3.0

Income before income taxes
93.8

 
74.8

(Benefit) provision for income taxes
(9.4
)
 
197.3

Net income (loss)
$
103.2

 
$
(122.5
)
Earnings (loss) per share - basic
$
2.09

 
$
(2.50
)
Earnings (loss) per share - diluted
$
2.07

 
$
(2.50
)
Number of shares used to compute earnings (loss) per share:

 

Basic
49.3

 
48.9

Diluted
49.9

 
48.9

See accompanying notes.

3


 
 
 

THE COOPER COMPANIES, INC. AND SUBSIDIARIES

Consolidated Statements of Comprehensive Income (Loss)
Three Months Ended January 31,
(In millions)
(Unaudited)
 
 
  
2019
 
2018
Net income (loss)
$
103.2

 
$
(122.5
)
Other comprehensive income:
 
 
 
Foreign currency translation adjustment, net of tax
32.7

 
102.3

Comprehensive income (loss)
$
135.9

 
$
(20.2
)
See accompanying notes.

4


 
 
 

 
THE COOPER COMPANIES, INC. AND SUBSIDIARIES

Consolidated Condensed Balance Sheets
(In millions)
(Unaudited)
 
January 31, 2019
 
October 31, 2018
ASSETS
 
 
 
Current assets:
 
 
 
Cash and cash equivalents
$
146.6

 
$
77.7

Trade accounts receivable, net of allowance for doubtful accounts of $19.7 at January 31, 2019 and $19.0 at October 31, 2018
389.7

 
374.7

Inventories
486.2

 
468.8

Prepaid expense and other current assets
170.5

 
169.7

Total current assets
1,193.0

 
1,090.9

Property, plant and equipment, at cost
2,009.3

 
1,930.3

Less: accumulated depreciation and amortization
985.5

 
954.3

 
1,023.8

 
976.0

Goodwill
2,449.3

 
2,392.1

Other intangibles, net
1,514.1

 
1,521.3

Deferred tax assets
55.2

 
58.4

Other assets
63.2

 
74.1

 
$
6,298.6

 
$
6,112.8

LIABILITIES AND STOCKHOLDERS’ EQUITY
 
 
 
Current liabilities:
 
 
 
Short-term debt
$
445.5

 
$
37.1

Accounts payable
129.6

 
146.4

Employee compensation and benefits
75.9

 
94.0

Other current liabilities
287.6

 
259.0

Total current liabilities
938.6

 
536.5

Long-term debt
1,686.9

 
1,985.7

Deferred tax liabilities
34.6

 
31.0

Long-term tax payable
124.8

 
141.5

Accrued pension liability and other
88.2

 
110.3

Total liabilities
2,873.1

 
2,805.0

Contingencies (see Note 13)

 

Stockholders’ equity:

 
 
Preferred stock, 10 cents par value, shares authorized: 1.0; zero shares issued or outstanding
—

 
—

Common stock, 10 cents par value, shares authorized: 120.0; issued 52.9 at January 31, 2019 and 52.8 at October 31, 2018
5.3

 
5.3

Additional paid-in capital
1,574.8

 
1,572.1

Accumulated other comprehensive loss
(398.0
)
 
(430.7
)
Retained earnings
2,664.4

 
2,576.0

Treasury stock at cost: 3.6 shares at January 31, 2019 and 3.6 shares at October 31, 2018
(421.2
)
 
(415.1
)
Noncontrolling interests
0.2

 
0.2

Stockholders’ equity
3,425.5

 
3,307.8

 
$
6,298.6

 
$
6,112.8

See accompanying notes.

5
THE COOPER COMPANIES, INC. AND SUBSIDIARIES


Consolidated Condensed Statements of Stockholders' Equity
 
Common Shares
 
Treasury Stock
 
Additional Paid-In Capital
 
Accumulated
Other
Comprehensive
Income (Loss)
 
Retained Earnings
 
Treasury Stock
 
Noncontrolling Interests
 
Total
Stockholders'
Equity
(In millions)
Shares
 
Amount
 
Shares
 
Amount
 
 
 
 
 
 
Balance at November 1, 2017
48.8

 
$
4.9

 
3.6

 
$
0.3

 
$
1,526.7

 
$
(375.3
)
 
$
2,434.2

 
$
(415.1
)
 
$
0.1

 
$
3,175.8

Net loss
—

 
—

 
—

 
—

 
—

 
—

 
(122.5
)
 
—

 
—

 
(122.5
)
Other comprehensive income, net of tax
—

 
—

 
—

 
—

 
—

 
102.3

 
—

 
—

 
—

 
102.3

Issuance of common stock for stock plans, net
0.2

 
0.1

 
—

 
—

 
(10.6
)
 
—

 
—

 
—

 
—

 
(10.5
)
Dividends on common stock
—

 
—

 
—

 
—

 
—

 
—

 
(1.4
)
 
—

 
—

 
(1.4
)
Share-based compensation expense
—

 
—

 
—

 
—

 
12.7

 
—

 
—

 
—

 
—

 
12.7

Balance at January 31, 2018
49.0

 
$
5.0

 
3.6

 
$
0.3

 
$
1,528.8

 
$
(273.0
)
 
$
2,310.3

 
$
(415.1
)
 
$
0.1

 
$
3,156.4

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance at November 1, 2018
49.2

 
$
5.0

 
3.6

 
$
0.3

 
$
1,572.1

 
$
(430.7
)
 
$
2,576.0

 
$
(415.1
)
 
$
0.2

 
$
3,307.8

Net income
—

 
—

 
—

 
—

 
—

 
—

 
103.2

 
—

 
—

 
103.2

Other comprehensive income, net of tax
—

 
—

 
—

 
—

 
—

 
32.7

 
—

 
—

 
—

 
32.7

Issuance of common stock for stock plans, net
0.1

 
—

 
—

 
—

 
(9.0
)
 
—

 
—

 
—

 
—

 
(9.0
)
Treasury stock repurchase
—

 
—

 
—

 
—

 
—

 
—

 
—

 
(6.1
)
 
—

 
(6.1
)
Dividends on common stock
—

 
—

 
—

 
—

 
—

 
—

 
(1.5
)
 
—

 
—

 
(1.5
)
Share-based compensation expense
—

 
—

 
—

 
—

 
11.7

 
—

 
—

 
—

 
—

 
11.7

ASU 2016-16 adoption (1)
—

 
—

 
—

 
—

 
—

 
—

 
(13.3
)
 
—

 
—

 
(13.3
)
Balance at January 31, 2019
49.3

 
$
5.0

 
3.6

 
$
0.3

 
$
1,574.8

 
$
(398.0
)
 
$
2,664.4

 
$
(421.2
)
 
$
0.2

 
$
3,425.5


See accompanying notes to consolidated financial statements.

(1) We adopted ASU 2016-16, Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory in the first quarter of fiscal 2019. Refer to “Note 1. General" for further information.

6


 
 
 

THE COOPER COMPANIES, INC. AND SUBSIDIARIES

Consolidated Condensed Statements of Cash Flows
Three Months Ended January 31,
(In millions)
(Unaudited)
 
2019
 
2018
Cash flows from operating activities:
 
 
 
Net income (loss)
$
103.2

 
$
(122.5
)
Depreciation and amortization
68.8

 
66.6

Increase in operating capital
(53.3
)
 
(177.0
)
Other non-cash items
(16.9
)
 
259.1

Net cash provided by operating activities
101.8

 
26.2

Cash flows from investing activities:
 
 
 
Purchases of property, plant and equipment
(79.2
)
 
(51.4
)
Acquisitions of businesses and assets, net of cash acquired, and other
(50.0
)
 
(1,193.2
)
Net cash used in investing activities
(129.2
)
 
(1,244.6
)
Cash flows from financing activities:
 
 
 
Proceeds from long-term debt
261.8

 
1,672.8

Repayments of long-term debt
(560.8
)
 
(445.8
)
Net proceeds from short-term debt
407.5

 
4.8

Net payments related to share-based compensation awards
(9.0
)
 
(10.5
)
Repurchase of common stock
(6.1
)
 
—

Debt acquisition costs
(0.2
)
 
(3.9
)
Net cash provided by financing activities
93.2

 
1,217.4

Effect of exchange rate changes on cash, cash equivalents and restricted cash
0.9

 
3.9

Net increase in cash, cash equivalents and restricted cash
66.7

 
2.9

Cash, cash equivalents and restricted cash at beginning of period
80.2

 
88.8

Cash, cash equivalents and restricted cash at end of period
$
146.9

 
$
91.7

Reconciliation of cash flow information:
 
 
 
Cash and cash equivalents
$
146.6

 
$
91.4

Restricted cash included in other current assets (1)
0.3

 
0.3

Total cash, cash equivalents, and restricted cash
$
146.9

 
$
91.7


(1) We adopted ASU 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash in the fourth quarter of fiscal 2018. Amounts included in restricted cash represent those required to be set aside by a financial arrangement.

See accompanying notes.

7
THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Notes to Consolidated Condensed Financial Statements
(Unaudited)






Note 1. General

The accompanying unaudited interim consolidated condensed financial statements and related notes should be read in conjunction with the audited Consolidated Financial Statements of the Cooper Companies, Inc. and its subsidiaries (the Company) and related notes as contained in the Company’s Annual Report on Form 10-K for the fiscal year ended October 31, 2018. The unaudited interim financial statements include all adjustments (consisting only of normal recurring adjustments) and accruals necessary in the judgment of management for a fair statement of the results for the periods presented. Readers should not assume that the results reported here either indicate or guarantee future performance. The terms "the Company", "we", "us", and "our" are used to refer collectively to the Cooper Companies, Inc. and its subsidiaries.
Accounting Pronouncements Recently Adopted

In March 2017, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2017-07, Compensation - Retirement Benefits (Topic 715): Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost. The ASU requires an entity to disaggregate the service cost component from the other components of net benefit cost. The service cost component is now presented in the same income statement line as other compensation costs arising from services rendered by the pertinent employees during the period and the other components of net benefit costs are presented separately as other income/expense below operating income. The Company adopted this guidance on November 1, 2018, and it did not have a material impact on the Company’s reported financial results.

In October 2016, the FASB issued ASU 2016-16, Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory, which requires entities to recognize the income tax consequences on an intra-entity transfer of an asset other than inventory when the transfer occurs. The ASU changes the timing of the recognition of the income tax consequences of non-inventory transfers which under current guidance defers the income tax consequences until the asset is sold to an outside party or otherwise recognized. The guidance for the amendments of ASU 2016-16 requires companies to apply a modified retrospective approach with a cumulative catch-up adjustment to opening retained earnings in the period of adoption. The Company adopted ASU 2016-16 in the first quarter of fiscal 2019 on a modified retrospective basis. The Company recorded the cumulative effect of the change as a decrease to retained earnings of approximately $13.3 million. The cumulative effect adjustment represents the recognition of unrecognized income tax effects from intra-entity transfers of assets other than inventory that occurred prior to the date of adoption.

In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606). The ASU requires revenue recognition to depict the transfer of goods or services to customers at an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The amendments in the ASU can be applied either retrospectively to each prior reporting period presented or alternatively, the modified retrospective transition method whereby the company recognizes the cumulative effect of initially applying the guidance as an opening balance sheet adjustment to equity in the period of initial application. This alternative approach must be supplemented by additional disclosures.

We adopted ASU 2014-09 on November 1, 2018, using the modified retrospective transition method. We did not recognize any cumulative effect of initially applying the new revenue standard as an adjustment to our opening balance of retained earnings due to its immaterial impact. The comparative information has not been restated and continues to be reported under the accounting standards in effect for those periods. There was no material impact of ASC 606 to our financial statements during the three months ended January 31, 2019. We do not expect the adoption of the new revenue standard to have a material impact to our net income on an ongoing basis.

The Company applies the provisions of Accounting Standards Codification (ASC) 606-10 or ASU 2014-09, Revenue from Contracts with Customers, and all related appropriate guidance. The Company recognizes revenue under the core principle to depict the transfer of control to the Company’s customers in an amount reflecting the consideration to which the Company expects to be entitled. In order to achieve that core principle, the Company applies the following five step approach: (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in

8
THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Notes to Consolidated Condensed Financial Statements
(Unaudited)





the contract, and (5) recognize revenue when a performance obligation is satisfied. For a complete discussion of accounting for net product revenue, see Note 2. Revenue Recognition.
Accounting Pronouncements Issued Not Yet Adopted

In November 2018, the FASB issued ASU 2018-18, Collaborative Arrangements (Topic 808), Clarifying the Interaction between Topic 808 and Topic 606. This guidance amended ASC 808 and ASC 606 to clarify that transactions in a collaborative arrangement should be accounted for under ASC 606 when the counterparty is a customer for a distinct good or service (i.e., unit of account). The amendments preclude an entity from presenting consideration from a transaction in a collaborative arrangement as revenue from contracts with customers if the counterparty is not a customer for that transaction. We are currently evaluating the impact of ASU 2018-18 which is effective for the Company in our fiscal year and interim periods beginning on November 1, 2020.
In August 2018, the FASB issued ASU 2018-15, Intangibles-Goodwill and Other - Internal Use Software (Subtopic 350-40): Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That is a Service Contract. This guidance requires companies to apply the internal-use software guidance in ASC 350-40 to implementation costs incurred in a hosting arrangement that is a service contract to determine whether to capitalize certain implementation costs or expense them as incurred. We are currently evaluating the impact of ASU 2018-15 which is effective for the Company in our fiscal year and interim periods beginning on November 1, 2020.

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842). ASU 2016-02 requires that a lessee recognize the assets and liabilities that arise from operating leases. A lessee should recognize in the statement of financial position a liability to make lease payments (the lease liability) and a right-of-use (ROU) asset representing its right to use the underlying asset for the lease term. For leases with a term of 12 months or less, a lessee is permitted to make an accounting policy election by class of underlying asset not to recognize lease assets and lease liabilities. In transition, lessees and lessors are required to recognize and measure leases at the beginning of the earliest period presented using a modified retrospective approach. In July 2018, the FASB issued ASU 2018-10, Codification Improvements to Topic 842, Leases and ASU 2018-11, Leases Topic 842 Target improvements, which provides an additional (and optional) transition method whereby the new lease standard is applied at the adoption date and recognized as an adjustment to retained earnings. This standard is effective for the Company in our fiscal year and interim periods beginning on November 1, 2019.

We anticipate this standard to have a material impact on our Consolidated Balance Sheets and related disclosures due to the recognition of ROU assets and lease liabilities for operating leases. However, we do not expect adoption to have a material impact on our Consolidated Income Statements. We are continuing to assess and evaluate the potential impacts of the standard as well as the election of transition method and certain practical expedients available within the ASU. We are in the process of documenting and analyzing our lease contracts, assessment of business processes and controls, selecting a system solution and completing our analysis of information necessary to determine the impact to the consolidated financial statements.

Accounts Receivable Factoring Program

We may factor certain designated trade receivables with one or more third party financial institutions pursuant to a factoring agreement. These are non-recourse factoring arrangements to assist us in managing operating cash flow and meet the requirements to be accounted for as sales in accordance with the “Transfers and Servicing” guidance in ASC 860, where the Company’s continuing involvement subsequent to the transfer is limited to providing certain servicing and collection actions on behalf of the purchasers of the designated trade receivables. Proceeds from amounts factored by the Company are recorded as an increase to cash and a reduction to accounts receivable outstanding in the Company's Consolidated Balance Sheets. Cash flows attributable to factoring are reflected as cash flows from operating activities in the Company’s Consolidated Statements of Cash Flows. Factoring fees associated with the sale of factored receivables for the three months ended January 31, 2019 were $0.4 million and were minimal for the three months ended January 31, 2018.

9
THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Notes to Consolidated Condensed Financial Statements
(Unaudited)






Note 2. Revenue Recognition

Product Revenue, Net

The Company sells its products principally to a limited number of distributors, group purchasing organizations, eye care or health care professionals including independent practices, corporate retailers, hospitals and clinics or authorized resellers (collectively, its Customers). These Customers subsequently resell the Company’s products to eye care or health care providers and patients. In addition to product supply and distribution agreements with Customers, the Company enters into arrangements with health care providers and payors that provide for government-mandated and/or privately-negotiated rebates, chargebacks and discounts with respect to the purchase of the Company’s products. The Company considers customer purchase orders, which in some cases are governed by master sales agreements, to be contracts with a customer. In situations where sales are to a distributor, the Company has concluded that its contracts are with the distributor. As part of its consideration of the contract, the Company evaluates certain factors including the customer’s ability to pay (or credit risk). For each contract, the Company considers the promise to transfer products, each of which is distinct, to be the identified performance obligations.

Revenues from product sales are recognized when the Customer obtains control of the Company’s product, which occurs at a point in time, typically upon shipment or delivery to the Customer. When the Company performs shipping and handling activities after the transfer of control to the Customer (e.g., when control transfers prior to delivery), they are considered as fulfillment activities, and accordingly, the costs are accrued for when the related revenue is recognized. Taxes collected from Customers relating to product sales and remitted to governmental authorities are excluded from revenues. The Company does not have any revenue recognized on payment expected to be received more than one year after the transfer of control of the products. The Company expenses incremental costs of obtaining a contract as and when incurred if the expected amortization period of the asset that the Company would have recognized is one year or less. See Note14. Business Segment Information, for disaggregation of revenue.
 
Reserves for Variable Consideration  

Revenues from product sales are recorded at the net sales price (transaction price), which includes estimates of variable consideration for which reserves are established and which result from discounts, returns, chargebacks, rebates and other allowances that are offered within contracts between the Company and its Customers, health care providers, payors and other indirect customers relating to the Company’s sales of its products. These reserves are based on the amounts earned or to be claimed on the related sales and are classified primarily in current liability. Variable consideration is estimated based on the most likely amount or expected value approach, depending on which method the Company expects to better predict the amount of consideration to which it will be entitled. Once the Company elects one of the methods to estimate variable consideration for a particular type of performance obligation, the Company will apply that method consistently.

Where appropriate, these estimates take into consideration a range of possible outcomes which are probability-weighted for relevant factors such as the Company’s historical experience, current contractual and statutory requirements, specific known market events and trends, industry data and forecasted customer buying and payment patterns. Overall, these reserves reflect the Company’s best estimates of the amount of consideration to which it is entitled based on the terms of the contract. Actual amounts of consideration ultimately received may differ from the Company’s estimates. If actual results in the future vary from the Company’s estimates, the Company adjusts these estimates, which would affect net product revenue and earnings in the period such variances become known.
 
Trade Discounts and Allowances

The Company generally provides Customers with discounts, which include incentive fees that are stated in the Company’s contracts and are recorded as a reduction of revenue in the period the related product revenue is recognized. In addition, the Company receives sales order management, data and distribution services from certain Customers. To the extent the services received are distinct from the Company’s sale of products to the Customer and have readily determinable fair value, these payments are classified in selling, general and administrative expenses in the consolidated statements of income of the Company.
 




10
THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Notes to Consolidated Condensed Financial Statements
(Unaudited)





Product Returns

Consistent with industry practice, the Company generally offers Customers a limited right of return for a product that has been purchased from the Company. The Company estimates the amount of its product sales that may be returned by its Customers and records this estimate as a reduction of revenue in the period the related product revenue is recognized. There is inherent judgment in estimating future refunds as they are susceptible to factors outside of our influence. However, we have significant experience in estimating the amount of refunds, based primarily on historical data. Our refund liability for product returns was $12.6 million at January 31, 2019 which is included in Accrued liabilities on our Condensed Consolidated Balance Sheets and represents the expected value of the aggregate refunds that will be due to our customers.
 
Rebates and Chargebacks

Rebates are estimated based on contractual terms, historical experience, customer mix, trend analysis and projected market conditions in the various markets served.

Chargebacks for fees and discounts to providers represent the estimated obligations resulting from contractual commitments to sell products to qualified healthcare providers at prices lower than the list wholesale prices charged to the Company’s direct customers. For certain office and surgical products in CooperSurgical, customers charge the Company for the difference between what they pay for the product and the ultimate selling price to the qualified healthcare providers. These reserves are established in the same period that the related revenue is recognized, resulting in a reduction of product revenue. Chargeback amounts are generally determined at the time of resale to the qualified healthcare provider by Customers. CooperSurgical rebates are predominately related to the Medicaid rebate provision that is estimated based upon contractual terms, historical experience, and trend analysis.

Contract balances

The timing of billing and revenue recognition primarily occurs simultaneously. The Company does not have material contract assets or liabilities.

Note 3. Acquisitions
The following is a summary of the allocation of the total purchase consideration for business and asset acquisitions that the Company completed during fiscal 2019 and 2018:
(In millions)
January 31, 2019
 
October 31, 2018
Technology
$
9.9

 
$
—

Customer relationships
7.5

 
23.5

Trademarks
9.7

 
100.0

Composite intangible asset
—

 
1,061.9

Other
—

 
4.2

Total identifiable intangible assets
$
27.1

 
$
1,189.6

Goodwill
35.8

 
70.6

Net tangible assets
1.4

 
59.6

Total purchase price
$
64.3

 
$
1,319.8

All the acquisitions were funded by cash generated from operations or facility borrowings.
For business acquisitions, we recorded the tangible and intangible assets acquired and liabilities assumed at their fair values as of the applicable date of acquisition. For assets acquisitions, we recorded the tangible and intangible assets acquired and liabilities assumed at their estimated and relative fair values as of the applicable date of acquisition.

We believe these acquisitions strengthen CooperSurgical's and CooperVision's businesses through the addition of new or complementary products and services.


11
THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Notes to Consolidated Condensed Financial Statements
(Unaudited)





Fiscal Year 2019

On December 31, 2018, CooperSurgical completed the acquisition of Incisive Surgical Inc., a privately-held U.S. medical device company that develops mechanical surgical solutions for skin closure. The purchase price allocation is preliminary and we are in the process of finalizing information primarily related to property, plant & equipment, inventories, receivables, certain accruals and other liabilities, taxes and the corresponding impact on goodwill.

On December 28, 2018, CooperVision completed the acquisition of Blanchard Contact Lenses. Blanchard is a privately-held scleral lens company, which expands CooperVision's specialty and scleral lens portfolio. The purchase price allocation is preliminary and we are in the process of finalizing information primarily related to property, plant & equipment, inventories, receivables, certain accruals and other liabilities, taxes and the corresponding impact on goodwill.
The pro forma results of operations of these acquisitions have not been presented because the effects of the business combinations described above, individually and in the aggregate, were not material to our consolidated results of operations.
Fiscal Year 2018

PARAGARD

On November 1, 2017, CooperSurgical acquired the assets of the PARAGARD Intrauterine Device (IUD) business (PARAGARD) from Teva Pharmaceuticals Industries Limited for $1.1 billion. This asset acquisition broadened and strengthened CooperSurgical's product portfolio. PARAGARD® is the only hormone-free, long lasting, reversible contraceptive approved by the United States Food and Drug Administration (FDA) available in the United States.

The following table summarizes the relative fair values of net assets acquired and liabilities assumed using the cost accumulation and allocation model:
(In millions)
Relative Fair Value
Composite intangible asset (1)
$
1,061.9

Assembled workforce intangible asset (2)
1.2

Property, plant and equipment
2.0

Inventory (3)
47.3

Other assets
9.4

Total assets acquired
$
1,121.8

Less: liabilities assumed
16.4

Total Purchase Price
$
1,105.4


The Company proportionally allocated the acquisition costs to the net assets acquired. The acquisition-related costs included advisory, legal, valuation and other professional fees.

(1) Composite Intangible asset consists of technology, trade name, New Drug Application (NDA) approval and physician relationships, which have been valued as a single composite intangible asset as they are inextricably linked. The composite asset was identified as the primary asset acquired, was valued using the Multi-Period Excess Earnings Method and will be amortized over 15 years.
(2) An assembled workforce was recognized as a separate acquired intangible asset, given the purchase of assets and will be amortized over 5 years.
(3) Inventory relative fair value includes step up of $45.4 million.
Other Acquisitions
On April 3, 2018, CooperSurgical completed the acquisition of The LifeGlobal Group (LifeGlobal). LifeGlobal was a privately held company that specializes primarily in in-vitro fertilization (IVF) media. LifeGlobal’s product categories include media products as well as IVF laboratory air filtration products and dishware. We have completed the purchase price allocation for this acquisition.

12
THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Notes to Consolidated Condensed Financial Statements
(Unaudited)





On December 1, 2017, CooperVision acquired Paragon Vision Sciences, a leading provider of orthokeratology (ortho-k) specialty contact lenses and oxygen permeable rigid contact lens materials. Ortho-k contact lenses are overnight lenses which enable corneal topography correction for myopia (nearsightedness) patients. We have completed the purchase price allocation for this acquisition.
On January 4, 2018, CooperVision acquired Blueyes Ltd, a long-standing distribution partner, with a leading position in the distribution of contact lenses to the Optical and Pharmacy sector in Israel. We have completed the purchase price allocation for this acquisition.

Note 4. Inventories
(In millions)
January 31, 2019
 
October 31, 2018
Raw materials
$
119.9

 
$
112.5

Work-in-process
12.6

 
12.6

Finished goods
353.7

 
343.7

 
$
486.2

 
$
468.8

Inventories are stated at the lower of cost and net realizable value. Cost is computed using standard cost that approximates actual cost, on a first-in, first-out basis.

Note 5. Intangible Assets

Goodwill
(In millions)
CooperVision
 
CooperSurgical
 
Total
Balance at October 31, 2017
$
1,735.7

 
$
619.1

 
$
2,354.8

Net additions during the year ended October 31, 2018
36.8

 
34.4

 
71.2

Translation
(29.6
)
 
(4.3
)
 
(33.9
)
Balance at October 31, 2018
1,742.9

 
649.2

 
2,392.1

Net additions during the three months ended January 31, 2019
13.9

 
21.9

 
35.8

Translation
19.9

 
1.5

 
21.4

Balance at January 31, 2019
$
1,776.7

 
$
672.6

 
$
2,449.3


The Company evaluates goodwill for impairment annually during the fiscal third quarter and when an event occurs or circumstances change such that it is reasonably possible that impairment may exist. The Company accounts for goodwill and evaluates its goodwill balances and tests them for impairment in accordance with related accounting standards. The Company performed its annual impairment assessment in its third quarters of fiscal 2018 and fiscal 2017 respectively, and its analysis indicated that the Company had no impairment of goodwill.

13
THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Notes to Consolidated Condensed Financial Statements
(Unaudited)





Other Intangible Assets
 
January 31, 2019
 
October 31, 2018
 
 
(In millions)
Gross Carrying
Amount
 
Accumulated
Amortization
 
Gross Carrying
Amount
 
Accumulated
Amortization
 
Weighted Average Amortization Period (In years)
 
 
 
 
 
 
 
 
 
 
Trademarks
$
149.3

 
$
19.4

 
$
139.2

 
$
16.9

 
14
Composite intangible asset
1,061.9

 
88.5

 
1,061.9

 
70.8

 
15
Technology
405.8

 
198.5

 
395.0

 
190.7

 
11
Customer relationships
359.0

 
175.3

 
350.0

 
168.6

 
13
License and distribution rights and other
76.0

 
56.2

 
74.9

 
52.7

 
9
 
2,052.0

 
$
537.9

 
2,021.0

 
$
499.7

 
14
Less: accumulated amortization and translation
537.9

 
 
 
499.7

 
 
 
 
Other intangible assets, net
$
1,514.1

 
 
 
$
1,521.3

 
 
 
 
Balances include foreign currency translation adjustments.
As of January 31, 2019, the estimation of amortization expenses for intangible assets with finite lives is as follows:
Fiscal years:
(In millions)
Remainder of 2019
$
109.1

2020
136.1

2021
134.8

2022
132.9

2023
130.7

Thereafter
861.6

Total remaining amortization for intangible assets
$
1,505.2


Note 6. Debt
(In millions)
January 31, 2019
 
October 31, 2018
Overdraft and other credit facilities
$
45.6

 
$
37.1

Term loans
400.0

 
—

Less: unamortized debt issuance cost
(0.1
)
 
—

Short-term Debt
$
445.5

 
$
37.1

 
 
 
 
Revolving credit
$
140.0

 
$
439.0

Term loans
1,550.0

 
1,550.0

Other
0.2

 
0.2

Less: unamortized debt issuance cost
(3.3
)
 
(3.5
)
Long-term Debt
$
1,686.9

 
$
1,985.7

 
 
 
 
Total Debt
$
2,132.4

 
$
2,022.8



14
THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Notes to Consolidated Condensed Financial Statements
(Unaudited)






$400 million Term Loan on November 1, 2018
On November 1, 2018, the Company entered into a 364-day, $400.0 million, senior unsecured term loan agreement by and among the Company, the lenders party thereto and PNC Bank, National Association, as administrative agent which matures on October 31, 2019 (the 2018 Term Loan Agreement). The Company used the funds to partially repay outstanding borrowings under the 2016 Revolving Credit Facility. At January 31, 2019, we had $400.0 million outstanding under the 2018 Term Loan Agreement.
Amounts outstanding under the 2018 Term Loan Agreement will bear interest, at the Company's option, at either the base rate, or the adjusted LIBO rate (each as defined in the 2018 Term Loan Agreement), plus, in each case, an applicable rate of 0.00% in respect of base rate loans and 0.60% in respect of adjusted LIBO rate loans. The weighted average interest rate for the three months ended January 31, 2019 was 2.99%.

The 2018 Term Loan Agreement contains customary restrictive covenants, as well as financial covenants that require the Company to maintain a certain Total Leverage Ratio and Interest Coverage Ratio (each as defined in the 2018 Term Loan Agreement) consistent with the 2016 Credit Agreement discussed below.
$1.425 billion Term Loan on November 1, 2017
On November 1, 2017, in connection with the PARAGARD acquisition, we entered into a five-year, $1.425 billion, senior unsecured term loan agreement (the 2017 Term Loan Agreement) by and among the Company, the lenders party thereto and DNB Bank ASA, New York Branch, as administrative agent which matures on November 1, 2022. The Company used part of the facility to fund the PARAGARD acquisition and used the remainder of the funds to partially repay outstanding borrowings under our revolving credit agreement.
Amounts outstanding under the 2017 Term Loan Agreement will bear interest, at our option, at either the base rate, or the adjusted LIBO rate (each as defined in the 2017 Term Loan Agreement), plus, in each case, an applicable rate of, between 0.00% and 0.75% in respect of base rate loans and between 1.00% and 1.75% in respect of adjusted LIBO rate loans, in each case in accordance with a pricing grid tied to the Total Leverage Ratio as defined in the 2017 Term Loan Agreement.

The 2017 Term Loan Agreement contains customary restrictive covenants, as well as financial covenants that require the Company to maintain a certain Total Leverage Ratio and Interest Coverage Ratio (each as defined in the 2017 Term Loan Agreement) consistent with the 2016 Credit Agreement discussed below. At January 31, 2019, we had $1.425 billion outstanding under the 2017 Term Loan Agreement.
Revolving Credit and Term Loan Agreement on March 1, 2016
On March 1, 2016, we entered into a Revolving Credit and Term Loan Agreement (the 2016 Credit Agreement), among the Company, CooperVision International Holding Company, LP, the lenders party thereto and KeyBank National Association, as administrative agent. The 2016 Credit Agreement provides for a multicurrency revolving credit facility in an aggregate principal amount of $1.0 billion (the 2016 Revolving Credit Facility) and a term loan facility in an aggregate principal amount of $830.0 million (the 2016 Term Loan Facility), each of which, unless terminated earlier, mature on March 1, 2021. In addition, we have the ability from time to time to request an increase to the size of the 2016 Revolving Credit Facility or establish one or more new term loans under the 2016 Term Loan Facility in an aggregate amount up to $750.0 million, subject to the discretionary participation of the lenders.

Amounts outstanding under the 2016 Credit Agreement will bear interest, at our option, at either the base rate, or the adjusted LIBO rate or adjusted foreign currency rate (each as defined in the 2016 Credit Agreement), plus, in each case, an applicable rate of between 0.00% and 0.75% in respect of base rate loans and between 1.00% and 1.75% in respect of adjusted LIBO rate or adjusted foreign currency rate loans, in each case in accordance with a pricing grid tied to the Total Leverage Ratio, as defined in the 2016 Credit Agreement.

We pay an annual commitment fee that ranges from 0.125% to 0.25% of the unused portion of the 2016 Revolving Credit Facility depending on certain financial ratios. In addition to the annual commitment fee described above, we are also required to pay certain letter of credit and related fronting fees and other administrative fees pursuant to the terms of the 2016 Credit Agreement.


15
THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Notes to Consolidated Condensed Financial Statements
(Unaudited)





At January 31, 2019, we had $125.0 million outstanding under the 2016 Term Loan Facility and $859.5 million available under the 2016 Revolving Credit Facility.

The 2016 Credit Agreement contains customary restrictive covenants, as well as financial covenants that require us to maintain a certain Total Leverage Ratio and Interest Coverage Ratio (each as defined in the 2016 Credit Agreement):
•
Interest Coverage Ratio, as defined, to be at least 3.00 to 1.00 at all times.
•
Total Leverage Ratio, as defined, to be no higher than 3.75 to 1.00.
At January 31, 2019, we were in compliance with the Interest Coverage Ratio at 10.70 to 1.00 and the Total Leverage Ratio at 2.25 to 1.00 for 2018 Term Loan Agreement, the 2017 Term Loan Agreement, and the 2016 Credit Agreement.
Refer to our Annual Report on Form 10-K for the fiscal year ended October 31, 2018 for more details.

Note 7. Income Taxes
Recent Tax Legislation
The 2017 Act was enacted into law on December 22, 2017 and significantly changes existing U.S. tax law. The 2017 Act adopts a territorial tax system, imposes a mandatory one-time transition tax on earnings of foreign subsidiaries that were previously indefinitely reinvested, and reduces the U.S. federal statutory tax rate from 35% to 21%. For first quarter of fiscal 2019, the Company has utilized the enacted U.S. federal statutory tax rate of 21%.
The 2017 Act includes several provisions that are effective for our fiscal 2019: (i) tax on global intangible low-taxed income (GILTI) of foreign subsidiaries, (ii) tax on certain payments between a U.S. corporation and its foreign subsidiaries referred to as the base erosion and anti-abuse tax (BEAT), (iii) limitation on the tax deduction for interest payments, and (iv) expanded limitation on the tax deduction for compensation paid to certain executives.
The 2017 Act was effective in the first quarter of fiscal 2018. As of January 31, 2019, we have completed our accounting for the tax effects of the enactment of the 2017 Act and recorded a final adjustment to our provisional tax expense pursuant to SAB 118. During the first quarter of fiscal 2019, we recorded tax benefit of $4.4 million in our financial statements to finalize the tax effects of the 2017 Act. The Company is no longer asserting that earnings from our foreign subsidiaries are indefinitely reinvested.

The 2017 Act imposes a new tax on foreign earnings and profits in excess of a deemed return on tangible assets of foreign subsidiaries referred to as GILTI which is effective in fiscal 2019. In accordance with FASB Staff Q&A, Topic 740, No. 5, Accounting for Global Intangible Low-Taxed Income, the Company is making an accounting policy election to recognize the tax expense related to GILTI in the year the tax is incurred.
Effective Tax Rate
The Company's effective tax rates were a benefit of 10.0% and expense of 263.7% for the first quarters of fiscal 2019 and fiscal 2018, respectively. The decrease in our effective tax rate for the first quarter of fiscal 2019 compared to the first quarter of fiscal 2018 was primarily due to the provisional charge of $202.0 million relating to the 2017 Act that was recorded in the first quarter of fiscal 2018. Our effective tax rate for the first quarter of fiscal 2019 was lower than the U.S. statutory rate because of discrete tax benefits which were partially offset by a less favorable mix of income from our foreign jurisdictions with lower tax rates. Total discrete tax benefits for the first quarter of fiscal 2019 were $18.7 million primarily relating to settlement of tax audits, revisions to the provisional tax charges relating to the 2017 Act, and excess tax benefits from share-based compensation. Our effective tax rate for the first quarter of fiscal 2018 was higher than the U.S. statutory rate because of the discrete tax expense relating to the 2017 Act, which was partially offset by a favorable mix of income from our foreign jurisdictions with lower tax rates and an excess tax benefit from share-based compensation.

We recognize the benefit from a tax position only if it is more likely than not that the position would be sustained upon audit based solely on the technical merits of the tax position. As of January 31, 2019, and October 31, 2018, Cooper had unrecognized tax benefits of $47.1 million and $68.9 million, respectively. The decrease is primarily related to settling prior year tax audits, partially offset by additions to current period transfer pricing reserves. It is our policy to recognize interest and penalties directly related to income taxes as additional income tax expense. It is reasonably possible that $3.1 million of unrecognized tax benefits could be settled during the next twelve months.

The Company is subject to U.S. Federal income tax examinations for fiscal 2015 through 2018 and the Internal Revenue Service is currently auditing our U.S. Consolidated Corporation Income Tax Returns for fiscal 2015 and 2016. The

16
THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Notes to Consolidated Condensed Financial Statements
(Unaudited)





Company remains subject to income tax examinations in other significant tax jurisdictions including the United Kingdom, Japan, France and Australia for the tax years 2015 through 2018.


Note 8. Earnings Per Share
Three Months Ended January 31,
 
(In millions, except per share amounts)
2019
 
2018
Net income (loss)
$
103.2

 
$
(122.5
)
Basic:
 
 
 
Weighted average common shares
49.3

 
48.9

Basic earnings (loss) per share
$
2.09

 
$
(2.50
)
Diluted:
 
 
 
Weighted average common shares
49.3

 
48.9

Effect of potential dilutive shares
0.6

 
—

Diluted weighted average common shares*
49.9

 
48.9

Diluted earnings (loss) per share attributable to Cooper stockholders
$
2.07

 
$
(2.50
)
*The number of diluted weighted average common shares used to calculate fiscal 2018 diluted loss per share excludes all potentially dilutive instrument because they would be antidilutive due to the net loss position.
The following table sets forth stock options to purchase Cooper’s common stock and restricted stock units that were not included in the diluted earnings per share calculation because their effect would have been antidilutive for the periods presented:
Three Months Ended January 31,
 
(In thousands, except exercise prices)
2019
 
2018
Number of stock option shares excluded
377

 
1,202

Range of exercise prices
$226.30-$254.77

 
$15.83-$229.66

Number of restricted stock units excluded
17

 
546


Note 9. Share-Based Compensation Plans
Cooper has several share-based compensation plans that are described in the Company’s Annual Report on Form 10‑K for the fiscal year ended October 31, 2018. The compensation expense and related income tax benefit recognized in our consolidated condensed financial statements for share-based awards were as follows:
Three Months Ended January 31,
 
(In millions)
2019
 
2018
Selling, general and administrative expense
$
9.3

 
$
10.7

Cost of sales
1.5

 
1.3

Research and development expense
0.9

 
0.7

Total share-based compensation expense
$
11.7

 
$
12.7

Related income tax benefit
$
1.7

 
$
2.5



17
THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Notes to Consolidated Condensed Financial Statements
(Unaudited)





Note 10. Stockholders’ Equity
Analysis of Changes in Accumulated Other Comprehensive (Loss) Income:
(In millions)
Foreign Currency Translation Adjustment
 
Minimum Pension Liability
 
Total
Balance at October 31, 2017
$
(353.7
)
 
$
(21.6
)
 
$
(375.3
)
Gross change in value during the year ended October 31, 2018
(58.5
)
 
11.0

 
(47.5
)
Tax effect for the period
—

 
(3.1
)
 
(3.1
)
ASU 2018-02 adoption(1)
—

 
(4.8
)
 
(4.8
)
Balance at October 31, 2018
$
(412.2
)
 
$
(18.5
)
 
$
(430.7
)
Gross change in value during the three months ended January 31, 2019
32.7

 
—

 
32.7

Balance at January 31, 2019
$
(379.5
)
 
$
(18.5
)
 
$
(398.0
)
(1)
Represents reclassification to retained earnings from adoption of ASU 2018-02. Refer to our Annual Report on Form 10-K for the fiscal year ended October 31, 2018 for more details.
Share Repurchases
In December 2011, our Board of Directors authorized the 2012 Share Repurchase Program and through subsequent amendments, the most recent in March 2017, the total repurchase authorization was increased from $500.0 million to $1.0 billion of the Company's common stock. This program has no expiration date and may be discontinued at any time. Purchases under the 2012 Share Repurchase Program are subject to a review of the circumstances in place at the time and may be made from time to time as permitted by securities laws and other legal requirements.
In the fiscal first quarter of 2019, we repurchased 24.5 thousand shares of the Company's common stock for $6.1 million, at an average purchase price of $248.70 per share. We did not repurchase shares during the fiscal year ended October 31, 2018. At January 31, 2019, $557.4 million remains authorized for repurchase under the program.
Dividends
We paid a semiannual dividend of approximately $1.5 million or 3 cents per share on February 8, 2019, to stockholders of record on January 22, 2019.

Note 11. Fair Value Measurements
Accounting standards define fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value hierarchy prioritizes the inputs to valuation techniques used to measure fair value. An asset’s or liability’s level is based on the lowest level of input that is significant to the fair value measurement. Assets and liabilities carried at fair value are valued and disclosed in one of the following three levels of the valuation hierarchy:
Level 1: Quoted market prices in active markets for identical assets or liabilities.
Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.
Level 3: Unobservable inputs reflecting the reporting entity’s own assumptions.
At January 31, 2019 and October 31, 2018, the carrying value of cash and cash equivalents, accounts receivable, prepaid expense and other current assets, lines of credit, accounts payable and other current liabilities approximate fair value due to the short-term nature of such instruments and the ability to obtain financing on similar terms.

The carrying value of our revolving credit facility and term loans approximates fair value estimated based on current market rates (Level 2). The Company did not have any derivative assets or liabilities that may include interest rate swaps, cross currency swaps or foreign currency forward contracts as of January 31, 2019 and October 31, 2018.



18
THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Notes to Consolidated Condensed Financial Statements
(Unaudited)





Nonrecurring fair value measurements

The Company uses fair value measures when determining assets and liabilities acquired in an acquisition as described in Note 3. Acquisitions which are considered a Level 3 measurement.

Note 12. Employee Benefits
Cooper’s Retirement Income Plan (the Plan), a defined benefit plan, covers substantially all full-time United States employees. Our contributions are designed to fund normal cost on a current basis and to fund the estimated prior service cost of benefit improvements. The unit credit actuarial cost method is used to determine the annual cost. Cooper pays the entire cost of the Plan and funds such costs as they accrue. Virtually all of the assets of the Plan are comprised of equities and participation in equity and fixed income funds.
Our results of operations for the three months ended January 31, 2019 and 2018, reflect the following components of net periodic pension costs:
Three Months Ended January 31,
 
(In millions)
2019
 
2018
Service cost
$
2.5

 
$
2.7

Interest cost
1.5

 
1.3

Expected return on plan assets
(2.4
)
 
(2.3
)
Recognized net actuarial loss
0.2

 
0.4

Net periodic pension cost
$
1.8

 
$
2.1

We did not contribute to the Plan in the first quarter of fiscal 2019 and expect to contribute $10.0 million during the remainder of fiscal 2019. We did not contribute to the Plan in the first quarter of fiscal 2018. The expected rate of return on Plan assets for determining net periodic pension cost is 8%.

Note 13. Contingencies

Since March 2015, over 50 putative class action complaints were filed by contact lens consumers alleging that contact lens manufacturers, in conjunction with their respective Unilateral Pricing Policy (UPP), conspired to reach agreements between each other and certain distributors and retailers regarding the prices at which certain contact lenses could be sold to consumers. The plaintiffs are seeking damages against CooperVision, Inc., other contact lens manufacturers, distributors and retailers, in various courts around the United States. In June 2015, all of the class action cases were consolidated and transferred to the United States District Court for the Middle District of Florida. In August 2017, CooperVision entered into a settlement agreement with the plaintiffs, without any admission of liability, to settle all claims against CooperVision. In July 2018, the Court approved the plaintiffs’ motion for preliminary approval of the settlement, and the Company paid the $3.0 million settlement amount into an escrow account. The settlement remains subject to final Court approval at a future hearing to be set by the Court.

The Company is involved in various lawsuits, claims and other legal matters from time to time that arise in the ordinary course of conducting business, including matters involving our products, intellectual property, supplier relationships, distributors, competitor relationships, employees and other matters. The Company does not believe that the ultimate resolution of these proceedings or claims pending against it could have a material adverse effect on its financial condition or results of operations. At each reporting period, the Company evaluates whether or not a potential loss amount or a potential range of loss is probable and reasonably estimable under ASC 450, Contingencies. Legal fees are expensed as incurred.

Note 14. Business Segment Information
Cooper uses operating income, as presented in our financial reports, as the primary measure of segment profitability. We do not allocate costs from corporate functions to segment operating income. Items below operating income are not considered when measuring the profitability of a segment. We use the same accounting policies to generate segment results as we do for our consolidated results.

19
THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Notes to Consolidated Condensed Financial Statements
(Unaudited)





Total identifiable assets are those used in continuing operations except cash and cash equivalents, which we include as corporate assets.
Segment information:
Three Months Ended January 31,
 
(In millions)
2019
 
2018
CooperVision net sales by category:
 
 
 
Toric lens
$
146.0

 
$
137.8

Multifocal lens
49.1

 
46.9

Single-use sphere lens
132.1

 
116.3

Non single-use sphere and other
142.9

 
143.8

Total CooperVision net sales
470.1

 
444.8

CooperSurgical net sales by category:
 
 
 
Office and surgical procedures
95.7

 
88.2

Fertility
62.3

 
57.0

Total CooperSurgical net sales
158.0

 
145.2

Total net sales
$
628.1

 
$
590.0

Operating income (loss):
 
 
 
CooperVision
$
116.3

 
$
112.3

CooperSurgical
7.2

 
(9.3
)
Corporate
(12.6
)
 
(12.8
)
Total operating income
110.9

 
90.2

Interest expense
18.2

 
18.4

Other income, net
1.1

 
3.0

Income before income taxes
$
93.8

 
$
74.8

(In millions)
January 31, 2019
 
October 31, 2018
Total identifiable assets:
 
 
 
CooperVision
$
3,869.8

 
$
3,746.0

CooperSurgical
2,214.6

 
2,201.7

Corporate
214.2

 
165.1

Total
$
6,298.6

 
$
6,112.8

Geographic information:
Three Months Ended January 31,
 
(In millions)
2019
 
2018
Net sales to unaffiliated customers by country of domicile:
 
 
 
United States
$
278.9

 
$
261.5

Europe
209.7

 
203.8

Rest of world
139.5

 
124.7

Total
$
628.1

 
$
590.0



20
THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Notes to Consolidated Condensed Financial Statements
(Unaudited)





(In millions)
January 31, 2019
 
October 31, 2018
Net property, plant and equipment by country of domicile:
 
 
 
United States
$
550.2

 
$
516.7

Europe
349.6

 
340.7

Rest of world
124.0

 
118.6

Total
$
1,023.8

 
$
976.0

 

Note 15. Subsequent Event

Filshie Clip System

On February 1, 2019, subsequent to the first quarter of fiscal 2019, the Company agreed to the early termination of an exclusive distribution agreement with Femcare Ltd. which had given CooperSurgical the exclusive rights to distribute the Filshie Clip System in the U.S. The Company received consideration of $21 million on January 31, 2019, from Utah Medical Products, Inc. (UTMD), the parent company of Femcare Ltd., in exchange for the agreement to terminate the exclusive distribution agreement prior to the end of the contractual term. UTMD has also agreed to buyback resaleable Filshie Clip System inventory.

Diverted Profit Tax

On February 26, 2019, subsequent to the first quarter of fiscal 2019, the Company received a refund of approximately GBP 22.1 million (USD 29.0 million) from the GBP 31 million (USD 42.0 million) payment made on January 19, 2018 to the U.K. Tax Authorities. The payment had been made in regard to the Diverted Profit Tax matter related to the transfer of certain intellectual property rights in connection with the 2014 acquisition of Sauflon Pharmaceutical Ltd.



21
THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Item 2. Management’s Discussion and Analysis of Financial Condition
and Results of Operations




Note numbers refer to “Notes to Consolidated Condensed Financial Statements” in Item 1. Unaudited Financial Statements.

Forward-Looking Statements
This Quarterly Report on Form 10-Q contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995. These include statements relating to plans, prospects, goals, strategies, future actions, events or performance and other statements which are other than statements of historical fact, including all statements regarding acquisitions including the acquired companies' financial position, market position, product development and business strategy, expected cost synergies, expected timing and benefits of the transaction, difficulties in integrating entities or operations, as well as estimates of our and the acquired entities' future expenses, sales and earnings per share are forward-looking. In addition, all statements regarding anticipated growth in our revenue, anticipated effects of any product recalls, anticipated market conditions, planned product launches and expected results of operations and integration of any acquisition are forward-looking. To identify these statements, look for words like “believes,” “outlook,” “probable,” “expects,” “may,” “will,” “should,” “could,” “seeks,” “intends,” “plans,” “estimates” or “anticipates” and similar words or phrases. Forward-looking statements necessarily depend on assumptions, data or methods that may be incorrect or imprecise and are subject to risks and uncertainties. Among the factors that could cause our actual results and future actions to differ materially from those described in forward-looking statements are:
•
Adverse changes in global political and economic conditions, and related uncertainty caused by the United Kingdom’s election to withdraw from the European Union and its potential impact on, among other things, the movement of goods and materials in our supply chain, additional regulatory approvals and requirements, and increased tariffs and duties.
•
Adverse changes in the global or regional general business, political and economic conditions, including the impact of continuing uncertainty and instability of certain countries that could adversely affect our global markets, and the potential adverse economic impact and related uncertainty caused by these items, including but not limited to, escalating global trade barriers including additional tariffs.
•
Foreign currency exchange rate and interest rate fluctuations including the risk of fluctuations in the value of foreign currencies or interest rates that would decrease our revenues and earnings.
•
Changes in tax laws or their interpretation and changes in statutory tax rates, including but not limited to, the U.S., the United Kingdom and other countries may affect our taxation of earnings recognized in foreign jurisdictions and/or negatively impact our effective tax rate.
•
Our existing indebtedness and associated interest expense, most of which is variable and impacted by rate increases, which could adversely affect our financial health or limit our ability to borrow additional funds.
•
Acquisition-related adverse effects including the failure to successfully obtain the anticipated revenues, margins and earnings benefits of acquisitions, integration delays or costs and the requirement to record significant adjustments to the preliminary fair value of assets acquired and liabilities assumed within the measurement period, required regulatory approvals for an acquisition not being obtained or being delayed or subject to conditions that are not anticipated, adverse impacts of changes to accounting controls and reporting procedures, contingent liabilities or indemnification obligations, increased leverage and lack of access to available financing (including financing for the acquisition or refinancing of debt owed by us on a timely basis and on reasonable terms).
•
Compliance costs and potential liability in connection with U.S. and foreign laws and health care regulations pertaining to privacy and security of third- party information, such as HIPAA in the U.S. and the General Data Protection Regulation requirements in Europe, including but not limited to those resulting from data security breaches.

22
THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Item 2. Management’s Discussion and Analysis of Financial Condition
and Results of Operations




•
A major disruption in the operations of our manufacturing, accounting and financial reporting, research and development, distribution facilities or raw material supply chain due to integration of acquisitions, natural disasters or other causes.
•
A major disruption in the operations of our manufacturing, accounting and financial reporting, research and development or distribution facilities due to technological problems, including any related to our information systems maintenance, enhancements or new system deployments, integrations or upgrades.
•
Disruptions in supplies of raw materials, particularly components used to manufacture our silicone hydrogel lenses.
•
New U.S. and foreign government laws and regulations, and changes in existing laws, regulations and enforcement guidance, which affect areas of our operations including, but not limited to, those affecting the health care industry, including the contact lens industry specifically and the medical device or pharmaceutical industries generally.
•
Legal costs, insurance expenses, settlement costs and the risk of an adverse decision, prohibitive injunction or settlement related to product liability, patent infringement or other litigation.
•
Limitations on sales following product introductions due to poor market acceptance.
•
New competitors, product innovations or technologies, including but not limited to, technological advances by competitors, new products and patents attained by competitors, and competitors' expansion through acquisitions.
•
Reduced sales, loss of customers and costs and expenses related to product recalls and warning letters.
•
Failure to receive, or delays in receiving, regulatory approvals for products.
•
Failure of our customers and end users to obtain adequate coverage and reimbursement from third-party payors for our products and services.
•
The requirement to provide for a significant liability or to write off, or accelerate depreciation on, a significant asset, including goodwill, other intangible assets and idle manufacturing facilities and equipment.
•
The success of our research and development activities and other start-up projects.
•
Dilution to earnings per share from acquisitions or issuing stock.
•
Impact and costs incurred from changes in accounting standards and policies.
•
Environmental risks, including increasing environmental legislation and the broader impacts of climate change.
•
Other events described in our Securities and Exchange Commission filings, including the “Business” and “Risk Factors” sections in our Annual Report on Form 10-K for the fiscal year ended October 31, 2018, as such Risk Factors may be updated in quarterly filings.
We caution investors that forward-looking statements reflect our analysis only on their stated date. We disclaim any intent to update them except as required by law.



23
THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Item 2. Management’s Discussion and Analysis of Financial Condition
and Results of Operations





Results of Operations
In this section, we discuss the results of our operations for the first quarter of fiscal 2019 ended January 31, 2019 and compare them with the same periods of fiscal 2018. We discuss our cash flows and current financial condition under “Capital Resources and Liquidity.” Within the tables presented, percentages are calculated based on the underlying whole-dollar amounts and, therefore, may not recalculate exactly from the rounded numbers used for disclosure purposes.
            netsalesq119.jpg
First Quarter Highlights
•
Gross profit $418.5 million, up 13% from $370.9 million in the prior year period
•
Operating income $110.9 million, up 23% from $90.2 million in the prior year period
•
Diluted earnings per share of $2.07, up from $2.50 diluted loss per share in the prior year period
•
Cash provided by operations $101.8 million, compared to $26.2 million in the prior year period
Outlook
Overall, we remain optimistic about the long-term prospects for the worldwide contact lens and general health care markets. However, events affecting the economy as a whole, including but not limited to the uncertainty and instability of global markets driven by foreign currency volatility, changes in tax legislation, debt concerns, the uncertainty caused by the United Kingdom's upcoming withdrawal from the European Union, global trade barriers including additional tariffs and the trend of consolidations within the health care industry, impact our current performance and continue to represent a risk to our future performance.
CooperVision - We compete in the worldwide contact lens market with our spherical, toric and multifocal contact lenses offered in a variety of materials including using silicone hydrogel Aquaform® technology and phosphorylcholine technology (PC) Technology™. We believe that there will be lower contact lens wearer dropout rates as technology improves and enhances the wearing experience through a combination of improved designs and materials and the growth of preferred modalities such as single-use and monthly wearing options. CooperVision is focused on greater worldwide market penetration using recently introduced products, and we continue to expand our presence in existing and emerging markets, including through acquisitions.

24
THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Item 2. Management’s Discussion and Analysis of Financial Condition
and Results of Operations




CooperVision acquired the following entity during the three months ended January 31, 2019:

•
Blanchard Contact Lenses on December 28, 2018 - a privately-held scleral lens company, which expands CooperVision's specialty and scleral lens portfolio.
CooperVision acquired the following entities during the three months ended January 31, 2018:

•
Blueyes on January 4, 2018 - a long-standing distribution partner, which had a leading position in the distribution of contact lenses to the optical and pharmacy sector in Israel.

•
Paragon Vision Sciences on December 1, 2017 - a leading provider of orthokeratology (ortho-k) specialty contact lenses and oxygen permeable rigid contact lens materials.
Our ability to compete successfully with a full range of silicone hydrogel products is an important factor to achieving our desired future levels of sales growth and profitability. CooperVision manufactures and markets a wide variety of silicone hydrogel contact lenses within the daily, two-week and monthly modalities along with manufacturing some of these lenses as toric and/or multifocal lenses, including but not limited to Biofinity®, MyDay®, Avaira Vitality® and clariti®. Single-use lenses are designed for daily replacement and frequently replaced lenses are designed for two-week or monthly replacement. We expect increasing demand for clariti® 1day and MyDay® products, as well as future single-use products.
CooperSurgical - Our CooperSurgical business competes in the general health care market with a focus on advancing the health of women, babies and families through a diversified portfolio of products and services focusing on women's health, fertility, diagnostics and contraception. CooperSurgical has established its market presence and distribution system by developing products and acquiring companies, products and services that complement its business model.
CooperSurgical acquired the following entity during the three months ended January 31, 2019:

•
Incisive Surgical Inc. on December 31, 2018 - a privately-held U.S. medical device company that develops mechanical surgical solutions for skin closure.
CooperSurgical acquired the following entities during fiscal 2018:

•
LifeGlobal Group on April 3, 2018 - a privately held company that specializes primarily in IVF media. LifeGlobal’s product categories include media products, IVF laboratory air filtration products and dishware.

•
PARAGARD on November 1, 2017 - CooperSurgical acquired the assets of the PARAGARD IUD business from Teva for $1.1 billion. PARAGARD broadened and strengthened CooperSurgical's women's health product portfolio and it is the only non-hormonal, long lasting, reversible contraceptive option approved by the FDA and available in the United States. IUDs represent a large and growing segment of the Long Acting Reversible Contraceptive market.
We intend to continue investing in CooperSurgical's business with the goal of expanding our integrated solutions model within the areas of women's health, fertility, diagnostics and contraception.

Capital Resources - At January 31, 2019, we had $146.6 million in unrestricted cash, primarily held outside the United States, and $859.5 million available under our 2016 Revolving Credit Facility (as defined below). Term loans of $1,950.0 million remained outstanding at January 31, 2019.

On November 1, 2018, the Company entered into a 364-day, $400.0 million, senior unsecured term loan agreement by and among the Company, the lenders party thereto and PNC Bank, National Association, as administrative agent

25
THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Item 2. Management’s Discussion and Analysis of Financial Condition
and Results of Operations




which matures on October 31, 2019 (the 2018 Term Loan Agreement). The Company used the funds to partially repay outstanding borrowings under the 2016 Revolving Credit Facility. At January 31, 2019, we had $400.0 million outstanding under the 2018 Term Loan Agreement.
On November 1, 2017, we entered into a $1.425 billion syndicated Term Loan Agreement (the 2017 Term Loan Agreement) which matures on November 1, 2022, to fund the acquisition of PARAGARD, to partially repay outstanding amounts under the 2016 Revolving Credit Facility, and for general corporate purposes. At January 31, 2019, we had $1.425 billion outstanding under the 2017 Term Loan Agreement.
On March 1, 2016, we entered into a syndicated revolving Credit and Term Loan Agreement (the 2016 Credit Agreement). This agreement, maturing on March 1, 2021, provides for a multi-currency revolving credit facility in an aggregate principal amount of $1.0 billion (the 2016 Revolving Credit Facility) and a term loan facility in the aggregate principal amount of $830.0 million (the 2016 Term Loan Facility). At January 31, 2019, we had $125.0 million outstanding under the 2016 Term Loan Facility. See Note 6. Debt of the Consolidated Financial Statements for additional information.

The Company believes that current cash, cash equivalents and future cash flow from operating activities will be sufficient to meet the Company’s anticipated cash needs, including working capital needs, capital expenditures and contractual obligations for at least 12 months from the issuance date of the financial statements included in this quarterly report. To the extent additional funds are necessary to meet our liquidity needs such as that for acquisitions, share repurchases, cash dividends or other activities as we execute our business strategy, we anticipate that additional funds will be obtained through the incurrence of additional indebtedness, additional equity financings or a combination of these potential sources of funds; however, such financing may not be available on favorable terms, or at all.

Selected Statistical Information – Percentage of Net Sales
 
Percentage of Sales
 
2019 vs 2018 % Change in Absolute Values
Three Months Ended January 31,
2019
 
2018
 
Net sales
100
%
 
100
%
 
6
 %
Cost of sales
33
%
 
37
%
 
(4
)%
Gross profit
67
%
 
63
%
 
13
 %
Selling, general and administrative expense
40
%
 
38
%
 
11
 %
Research and development expense
3
%
 
3
%
 
11
 %
Amortization of intangibles
6
%
 
6
%
 
2
 %
Operating income
18
%
 
15
%
 
23
 %
Net Sales Growth by Business Unit
Three Months Ended January 31,
 
($ in millions)
2019
 
2018
 
Increase
2019 vs 2018 % Change
CooperVision
$
470.1

 
$
444.8

 
$
25.3

6
%
CooperSurgical
158.0

 
145.2

 
12.8

9
%
Net sales
$
628.1

 
$
590.0

 
$
38.1

6
%
CooperVision Net Sales
The contact lens market has two major product categories:
•
Spherical lenses including lenses that correct near- and farsightedness uncomplicated by more complex visual defects

26
THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Item 2. Management’s Discussion and Analysis of Financial Condition
and Results of Operations




•
Toric and multifocal lenses including lenses that, in addition to correcting near- and farsightedness, address more complex visual defects such as astigmatism and presbyopia by adding optical properties of cylinder and axis, which correct for irregularities in the shape of the cornea.
CooperVision Net Sales by Category
chart-3329bf5c849e51cc889.jpgchart-ca1d8d37f1b85322aaa.jpg
    
Three Months Ended January 31,
 
 
 
 
($ in millions)
 
2019
 
2018
 
2019 vs 2018 % Change
Toric
 
$
146.0

 
$
137.8

 
6
 %
Multifocal
 
49.1

 
46.9

 
5
 %
Single-use spheres
 
132.1

 
116.3

 
14
 %
Non single-use sphere, other
 
142.9

 
143.8

 
(1
)%
 
 
$
470.1

 
$
444.8

 
6
 %
In the three months ended January 31, 2019:
•
Toric and multifocal lenses grew primarily through the success of Biofinity, clariti and MyDay
•
Single-use sphere lenses growth was primarily attributed to clariti and MyDay lenses
•
Non-single-use spheres decline is primarily due to negative impact of foreign exchange rates offset by higher Biofinity sales.
•
"Other" products primarily include lens care which represent approximately 2% of net sales in first quarter of fiscal 2019 compared to 3% in prior year period
•
Increased sales of silicone hydrogel products were partially offset by lower sales of older hydrogel products. Total silicone hydrogel products grew 12% in first quarter of fiscal 2019, representing 71% of net sales compared to 67% in the prior year period.
•
Foreign exchange rates negatively impacted sales by $13.3 million in the first quarter of fiscal 2019, primarily attributable to the Euro and British Pound
•
Sales growth was primarily driven by increases in the volume of lenses sold. Average realized prices by product did not materially influence sales growth

27
THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Item 2. Management’s Discussion and Analysis of Financial Condition
and Results of Operations




CooperVision Net Sales by Geography

CooperVision competes in the worldwide soft contact lens market and services in three primary regions: the Americas, EMEA (Europe, Middle East and Africa) and Asia Pacific.
Three Months Ended January 31,


($ in millions)

2019

2018

2019 vs 2018 % Change
Americas

$
176.0


$
169.1


4
%
EMEA

184.3


177.9


4
%
Asia Pacific

109.8


97.8


12
%


$
470.1


$
444.8


6
%
CooperVision's regional growth was primarily attributable to market gains of silicone hydrogel contact lenses. Refer to CooperVision Net Sales by Category above for further discussion.
CooperSurgical Net Sales by Category
CooperSurgical supplies the family health care market with a diversified portfolio of products and services. Our office and surgical offerings include products that facilitate surgical and non-surgical procedures that are commonly performed primarily by obstetricians and gynecologists in hospitals, surgical centers, fertility clinics and medical offices. Fertility offerings include highly specialized products and services that target the IVF process, including diagnostics testing with a goal to make fertility treatment safer, more efficient and convenient.
The chart below shows the percentage of net sales of office and surgical procedures and fertility.
chart-ceb44c91116959d08de.jpgchart-be3681e339bd5b4a896.jpg
Three Months Ended January 31,
 
 
($ in millions)
 
2019
 
2018
 
2019 vs 2018 % Change
Office and surgical procedures
 
$
95.7

 
$
88.2

 
9
%
Fertility
 
$
62.3

 
$
57.0

 
9
%
 
 
$
158.0

 
$
145.2

 
9
%


28
THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Item 2. Management’s Discussion and Analysis of Financial Condition
and Results of Operations




In the three months ended January 31, 2019:
•
Office and surgical procedures increased compared to prior year periods due to continued growth in PARAGARD and surgical products, primarily Uterine Manipulators and recently acquired products of Incisive Surgical.
•
Fertility net sales increased compared to the prior year periods, primarily due to increased sales of IVF consumables, IVF equipment and LifeGlobal products, partially offset by a decrease in diagnostics revenue
•
Unit growth and product mix positively impacted sales growth
Gross Profit
Gross Profit Percentage of Net Sales
 
 
Three Months Ended January 31,
2019
 
2018
CooperVision
 
66
%
 
66
%
CooperSurgical
 
69
%
 
54
%
Consolidated
 
67
%
 
63
%
CooperVision's gross margin remained relatively flat in first quarter of fiscal 2019 compared to fiscal 2018 due to:
•
an increase in sales of higher margin products including Biofinity;
•
offset by the unfavorable impact to revenue from exchange rate fluctuations, primarily attributable to the Euro and British Pound; and product mix
CooperSurgical's increase in gross margin in first quarter of fiscal 2019 compared to fiscal 2018 was primarily due to:
•
an increase in sales of PARAGARD IUD product and inclusion of LifeGlobal products with higher gross margin;
•
partially offset by $4.2 million of acquisition, integration and manufacturing related costs.
•
First quarter of fiscal 2018 included $16.9 million of PARAGARD inventory step-up charges.

Selling, General and Administrative Expense (SGA)
Three Months Ended January 31,
($ in millions)
 
2019
 
% Net
Sales
 
2018
 
% Net
Sales
 
2019 vs 2018 % Change
CooperVision
 
$
168.7

 
36
%
 
$
157.9

 
36
%
 
7
 %
CooperSurgical
 
68.7

 
44
%
 
55.2

 
38
%
 
25
 %
Corporate
 
12.6

 
—

 
12.8

 
 -

 
(2
)%
 
 
$
250.0

 
40
%
 
$
225.9

 
38
%
 
11
 %
CooperVision's SGA increase in the first quarter of fiscal 2019 compared to fiscal 2018 was due to investments to support our long-term objectives, including increased headcount in SGA, investments in information technology and higher distribution expenses to support revenue growth. CooperVision's SGA in the three months ended January 31, 2019 included $2.4 million of integration and third-party consulting costs.
The increases in CooperSurgical's SGA in the first quarter of fiscal 2019 compared to fiscal 2018 in absolute dollars and as a percentage of sales were primarily due to higher PARAGARD marketing expenses and sales headcount investment to support growth. CooperSurgical's SGA in the three months ended January 31, 2019, included $8.4 million of primarily acquisition and integration expenses of acquired companies, as well as third-party consulting costs.
The Corporate SGA remained relatively flat in first quarter of fiscal 2019 compared to fiscal 2018.

29
THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Item 2. Management’s Discussion and Analysis of Financial Condition
and Results of Operations




Research and Development Expense (R&D)
Three Months Ended January 31,
($ in millions)
 
2019
 
% Net
Sales
 
2018
 
% Net
Sales
 
2019 vs 2018
% Change
CooperVision
 
$
13.5

 
3
%
 
$
12.2

 
3
%
 
10
%
CooperSurgical
 
7.5

 
5
%
 
6.6

 
5
%
 
11
%
 
 
$
21.0

 
3
%
 
$
18.8

 
3
%
 
11
%
In the three months ended January 31, 2019:
•
CooperVision's R&D increased mainly due to increased costs from acquisitions and clinical studies. As a percentage of sales, R&D expense remained flat. CooperVision's R&D activities are primarily focused on the development of contact lenses, manufacturing technology and process enhancements.
•
The increase in CooperSurgical's R&D were primarily due to acquisitions, increased investment and activities in developing new products and services and upgrades of existing products. As a percentage of sales, R&D expense remained flat. CooperSurgical's R&D activities include diagnostics, IVF product development and the design and upgrade of surgical procedure devices.
Amortization Expense
Three Months Ended January 31,
($ in millions)
2019
 
% Net
Sales
 
2018
 
% Net
Sales
 
2019 vs 2018
% Change
CooperVision
$
10.5

 
2
%
 
$
10.5

 
2
%
 
—
 %
CooperSurgical
26.1

 
17
%
 
25.5

 
18
%
 
3
 %
 
$
36.6

 
6
%
 
$
36.0

 
6
%
 
2
 %
CooperVision's amortization expense remained flat in first quarter of fiscal 2019 compared to fiscal 2018. CooperSurgical's increase in amortization expense in the first quarter of fiscal 2019 compared to fiscal 2018 was primarily due to amortization of intangible assets acquired in recent acquisitions.

Operating Income (Loss)
Three Months Ended January 31,
($ in millions)
 
2019
 
% Net
Sales
 
2018
 
% Net
Sales
 
2019 vs 2018
% Change
CooperVision
 
$
116.3

 
25
%
 
$
112.3

 
25
 %
 
4
%
CooperSurgical
 
7.2

 
5
%
 
(9.3
)
 
(6
)%
 
177
%
Corporate
 
(12.6
)
 
—

 
(12.8
)
 
 -

 
2
%
 
 
$
110.9

 
18
%
 
$
90.2

 
15
 %
 
23
%

CooperVision operating income remained flat as a percentage of net sales and increased in absolute dollars due to improved sales of higher margin products, including Biofinity, partially offset by the negative impact of foreign exchange rates. CooperSurgical operating income increased due to increase in sales including higher margin products and recent acquisitions. CooperSurgical operating income in the first quarter of fiscal 2018 included $16.9 million of PARAGARD inventory step up charges. On a consolidated basis, operating income increased in the first quarter of fiscal 2019 compared to fiscal 2018, in absolute dollars and as a percentage of net sales was primarily due to the increase in consolidated net sales.
Interest Expense
Three Months Ended January 31,
($ in millions)
2019
 
% Net
Sales
 
2018
 
% Net
Sales
 
2019 vs 2018
% Change
Interest expense
$
18.2

 
3
%
 
$
18.4

 
3
%
 
(1
)%

30
THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Item 2. Management’s Discussion and Analysis of Financial Condition
and Results of Operations




The decrease in interest expense was primarily due to lower average debt balances as a result of repayments, partially offset by higher interest rates.

Other Income, Net
Three Months Ended January 31,
 
 
($ in millions)
 
2019
 
2018
Foreign exchange gain
 
$
0.5

 
$
3.1

Other Income (loss), net
 
0.6

 
(0.1
)
 
 
$
1.1

 
$
3.0

Foreign exchange gain primarily resulted from the revaluation and settlement of foreign currencies-denominated balances.
Provision for Income Taxes
The Company's effective tax rates were a benefit of 10.0% and expense of 263.7% for the first quarters of fiscal 2019 and fiscal 2018, respectively. The decrease in our effective tax rate for the first quarter of fiscal 2019 compared to the first quarter of fiscal 2018 was primarily due to the provisional charge of $202.0 million relating to the 2017 Act that was recorded in the first quarter of fiscal 2018. Our effective tax rate for the first quarter of fiscal 2019 was lower than the U.S. statutory rate because of discrete tax benefits which were partially offset by a less favorable mix of income from our foreign jurisdictions with lower tax rates. Total discrete tax benefits for the first quarter of fiscal 2019 were $18.7 million primarily relating to settlement of tax audits, revisions to the provisional tax charges relating to the 2017 Act, and excess tax benefits from share-based compensation. Our effective tax rate for the first quarter of fiscal 2018 was higher than the U.S. statutory rate because of the discrete tax expense relating to the 2017 Act, which was partially offset by a favorable mix of income from our foreign jurisdictions with lower tax rates and an excess tax benefit from share-based compensation.
Share-Based Compensation Plans
Cooper has several share-based compensation plans that are described in our Annual Report on Form 10-K for the fiscal year ended October 31, 2018. The compensation expense and related income tax benefit recognized in our consolidated condensed financial statements for share-based awards were as follows:
Three Months Ended January 31,
 
 
($ in millions)
 
2019
 
2018
Selling, general and administrative expense
 
$
9.3

 
$
10.7

Cost of sales
 
1.5

 
1.3

Research and development expense
 
0.9

 
0.7

Total share-based compensation expense
 
$
11.7

 
$
12.7

Related income tax benefit
 
$
1.7

 
$
2.5


31
THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Item 2. Management’s Discussion and Analysis of Financial Condition
and Results of Operations





Capital Resources and Liquidity
First Quarter Highlights
•
Operating cash flow was $101.8 million compared to $26.2 million in the prior year period
•
Expenditures for purchases of property, plant and equipment were $79.2 million compared to $51.4 million in the prior year period
•
Cash payments for acquisitions and others, of $50.0 million, compared to $1,193.2 million in the prior year period
Comparative Statistics
($ in millions)
 
January 31, 2019
 
October 31, 2018
Cash and cash equivalents
 
$
146.6

 
$
77.7

Total assets
 
$
6,298.6

 
$
6,112.8

Working capital
 
$
254.4

 
$
554.4

Total debt
 
$
2,132.4

 
$
2,022.8

Stockholders' equity
 
$
3,425.5

 
$
3,307.8

Ratio of debt to equity
 
0.62:1

 
0.61:1

Debt as a percentage of total capitalization
 
38
%
 
38
%
Working Capital
The decrease in working capital at January 31, 2019 from the end of fiscal 2018 was primarily due to increase in short-term debt ($408.4 million), primarily from the $400 million 2018 Term Loan Agreement entered into on November 1, 2018. This was partially offset by increase in cash ($68.9 million), an increase accounts receivables ($15.0 million) from increased revenue, an increase in inventories ($17.4 million) and a decrease in accounts payable ($16.8 million).
At January 31, 2019, our inventory months on hand were 7.0 compared to 6.3 at October 31, 2018. The $17.4 million increase in inventories was primarily due to increase in finished goods and raw materials to support product launches and production levels. Our days sales outstanding (DSO) were 56 days at January 31, 2019, compared to 53 days at October 31, 2018 and 57 days at January 31, 2018. The increase in DSO was primarily due to higher accounts receivable from increased revenue.

Accounts Receivable Factoring Program - We may factor certain designated trade receivables with one or more third party financial institutions pursuant to a factoring agreement. These are non-recourse factoring arrangements to assist us in managing operating cash flow and meet the requirements to be accounted for as sales in accordance with the “Transfers and Servicing” guidance in ASC 860, where the Company’s continuing involvement subsequent to the transfer is limited to providing certain servicing and collection actions on behalf of the purchasers of the designated trade receivables. See Note 1. General of the Consolidated Financial Statements for additional information.

Operating Cash Flow

Cash provided by operating activities increased by $75.6 million from $26.2 million in the first quarter of fiscal 2018 to $101.8 million in the first quarter of fiscal 2019. This increase in cash flow provided by operating activities primarily consists of an increase in net income of $225.7 million from a net loss of $122.5 million in the first quarter of fiscal 2018 to $103.2 million in the first quarter of fiscal 2019 and an increase of $123.7 million in net cash flow from changes in operating capital, from $177.0 million in the first quarter of fiscal 2018 to $53.3 million in the first

32
THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Item 2. Management’s Discussion and Analysis of Financial Condition
and Results of Operations




quarter of fiscal 2019. This increase is partially offset by a decrease of $276.0 million in non-cash items, from $259.1 million in the first quarter of fiscal 2018 to $(16.9) million in the first quarter of fiscal 2019.

The increase in net income of $225.7 million is primarily due to a $202.0 million provisional tax expense charge related to the 2017 Act which unfavorably impacted the first quarter of fiscal 2018.

The $123.7 million increase in the net cash flow from changes in operating capital compared to the prior year period is due to a $93.3 million increase in the net changes in receivables from increased revenue, a $61.8 million increase in the net changes in prepayments and other assets due to a $42.0 million payment to the U.K. Tax Authorities in prior year period, and a $11.9 million increase in the net changes in accounts payable, partially offset by a $47.8 million decrease in net changes in accrued liabilities.

The $276.0 million decrease from non-cash items compared to the prior year period is due to a $16.8 million release of a fair value adjustment to inventory acquired mainly from PARAGARD in the prior year period and a decrease of $249.8 million driven by net changes in long term tax liabilities, deferred taxes and pension.

Investing Cash Flow

Cash used in investing activities decreased by $1,115.4 million to $129.2 million in the first quarter of fiscal 2019 from $1,244.6 million in first quarter of fiscal 2018. This is primarily due to a decrease in payments made for acquisitions in the first quarter of fiscal 2019 compared to the prior year period, largely due to the acquisition of PARAGARD at $1.1 billion in first quarter of fiscal 2018. The decrease is partially offset by an increase of $27.8 million in capital expenditures primarily used to invest in the expansion of our manufacturing capacity.

Financing Cash Flow

Cash provided by financing activities decreased by $1,124.2 million to $93.2 million in the first quarter of fiscal 2019. The decrease was driven by a $1,526 million decrease of net proceeds from long-term debt primarily due to additional debt taken on to fund the PARAGARD acquisition in prior year period. The decrease is partially offset by a $402.7 million increase in short-term notes payable, primarily due to $400 million short term loan taken on November 1, 2018. $6.1 million share repurchases were made in the first quarter of fiscal 2019 compared to nil in the first quarter of fiscal 2018.

The 2017 Term Loan Agreement contains customary restrictive covenants, as well as financial covenants that require the Company to maintain a certain Total Leverage Ratio and Interest Coverage Ratio (each as defined in the 2017 Term Loan Agreement) consistent with the 2016 Credit Agreement. As defined, in the 2018 Term Loan Agreement, the 2017 Term Loan Agreement and the 2016 Credit Agreement, we are required to maintain an Interest Coverage Ratio of at least 3.00 to 1.00, and a Total Leverage Ratio of no higher than 3.75 to 1.00.

At January 31, 2019, we had $859.5 million available under the 2016 Credit Agreement. We are in compliance with our financial covenants including the Interest Coverage Ratio at 10.70 to 1.00 and the Total Leverage Ratio at 2.25 to 1.00 for the 2018 Term Loan Agreement, the 2017 Term Loan Agreement and the 2016 Credit Agreement.

Share Repurchase

In December 2011, our Board of Directors authorized the 2012 Share Repurchase Program and through subsequent amendments, the most recent in March 2017, the total repurchase authorization was increased from $500.0 million to $1.0 billion of the Company's common stock. The program has no expiration date and may be discontinued at any time.


33
THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Item 2. Management’s Discussion and Analysis of Financial Condition
and Results of Operations




In the first quarter of fiscal 2019, we repurchased 24.5 thousand shares of our common stock for $6.1 million at an average purchase price of $248.70 per share. We did not repurchase shares during the first quarter of fiscal 2018. At January 31, 2019, we had remaining authorization to repurchase $557.4 million of our common stock.
Estimates and Critical Accounting Policies

Information regarding estimates and critical accounting policies is included in Management's Discussion and Analysis on Form 10-K for the fiscal year ended October 31, 2018. There have been no material changes in our policies from those previously discussed in our Form 10-K for the fiscal year October 31, 2018, with the exception of our critical accounting policies related to the adoption of ASU 2014-09, Revenue from Contracts with Customers (ASC 606) effective November 1, 2018. See Note 2. Revenue Recognition of the Consolidated Financial Statements for additional information.
Accounting Pronouncements
Information regarding new accounting pronouncements is included in Note 1. General of the Consolidated Financial Statements.
Trademarks

Aquaform®, Avaira®, Avaira Vitality®, Biofinity®, MyDay® and Proclear® are registered trademarks of The Cooper Companies, Inc., its affiliates and/or subsidiaries. PC Technology™, FIPS™, and A Quality of Life Company™ are trademarks of The Cooper Companies, Inc., its affiliates and/or subsidiaries. The clariti® mark is a registered trademark of The Cooper Companies, Inc., its affiliates and/or subsidiaries worldwide except in the United States where the use of clariti® is licensed. PARAGARD® is a registered trademark of CooperSurgical, Inc.

34
THE COOPER COMPANIES, INC. AND SUBSIDIARIES


Item 3. Quantitative and Qualitative Disclosure About Market Risk
Most of our operations outside the United States have their local currency as their functional currency. We are exposed to risks caused by changes in foreign exchange, principally our British pound sterling, euro, Japanese yen, Danish krone, Swedish krona and Australian dollar denominated debt and receivables denominated in currencies other than the United States dollar, and from operations in other foreign currencies. Although we may enter into foreign exchange agreements with financial institutions to reduce our exposure to fluctuations in foreign currency values relative to our debt or receivables obligations, these hedging transactions do not eliminate that risk entirely. We are also exposed to risks associated with changes in interest rates, as the interest rates on our revolving lines of credit and term loans may vary with the federal funds rate and LIBO rate. We may decrease this interest rate risk by hedging a portion of variable rate debt effectively converting it to fixed rate debt for varying periods. The Company did not have any derivative assets or liabilities that may include interest rate swaps, cross currency swaps or foreign currency forward contracts as of January 31, 2019 and October 31, 2018.

On November 1, 2018, the Company entered into a 364-day, $400.0 million, senior unsecured term loan agreement by and among the Company, the lenders party thereto and PNC Bank, National Association, as administrative agent which matures on October 31, 2019 (the 2018 Term Loan Agreement). The Company used the funds to partially repay outstanding borrowings under the 2016 Revolving Credit Facility. At January 31, 2019, we had $400.0 million outstanding under the 2018 Term Loan Agreement.

On November 1, 2017, in connection with the PARAGARD acquisition, we entered into a five-year, $1.425 billion, senior unsecured term loan agreement (the 2017 Term Loan Agreement) by and among the Company, the lenders party thereto and DNB Bank ASA, New York Branch, as administrative agent which matures on November 1, 2022. The Company used part of the facility to fund the PARAGARD acquisition and used the remainder of the funds to partially repay outstanding borrowings under our revolving credit agreement. At January 31, 2019, we had $1.425 billion outstanding under the 2017 Term Loan Agreement.

On March 1, 2016, we entered into a syndicated Revolving Credit and Term Loan Agreement (the 2016 Credit Agreement) with KeyBank as administrative agent. The agreement provides for a multicurrency revolving credit facility in an aggregate principal amount of $1.0 billion (the 2016 Revolving Credit Facility) and a term loan facility in the aggregate principal amount of $830.0 million (the 2016 Term Loan Facility). The 2016 Credit Agreement replaced our previous credit agreement and funds from the 2016 Term Loan Facility were used to repay the outstanding amounts under the previous credit agreement, to partially repay our other outstanding term loans and for general corporate purposes. At January 31, 2019, we had $125.0 million outstanding under the 2016 Term Loan Facility and $859.5 million available under the 2016 Revolving Credit Facility.
If interest rates were to increase or decrease by 1% or 100 basis points, quarterly interest expense would increase or decrease by approximately $5.3 million based on average debt outstanding for the first fiscal quarter of 2019.

See Note 6. Debt of the Consolidated Financial Statements for additional information.

35
THE COOPER COMPANIES, INC. AND SUBSIDIARIES


Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Based on management’s evaluation (with the participation of our Chief Executive Officer (our Principal Executive Officer) and Chief Financial Officer (our Principal Financial Officer)), as of the end of the period covered by this report, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, (the “Exchange Act”)) are effective to provide reasonable assurance that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms and is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

There has been no change in our internal control over financial reporting that occurred during our first quarter of fiscal 2019, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.




36
THE COOPER COMPANIES, INC. AND SUBSIDIARIES



PART II—OTHER INFORMATION
Item 1. Legal Proceedings

Since March 2015, over 50 putative class action complaints were filed by contact lens consumers alleging that contact lens manufacturers, in conjunction with their respective Unilateral Pricing Policy (UPP), conspired to reach agreements between each other and certain distributors and retailers regarding the prices at which certain contact lenses could be sold to consumers. The plaintiffs are seeking damages against CooperVision, Inc., other contact lens manufacturers, distributors and retailers, in various courts around the United States. In June 2015, all of the class action cases were consolidated and transferred to the United States District Court for the Middle District of Florida. In August 2017, CooperVision entered into a settlement agreement with the plaintiffs, without any admission of liability, to settle all claims against CooperVision. In July 2018, the Court approved the plaintiffs’ motion for preliminary approval of the settlement, and the Company paid the $3.0 million settlement amount into an escrow account. The settlement remains subject to final Court approval at a future hearing to be set by the Court.

The Company is involved in various lawsuits, claims and other legal matters from time to time that arise in the ordinary course of conducting business, including matters involving our products, intellectual property, supplier relationships, distributors, competitor relationships, employees and other matters. The Company does not believe that the ultimate resolution of these proceedings or claims pending against it could have a material adverse effect on its financial condition or results of operations. At each reporting period, the Company evaluates whether or not a potential loss amount or a potential range of loss is probable and reasonably estimable under Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) 450, Contingencies. Legal fees are expensed as incurred.

Item 1A. Risk Factors

Risk factors describing the major risks to our business can be found under Item 1A. Risk Factors in our Annual Report on Form 10-K for the fiscal year ended October 31, 2018. There have been no material changes in our risk factors from those previously discussed in our Form 10-K for the fiscal year October 31, 2018.









37
THE COOPER COMPANIES, INC. AND SUBSIDIARIES


Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Issuer Purchases of Equity Securities
The Company's share repurchase activity during the three-month period ended January 31, 2019, was as follows:
Period
 
Total Number
of Shares
Purchased
 
Average
Price Paid
Per Share
 
Total Number of
Shares Purchased
as Part of Publicly
Announced Plans
or Programs
 
Maximum Approximate
Dollar Value of Shares
that May Yet Be
Purchased Under
Publicly Announced
Plans or Programs
11/1/18 - 11/30/18
 
—

 
$
—

 
—

 
$
563,500,000

12/1/18 - 12/31/18
 
—

 
$
—

 
—

 
$
563,500,000

01/1/19 - 01/31/19
 
24,500

 
$
248.70

 
24,500

 
$
557,400,000

Total
 
24,500

 
$
248.70

 
24,500

 
 

The transactions described in the table above represent the repurchase of the Company’s common stock on the New York Stock Exchange as part of the share repurchase program approved by the Company’s Board of Directors in December 2011 (the 2012 Share Repurchase Program). The program as amended in December 2012, December 2013 and March 2017 provides authorization to repurchase up to a total of $1.0 billion of the Company's common stock. Purchases under the 2012 Share Repurchase Program may be made from time-to-time on the open market at prevailing market prices or in privately negotiated transactions and are subject to a review of the circumstances in place at the time and will be made from time to time as permitted by securities laws and other legal requirements. This program has no expiration date and may be discontinued at any time.
At January 31, 2019, approximately $557.4 million remained authorized under the 2012 Share Repurchase Program.

38
THE COOPER COMPANIES, INC. AND SUBSIDIARIES


Item 6. Exhibits
Exhibit
Number
Description
 
 
10.1
 
 
31.1
 
 
31.2
 
 
32.1
 
 
32.2
 
 
101.1
The following materials from the Company's Quarterly Report on Form 10-Q for the three months period ended January 31, 2019, formatted in Extensible Business Reporting Language (XBRL): (i) Consolidated Statements of Income for the three months ended January 31, 2019 and 2018, (ii) Consolidated Statements of Comprehensive Income (Loss) for the three months ended January 31, 2019 and 2018, (iii) Consolidated Condensed Balance Sheets at January 31, 2019 and October 31, 2018, (iv) Consolidated Condensed Statements of Cash Flows for the three months ended January 31, 2019 and 2018 and (v) related notes to consolidated condensed financial statements.




39
THE COOPER COMPANIES, INC. AND SUBSIDIARIES


SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
The Cooper Companies, Inc.
 
(Registrant)
 
 
Date: March 6, 2019
/s/ Brian G. Andrews
 
Brian G. Andrews
 
Senior Vice President, Chief Financial Officer & Treasurer
(Principal Financial Officer)

 
 
 
 
 
 
Date: March 6, 2019
/s/ Agostino Ricupati
 
Agostino Ricupati
 
Chief Accounting Officer & Senior Vice President, Finance & Tax (Principal Accounting Officer)


40
 EX-10.1 2 coo-ex101_2019x01x31x10q.htm EXHIBIT 10.1 Exhibit
Exhibit 10.1


 
JOINDER AND AMENDMENT NO. 1 TO REVOLVING CREDIT AND TERM LOAN AGREEMENT

This AMENDMENT NO. 1 TO REVOLVING CREDIT AND TERM LOAN AGREEMENT (this “Amendment”) is entered into as of January 31, 2019 among (i) THE COOPER COMPANIES, INC., a Delaware corporation (the “Company”), (ii) COOPERVISION INTERNATIONAL HOLDING COMPANY, LP, an entity organized under the laws of England and Wales and registered in Barbados as an External Company under the laws of Barbados (“CooperVision International”, and together with the Company, the “Existing Borrowers”), (iii) COOPERSURGICAL NETHERLANDS B.V., a Netherlands private company with limited liability (besloten vennootschap met beperkte aansprakelijkheid) (“Cooper Netherlands”), (iv) COOPERVISION MANUFACTURING COSTA RICA, S.R.L., a Costa Rican limited liability company (“Cooper Costa Rica”), (v) the Lenders (defined below) executing signatures page hereto, and (vi) KEYBANK NATIONAL ASSOCIATION, as the administrative agent (the “Administrative Agent”).

RECITALS:

A.    WHEREAS, the Existing Borrowers, the Administrative Agent and the lenders party thereto (each, a “Lender” and collectively, the “Lenders”) are parties to the Revolving Credit and Term Loan Agreement, dated as of March 1, 2016 (as amended, restated, amended and restated, supplemented or otherwise modified from time to time, the “Credit Agreement”);
B.    WHEREAS, the Existing Borrowers have requested that the Credit Agreement be modified to allow for additional Revolving Borrowers thereunder; and
C.    WHEREAS, in connection with the foregoing, the Borrowers, the Administrative Agent and the Lenders party hereto, which constitute the Required Lenders, desire to amend the Credit Agreement to modify certain provisions thereof.
AGREEMENT:

In consideration of the premises and mutual covenants herein and for other valuable consideration, the Borrowers, the Administrative Agent and the Lenders party hereto agree as follows:

NAI-1506002948v15


Section 1. Definitions. Unless otherwise defined herein, each capitalized term used in this Amendment and not defined herein shall be defined in accordance with the Credit Agreement.
Section 2.     Amendment to Section 1.01 of the Credit Agreement. Section 1.01 of the Credit Agreement is hereby amended to add the following new definitions thereto in appropriate alphabetical order:
“Additional Revolving Borrower” means any Revolving Borrower that becomes a Borrower hereunder on or after the Amendment No. 1 Effective Date pursuant to Section 2.21 hereof.
“Additional Revolving Borrower Joinder Agreement” means a joinder to this Agreement executed pursuant to Section 2.21 hereof in a form reasonably acceptable to the Administrative Agent and executed by the Administrative Agent, the Company and the Additional Revolving Borrower(s) becoming a party to this Agreement.
“Amendment No. 1” means Joinder and Amendment No. 1 to Revolving Credit and Term Loan Agreement among the Borrowers, the Administrative Agent and the Lenders party thereto dated as of the Amendment No. 1 Effective Date.
“Amendment No. 1 Effective Date” means January 31, 2019.
“Beneficial Ownership Certification” means a certification regarding beneficial ownership as required by the Beneficial Ownership Regulation.
“Beneficial Ownership Regulation” means 31 C.F.R. § 1010.230.
“Cooper Costa Rica” means CooperVision Manufacturing Costa Rica, S.R.L., a Costa Rican limited liability company.
“Cooper Netherlands” means CooperSurgical Netherlands B.V., a Netherlands private company with limited liability (besloten vennootschap met beperkte aansprakelijkheid).
Section 3.     Amendment to Section 1.01 of the Credit Agreement. Section 1.01 of the Credit Agreement is hereby amended to amend and restate the definition of “Revolving Borrowers” in its entirety as follows:
“Revolving Borrowers” means, collectively, (a) the Company, (b) CooperVision International, (c) Cooper Netherlands, (d) Cooper Costa Rica and (e) any other Additional Revolving Borrower, and “Revolving Borrower” means each of them individually.
Section 4.     Amendment to Article I of the Credit Agreement. Article I of the Credit Agreement is hereby amended to add the following new Section 1.06 immediately following Section 1.05 thereof:
Section 1.06    Dutch Terms. In this Agreement, where it relates to an entity incorporated in the Netherlands, a reference to:

NAI-1506002948v15


(i) a “director” means a managing director (bestuurder) and “board of directors” means its managing board (bestuur);
(ii) an “action to authorize” or “duly authorized”, where applicable, includes without limitation any action required to comply with the Dutch Works Council Act (Wet op de ondernemingsraden);
(iii) any “proceeding under any bankruptcy or insolvency law”, “bankruptcy”, “insolvency”, or “dissolution” includes a Dutch entity being declared bankrupt (failliet verklaard) or dissolved (ontbonden);
(iv) “bankruptcy, insolvency, receivership or similar proceeding” or “liquidation proceeding” (or words of similar import) includes an application for moratorium (surseance van betaling) and the appointment of a receiver, liquidator, custodian, trustee includes the appointment of an administrator and that a moratorium has been granted (surseance verleend);
(v) any procedure or step taken in connection with an insolvency proceeding includes such Dutch entity having filed a notice under Section 36 of the Tax Collection Act of the Netherlands (Invorderingswet 1990) or Section 60 of the Social Insurance Financing Act of the Netherlands (Wet Financiering Sociale Verzekeringen) in conjunction with Section 36 of the Tax Collection Act of the Netherlands (Invorderingswet 1990);
(vi) a “trustee” in any bankruptcy or insolvency proceeding includes a curator;
(vii) an “administrator” includes a bewindvoerder;
(viii) an “attachment” includes a beslag;
(ix) “gross negligence” means grove schuld;
(x) “indemnify” means vrijwaren;
(xi) “negligence” means schuld;
(xii) “bad faith” means kwade trouw; and
(xiii) “willful misconduct” means opzet.
Section 5.     Amendment to Section 2.02(b) of the Credit Agreement. Section 2.02(b) of the Credit Agreement is hereby amended by deleting the last sentence of such Section and replacing it with the following:
Each Lender at its option may make any Loan by causing any domestic or foreign branch or Affiliate of such Lender to make such Loan; provided that any exercise of such option shall not affect the obligation of the applicable Borrower to repay such Loan in accordance with the terms of this Agreement.
Section 6.     Addition of Section 2.21 to the Credit Agreement. Article II of the Credit Agreement is hereby amended to add the following new Section 2.21 thereto immediately following Section 2.20 of the Credit Agreement:

NAI-1506002948v15


Section 2.21    Designation of Additional Revolving Borrowers.
(a)    Designation. Subject to the terms and conditions of this Section 2.21, the Company may, at any time or from time to time on or after the Amendment No. 1 Effective Date, upon not less than 5 Business Days’ notice (or such shorter period which is reasonably acceptable to the Administrative Agent) to the Administrative Agent (which shall promptly notify the Lenders thereof), request the designation of a wholly-owned Subsidiary as an Additional Revolving Borrower hereunder, provided that subject to the satisfaction of the applicable conditions precedent set forth in Amendment No. 1, Cooper Netherlands and Cooper Costa Rica have each been designated as an Additional Revolving Borrower as of the Amendment No. 1 Effective Date. Each such notice shall specify (A) the name of the applicable Subsidiary and (B) its jurisdiction of organization.
(b)    Effect of Designation. Upon the satisfaction of the conditions specified in paragraph ‎(c) of this Section 2.21, the applicable designated Additional Revolving Borrower shall become a party to this Agreement as a Revolving Borrower and a Borrower hereunder and, subject to the terms and conditions of this Agreement, such Additional Revolving Borrower shall be entitled to borrow Revolving Loans or request the issuance of Letters of Credit hereunder (and, in each case, such Additional Revolving Borrower shall have and shall assume all of the obligations of a Borrower hereunder). The Administrative Agent shall promptly notify the Lenders of the effectiveness of any such designation.
(c)    Conditions to Designation. The designation by the Company of any Subsidiary as an Additional Revolving Borrower hereunder shall be subject to the satisfaction of the following conditions (including delivery to the Administrative Agent of the following documents, each of which shall be reasonably satisfactory to the Administrative Agent in form and substance or may be waived by the Administrative Agent in its sole discretion) and such designation shall become effective on the date on which all such conditions are satisfied (or so waived):
(A)
immediately prior to and after giving effect to such designation, no Default shall have occurred and be continuing;
(B)
in the case of Cooper Netherlands and Cooper Costa Rica, each Existing Borrower and each such Additional Revolving Borrower shall have executed Amendment No. 1 and in the case of any Additional Revolving Borrower becoming a party hereto after the Amendment No. 1 Effective Date, the Administrative Agent shall have received an Additional Revolving Borrower Joinder Agreement, duly completed and executed by the Company, such Additional Revolving Borrower and the Administrative Agent;
(D)
the Administrative Agent shall have received a certificate of an Authorized Officer of the Company to the effect that the conditions to such designation set forth in this Section 2.21 shall be satisfied;
(E)
the Administrative Agent shall have received such proof of corporate or other action, incumbency of officers, legal opinion and other documents as are consistent with those delivered by the Borrowers pursuant to ‎Section 4.01 on the Closing Date as the Administrative Agent shall reasonably request, all in form, content and scope substantially consistent with those delivered by the Borrowers on the Closing Date; and

NAI-1506002948v15


(F)
to the extent requested by the Administrative Agent or any Lender at least three (3) Business Days in advance of the effectiveness of such designation, the Administrative Agent or such Lender shall have received all documentation and other information with respect to such Subsidiary required by regulatory authorities under applicable Sanctions Laws and Regulations or the Beneficial Ownership Regulation.
(d)    Inability to Lend. If (a) by reason of the fact that any Additional Revolving Borrower is organized in, or conducts business in, a jurisdiction outside the United States (including, for purposes of this Section 2.21(d), Puerto Rico) (other than the Netherlands or Costa Rica), it is unlawful, in the sole determination of any Lender, for such Lender (or its applicable lending office) to make or maintain Loans to such Additional Revolving Borrower or (b) on or after the date hereof, it becomes unlawful for any Lender (or its applicable lending office) to perform any of its obligations as contemplated by this Agreement or make, maintain or fund any of its Loans to any Additional Revolving Borrower, and such Lender shall so notify the Administrative Agent, the Administrative Agent shall forthwith give notice thereof to the other Lenders and the Company, whereupon until such Lender notifies the Company and the Administrative Agent that the circumstances giving rise to such suspension no longer exist, the obligation of such Lender to make or maintain Loans to such Additional Revolving Borrower shall be suspended.
Section 7.     Amendment to Section 5.02 of the Credit Agreement. Section 5.02 of the Credit Agreement is hereby amended by (i) deleting the “and” at the end of clause (c) thereof, (ii) deleting the “.” at the end of clause (d) thereof and replacing it with “; and”, and (iii) adding the following new clause (e) immediately following clause (d) thereof:
(e)    solely to the extent that any Borrower qualifies as a “legal entity customer” under the Beneficial Ownership Regulation, any change in the information provided in any Beneficial Ownership Certification that would result in a change to the list of beneficial owners identified in parts (c) or (d) of such certification.
Section 8.     Amendment to Section 6.02 of the Credit Agreement. Section 6.02(a) of the Credit Agreement is hereby amended by deleting each reference to “CooperVision International” and replacing it with “any Borrower”.
Section 9.     Amendment to Section 9.01 of the Credit Agreement. Section 9.01 of the Credit Agreement is hereby amended by deleting each reference to “CooperVision International” and replacing it with “any Borrower (other than the Company)”.
Section 10.     Amendment to Section 10.18 of the Credit Agreement. Section 10.18 of the Credit Agreement is hereby amended and restated in its entirety to read as follows:
Section 10.18    Several Liability of CooperVision International and Additional Revolving Borrowers. Notwithstanding anything in this Agreement or any other Loan Document to the contrary, the Obligations of (x) CooperVision International hereunder and (y) each Additional Revolving Borrower, in each case, shall be several (and not joint) and each of CooperVision International and each Additional Revolving Borrower shall only be liable for any Loans and any other Obligations incurred directly by it and shall not be liable for any of the Obligations of the Company or any other Loan Party hereunder. The foregoing shall not in any way limit the guaranty obligations of the Company pursuant to Article IX hereof or the guaranty obligations of any Subsidiary Guarantor under the Subsidiary Guaranty.

NAI-1506002948v15


Section 11.     Joinder. Subject to the effectiveness of this Amendment pursuant to Section 12 of this Amendment and the satisfaction of the conditions precedent set forth in Section 13 of this Amendment, each of Cooper Netherlands and Cooper Costa Rica hereby acknowledges, agrees and confirms that, by its execution of this Amendment, it shall become an Additional Revolving Borrower under the Credit Agreement in accordance with Section 2.21 of the Credit Agreement (as amended by this Amendment) and shall be fully bound by, and subject to, all of the covenants, terms, obligations (including, without limitation, all payment obligations) and conditions of the Credit Agreement applicable to a “Revolving Borrower,” “Borrower,” or a “Loan Party” as though originally party thereto as a “Revolving Borrower,” “Borrower” and a “Loan Party”, and each of Cooper Netherlands and Cooper Costa Rica shall be deemed a “Revolving Borrower,” a “Borrower” and a “Loan Party” for all purposes of the Credit Agreement and the other Loan Documents from and after the date hereof. By its signature below, each Existing Borrower and each Subsidiary Guarantor, each Lender party hereto and the Administrative Agent hereby agree and consent to each of Cooper Netherlands and Cooper Costa Rica becoming bound by, and subject to, the terms and conditions of the Credit Agreement as provided herein, and agree and acknowledge that each of Cooper Netherlands and Cooper Costa Rica shall be subject to the terms and conditions of the Credit Agreement provided therein, in each case as fully and the same as if Cooper Netherlands and Cooper Costa Rica were originally party thereto as a “Revolving Borrower,” “Borrower” and a “Loan Party”. Each of Cooper Netherlands and Cooper Costa Rica acknowledges and confirms that it has received a copy of the Credit Agreement, this Amendment, the other Loan Documents and all exhibits, annexes and schedules thereto and has reviewed and understands all of the terms and provisions thereof.

NAI-1506002948v15


Section 12.     Effectiveness of Amendment. This Amendment shall be effective on the date upon which each of the following conditions precedent has been satisfied (the “Effective Date”):
(a)    This Amendment shall have been executed by the Existing Borrowers, Cooper Netherlands, Cooper Costa Rica, each Subsidiary Guarantor, the Administrative Agent and the Required Lenders, and counterparts hereof as so executed shall have been delivered to the Administrative Agent.
(b)    The Administrative Agent shall have received all documented out-of-pocket expenses (including reasonable fees and disbursements of counsel to the Administrative Agent, to the extent invoiced on or prior to the Effective Date) in connection with the preparation, negotiation and effectiveness of this Amendment and the other documents being executed or delivered in connection herewith.
For all purposes of this Amendment, the modifications set forth in Sections 2 through 10 of this Amendment shall be deemed effective on the Effective Date upon satisfaction of the foregoing conditions precedent and shall be deemed effective immediately prior to the joinders contemplated pursuant to Section 11 of this Amendment.
Section 13.     Effectiveness of Joinder. The joinder of Cooper Netherlands and Cooper Costa Rica as Additional Revolving Borrowers pursuant to Section 11 of this Amendment shall be effective on the date upon which each of the following conditions precedent has been satisfied:
(a)    The conditions precedent set forth in Section 12 of this Amendment shall have been satisfied.
(b)    The Administrative Agent (or its counsel) shall have received from each of Cooper Netherlands and Cooper Costa Rica duly executed Notes in favor of each Lender requesting a Note at least three (3) Business Days prior to the Effective Date.
(c)    The Administrative Agent shall have received (i) a certificate of each of Cooper Netherlands and Cooper Costa Rica, dated the Effective Date and executed by its Secretary, Assistant Secretary, appointed Manager, or other authorized signatory, as applicable, which shall (A) certify the resolutions of its Board of Directors, members or other governing body authorizing the execution, delivery and performance of this Amendment, (B) identify by name and title and bear the signatures of the officers authorized to sign this Amendment and any other Loan Document, (C) contain appropriate attachments, including the certificate or articles of incorporation or organization certified by the relevant authority of the jurisdiction of organization and a true and correct copy of its by‑laws or operating, management or partnership agreement, or other organizational or governing documents and (D) for Cooper Netherlands, attach and certify as true and correct and in full force and effect: (a) its deed of incorporation (oprichtingsakte) and if amended after incorporation, its articles of association (statuten), (b) an up-to-date certified (gewaarmerkt) extract of the Dutch Chamber of Commerce (Kamer van Koophandel) dated no later than 3 Business Days prior to the Effective Date, and (c) if required by applicable law or its articles of association: a copy of a signed, unconditional and positive advice from each relevant works council (ondernemingsraad) or central or European works council of Cooper Netherlands approving the terms of, and the transactions contemplated by, this Agreement and the Loan Documents to which Cooper Netherlands will become party, together with the signed request for advice, and (ii) a good standing certificate for Cooper Costa Rica as of a recent date from its jurisdiction of organization or the substantive equivalent available in its jurisdiction of organization from the appropriate governmental officer in such jurisdiction.

NAI-1506002948v15


(d)    The Administrative Agent shall have received a favorable written opinion (addressed to the Administrative Agent and the Lenders and dated the Effective Date) of (a) Latham & Watkins LLP, counsel for the Borrowers and the other Loan Parties, and (b) applicable local counsel for each of Cooper Netherlands and Cooper Costa Rica, in each case, in form and substance reasonably acceptable to the Administrative Agent. The Borrowers hereby request each such counsel to deliver such opinion.
(e)    The Administrative Agent shall have received a properly completed and signed IRS Form W-8 or W-9, as applicable, for each of Cooper Netherlands and Cooper Costa Rica.
(f)    The Administrative Agent and the Lenders shall have received all documentation and other information required by bank regulatory authorities under applicable “know your customer” and anti-money laundering rules and regulations, including the USA PATRIOT Act, for each of Cooper Netherlands and Cooper Costa Rica and, if any Loan Party qualifies as a “legal entity customer” under the Beneficial Ownership Regulation, a Beneficial Ownership Certification in relation to such entity, all to the extent requested at least three (3) Business Days prior to the Effective Date.
Section 14.     Representations and Warranties. Each Borrower (which shall include each of Cooper Netherlands and Cooper Costa Rica) and each Subsidiary Guarantor, by signing below, hereby represents and warrants to the Administrative Agent and the Lenders that:
(a)    each Borrower and each Subsidiary Guarantor has the legal power and authority to execute and deliver this Amendment;
(b)    the officers executing this Amendment on behalf of each Borrower and each Subsidiary Guarantor have been duly authorized to execute and deliver the same and bind such Borrower or such Subsidiary Guarantor with respect to the provisions hereof;
(c)    no Default or Event of Default exists under the Credit Agreement, nor will any occur immediately after the execution and delivery of this Amendment;
(d)    this Amendment constitutes the legal, valid and binding agreement and obligation of the Borrowers and each Subsidiary Guarantor, enforceable in accordance with its terms, except to the extent that the enforceability thereof may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or other similar laws generally affecting creditors’ rights and by equitable principles (regardless of whether enforcement is sought in equity or at law);
(e)    the information included in each Beneficial Ownership Certification provided by the Borrowers is true and correct in all respects; and
(f)    each of the representations and warranties set forth in Article III of the Credit Agreement is true and correct in all material respects as of the date hereof, except to the extent that any thereof expressly relate to an earlier date, in which case such representations and warranties shall have been true and correct in all material respects as of the date when made.
Section 15.     Credit Agreement Unaffected. Each reference to the Credit Agreement in any Loan Document shall hereafter be construed as a reference to the Credit Agreement as amended hereby. Except as herein otherwise specifically provided, all provisions of the Credit Agreement shall remain in full force and effect and be unaffected hereby. This Amendment shall be a Loan Document.

NAI-1506002948v15


Section 16.     Subsidiary Guarantor Acknowledgment. Each Subsidiary Guarantor, by signing this Amendment:
(a)    consents and agrees to and acknowledges the terms of this Amendment;
(b)    acknowledges and agrees that all of the Loan Documents to which such Subsidiary Guarantor is a party or is otherwise bound shall continue in full force and effect and that all of such Subsidiary Guarantor’s obligations thereunder shall be valid and enforceable and shall not be impaired or limited by the execution or effectiveness of this Amendment; and
(c)    acknowledges and agrees that (i) notwithstanding the conditions to effectiveness set forth in this Amendment, such Subsidiary Guarantor is not required by the terms of the Credit Agreement or any other Loan Document to which such Subsidiary Guarantor is a party to consent to the amendments to the Credit Agreement effected pursuant to this Amendment and (ii) nothing in the Credit Agreement, this Amendment or any other Loan Document shall be deemed to require the consent of such Subsidiary Guarantor to any future amendments or modifications to the Credit Agreement.
Section 17.     Entire Agreement. This Amendment, together with the Credit Agreement and the other Loan Documents, integrates all the terms and conditions mentioned herein or incidental hereto and supersedes all oral representations and negotiations and prior writings with respect to the subject matter hereof.
Section 18.     Counterparts. This Amendment may be executed in any number of counterparts, by different parties hereto in separate counterparts and by facsimile signature, each of which when so executed and delivered shall be deemed to be an original and all of which taken together shall constitute but one and the same agreement.
Section 19.     Governing Law. THIS AMENDMENT AND THE OTHER LOAN DOCUMENTS AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES HEREUNDER AND THEREUNDER SHALL BE CONSTRUED IN ACCORDANCE WITH AND BE GOVERNED BY THE LAW OF THE STATE OF NEW YORK. TO THE FULLEST EXTENT PERMITTED BY LAW, THE BORROWERS HEREBY UNCONDITIONALLY AND IRREVOCABLY WAIVE ANY CLAIM TO ASSERT THAT THE LAW OF ANY JURISDICTION OTHER THAN THE STATE OF NEW YORK GOVERNS THIS AMENDMENT OR ANY OF THE OTHER LOAN DOCUMENTS.
Section 20.     Jurisdiction. EACH BORROWER HEREBY IRREVOCABLY AND UNCONDITIONALLY SUBMITS, FOR ITSELF AND ITS PROPERTY, TO THE EXCLUSIVE JURISDICTION OF THE SUPREME COURT OF THE STATE OF NEW YORK SITTING IN NEW YORK COUNTY, BOROUGH OF MANHATTAN, AND OF THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF NEW YORK, AND ANY APPELLATE COURT FROM ANY THEREOF, IN ANY ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS AMENDMENT OR ANY OTHER LOAN DOCUMENT, OR FOR RECOGNITION OR ENFORCEMENT OF ANY JUDGMENT, AND EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY AND UNCONDITIONALLY AGREES THAT ALL CLAIMS IN RESPECT OF ANY SUCH ACTION OR PROCEEDING MAY BE HEARD AND DETERMINED IN SUCH NEW YORK STATE OR, TO THE EXTENT PERMITTED BY LAW, IN SUCH FEDERAL COURT. EACH OF THE PARTIES HERETO AGREES THAT A FINAL JUDGMENT IN ANY SUCH ACTION OR PROCEEDING SHALL BE CONCLUSIVE AND MAY BE ENFORCED IN OTHER JURISDICTIONS BY SUIT ON THE JUDGMENT OR IN ANY OTHER MANNER PROVIDED BY LAW. NOTHING IN THIS AMENDMENT

NAI-1506002948v15


SHALL AFFECT ANY RIGHT THAT THE ADMINISTRATIVE AGENT, THE ISSUING BANK OR ANY LENDER MAY OTHERWISE HAVE TO BRING ANY ACTION OR PROCEEDING RELATING TO THIS AMENDMENT OR ANY OF THE OTHER LOAN DOCUMENTS AGAINST ANY BORROWER OR ITS PROPERTIES IN THE COURTS OF ANY JURISDICTION.
Section 21.     JURY TRIAL WAIVER. EACH OF THE PARTIES TO THIS AMENDMENT HEREBY IRREVOCABLY WAIVES ALL RIGHT TO A TRIAL BY JURY IN ANY ACTION, PROCEEDING OR COUNTERCLAIM ARISING OUT OF OR RELATING TO THIS AMENDMENT OR ANY OF THE OTHER LOAN DOCUMENTS (INCLUDING, WITHOUT LIMITATION, ANY AMENDMENTS, WAIVERS OR OTHER MODIFICATIONS RELATING TO ANY OF THE FOREGOING), OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY.
[Signature pages follow.]


NAI-1506002948v15




IN WITNESS WHEREOF, this Amendment has been duly executed and delivered as of the date first above written.

 
 
THE COOPER COMPANIES, INC., as an Existing Borrower 

 
By:___________/s/ Randal L. Golden_____________
      Name: Randal L. Golden      
      Title: Vice President, General Counsel & Secretary


COOPERVISION INTERNATIONAL HOLDING COMPANY, LP, as an Existing Borrower

By: COOPER HOLDING COMPANY LLC
as General Partner 

 
By:___________/s/ Randal L. Golden____________
     Name: Randal L. Golden   
     Title: Manager


COOPERSURGICAL NETHERLANDS B.V., as an Additional Revolving Borrower 

 
By:___________/s/ Randal L. Golden_____________
      Name: Randal L. Golden      
      Title: Managing Director B
   

COOPERVISION MANUFACTURING COSTA RICA, S.R.L., as an Additional Revolving Borrower 

 
By:___________/s/ Randal L. Golden_____________
      Name: Randal L. Golden   
      Title: Manager







NAI-1506002948



IN WITNESS WHEREOF, this Amendment has been duly executed and delivered as of the date first above written.

    
 
 
 
 
THE COOPER COMPANIES, INC., as an Existing Borrower

 
By:______________________________________
      Name: Randal L. Golden
      Title: Vice President, General Counsel & Secretary


COOPERVISION INTERNATIONAL HOLDING COMPANY, LP, as an Existing Borrower

By: COOPER HOLDING COMPANY LLC
as General Partner

 
By:______________________________________
     Name: Randal L. Golden
     Title: Manager


COOPERSURGICAL NETHERLANDS B.V., as an Additional Revolving Borrower

 
By:_____/s/ E.J.F. Langemeijer__/s/ AMC van Zuilen
      Name: E.J.F. Langemeijer AMC van Zuilen
      Title: Director A
   

COOPERVISION MANUFACTURING COSTA RICA, S.R.L., as an Additional Revolving Borrower

 
By:______________________________________
      Name: Randal L. Golden
      Title: Manager



NAI-1506002948



 
 
 
   
 
 
 
KEYBANK NATIONAL ASSOCIATION,
   as the Administrative Agent and a Lender

By:_____/s/ Marianne T. Meil ________________
Name: Marianne T. Meil
Title: Senior Vice President


NAI-1506002948


Each of the undersigned Subsidiary
Guarantors acknowledges the terms of and
consents to the foregoing:


COOPERVISION, INC.

By:______/s/ Randal L. Golden_____________
Name: Randal L. Golden    
Title: Vice President, General Counsel & Secretary


COOPERSURGICAL, INC.

By:______/s/ Randal L. Golden_____________
Name: Randal L. Golden    
Title: Vice President, General Counsel & Secretary


COOPER MEDICAL, INC.

By:______/s/ Randal L. Golden_____________
Name: Randal L. Golden    
Title: Vice President, General Counsel & Secretary

ORIGIO, INC.

By:______/s/ Randal L. Golden_____________
Name: Randal L. Golden    
Title: Vice President, General Counsel & Secretary




NAI-1506002948


Signature Page to
Joinder and Amendment No. 1 to Revolving Credit and Term Loan Agreement,
dated as of the date first above written,
among The Cooper Companies, Inc. and CooperVision International Holding Company, LP,
as the Existing Borrowers,
CooperSurgical Netherlands B.V. and CooperVision Manufacturing Costa Rica, S.R.L.,
as the Joining Borrowers
KeyBank National Association, as the Administrative Agent,
and the Lenders party thereto


Name of Institution:
Bank of America, N.A.


By: :_______/s/ Sebastian Lurie___________
   Name: Sebastian Lurie
   Title: SVP







NAI-1506002948



Signature Page to
Joinder and Amendment No. 1 to Revolving Credit and Term Loan Agreement,
dated as of the date first above written,
among The Cooper Companies, Inc. and CooperVision International Holding Company, LP,
as the Existing Borrowers,
CooperSurgical Netherlands B.V. and CooperVision Manufacturing Costa Rica, S.R.L.,
as the Joining Borrowers
KeyBank National Association, as the Administrative Agent,
and the Lenders party thereto


Name of Institution:
Bank of the West


By: :_______/s/ Adriana Collins ___________
   Name: Adriana Collins
   Title: Director










NAI-1506002948



Signature Page to
Joinder and Amendment No. 1 to Revolving Credit and Term Loan Agreement,
dated as of the date first above written,
among The Cooper Companies, Inc. and CooperVision International Holding Company, LP,
as the Existing Borrowers,
CooperSurgical Netherlands B.V. and CooperVision Manufacturing Costa Rica, S.R.L.,
as the Joining Borrowers
KeyBank National Association, as the Administrative Agent,
and the Lenders party thereto


Name of Institution:
Branch Banking and Trust Company,


By:_______/s/ Erron Powers___________
   Name: Erron Powers
   Title: Senior Vice President






NAI-1506002948



Signature Page to
Joinder and Amendment No. 1 to Revolving Credit and Term Loan Agreement,
dated as of the date first above written,
among The Cooper Companies, Inc. and CooperVision International Holding Company, LP,
as the Existing Borrowers,
CooperSurgical Netherlands B.V. and CooperVision Manufacturing Costa Rica, S.R.L.,
as the Joining Borrowers
KeyBank National Association, as the Administrative Agent,
and the Lenders party thereto


Name of Institution:
CITIBANK, N.A.


By:_______/s/ Eugene Yermash ___________
   Name: Eugene Yermash
   Title: Vice President

 
 





NAI-1506002948



Signature Page to
Joinder and Amendment No. 1 to Revolving Credit and Term Loan Agreement,
dated as of the date first above written,
among The Cooper Companies, Inc. and CooperVision International Holding Company, LP,
as the Existing Borrowers,
CooperSurgical Netherlands B.V. and CooperVision Manufacturing Costa Rica, S.R.L.,
as the Joining Borrowers
KeyBank National Association, as the Administrative Agent,
and the Lenders party thereto


Name of Institution:
Citizens Bank, N.A.


By:_______/s/ Mark Guyeski ___________
   Name: Mark Guyeski
   Title: Vice President






NAI-1506002948



Signature Page to
Joinder and Amendment No. 1 to Revolving Credit and Term Loan Agreement,
dated as of the date first above written,
among The Cooper Companies, Inc. and CooperVision International Holding Company, LP,
as the Existing Borrowers,
CooperSurgical Netherlands B.V. and CooperVision Manufacturing Costa Rica, S.R.L.,
as the Joining Borrowers
KeyBank National Association, as the Administrative Agent,
and the Lenders party thereto


Name of Institution:
DNB Capital LLC


By: /s/ Kristie Li /s/ Kristi Birkeland Sorensen   
   Name: Kristie Li Kristi Birkeland Sorensen
   Title: Senior Vice Senior Vice
President President
Head of Corporate 
                                                                   Banking

 
 


NAI-1506002948



Signature Page to
Joinder and Amendment No. 1 to Revolving Credit and Term Loan Agreement,
dated as of the date first above written,
among The Cooper Companies, Inc. and CooperVision International Holding Company, LP,
as the Existing Borrowers,
CooperSurgical Netherlands B.V. and CooperVision Manufacturing Costa Rica, S.R.L.,
as the Joining Borrowers
KeyBank National Association, as the Administrative Agent,
and the Lenders party thereto


Name of Institution:
JPMorgan Chase, N.A.


By:_______/s/ Lynn Braun__________
   Name: Lynn Braun
   Title: Executive Director







NAI-1506002948



Signature Page to
Joinder and Amendment No. 1 to Revolving Credit and Term Loan Agreement,
dated as of the date first above written,
among The Cooper Companies, Inc. and CooperVision International Holding Company, LP,
as the Existing Borrowers,
CooperSurgical Netherlands B.V. and CooperVision Manufacturing Costa Rica, S.R.L.,
as the Joining Borrowers
KeyBank National Association, as the Administrative Agent,
and the Lenders party thereto


Name of Institution:
KBC Bank N.V., New York Branch


By:_______/s/ Nicholas Fiore___________
   Name: Nicholas Fiore
   Title: Director



By:_______/s/ Susan M. Silver___________
   Name: Susan M. Silver
   Title: Managing Director










NAI-1506002948



Signature Page to
Joinder and Amendment No. 1 to Revolving Credit and Term Loan Agreement,
dated as of the date first above written,
among The Cooper Companies, Inc. and CooperVision International Holding Company, LP,
as the Existing Borrowers,
CooperSurgical Netherlands B.V. and CooperVision Manufacturing Costa Rica, S.R.L.,
as the Joining Borrowers
KeyBank National Association, as the Administrative Agent,
and the Lenders party thereto


Name of Institution:
Lloyds Bank Corporate Markets plc


By: /s/ Enn Walsh   
   Name: Enn Walsh
   Title: Assistant Vice President
Transaction Execution
Category A
    W004



By: /s/ Daven Popat   
   Name: Daven Popat
   Title: Senior Vice President
Transaction Execution
Category A
     P003

 
 





NAI-1506002948



Signature Page to
Joinder and Amendment No. 1 to Revolving Credit and Term Loan Agreement,
dated as of the date first above written,
among The Cooper Companies, Inc. and CooperVision International Holding Company, LP,
as the Existing Borrowers,
CooperSurgical Netherlands B.V. and CooperVision Manufacturing Costa Rica, S.R.L.,
as the Joining Borrowers
KeyBank National Association, as the Administrative Agent,
and the Lenders party thereto


Name of Institution:
MUFG Union Bank, N.A.


By:_______/s/ Kenneth J. Beck__________
   Name: Kenneth J. Beck
   Title: Director






NAI-1506002948



Signature Page to
Joinder and Amendment No. 1 to Revolving Credit and Term Loan Agreement,
dated as of the date first above written,
among The Cooper Companies, Inc. and CooperVision International Holding Company, LP,
as the Existing Borrowers,
CooperSurgical Netherlands B.V. and CooperVision Manufacturing Costa Rica, S.R.L.,
as the Joining Borrowers
KeyBank National Association, as the Administrative Agent,
and the Lenders party thereto


Name of Institution:
PNC Bank, National Association


By:_______/s/ Jennifer L. Shafer__________
   Name: Jennifer L. Shafer
   Title: Vice President






NAI-1506002948



Signature Page to
Joinder and Amendment No. 1 to Revolving Credit and Term Loan Agreement,
dated as of the date first above written,
among The Cooper Companies, Inc. and CooperVision International Holding Company, LP,
as the Existing Borrowers,
CooperSurgical Netherlands B.V. and CooperVision Manufacturing Costa Rica, S.R.L.,
as the Joining Borrowers
KeyBank National Association, as the Administrative Agent,
and the Lenders party thereto


Name of Institution:
REGIONS BANK


By:_______/s/ Ned Spitzer___________
Name: Ned Spitzer
Title: Managing Director










NAI-1506002948



Signature Page to
Joinder and Amendment No. 1 to Revolving Credit and Term Loan Agreement,
dated as of the date first above written,
among The Cooper Companies, Inc. and CooperVision International Holding Company, LP,
as the Existing Borrowers,
CooperSurgical Netherlands B.V. and CooperVision Manufacturing Costa Rica, S.R.L.,
as the Joining Borrowers
KeyBank National Association, as the Administrative Agent,
and the Lenders party thereto


Name of Institution:
TD Bank, N.A.


By:_______/s/ Shreya Shah___________
   Name: Shreya Shah
   Title: Senior Vice President

 
 





NAI-1506002948



Signature Page to
Joinder and Amendment No. 1 to Revolving Credit and Term Loan Agreement,
dated as of the date first above written,
among The Cooper Companies, Inc. and CooperVision International Holding Company, LP,
as the Existing Borrowers,
CooperSurgical Netherlands B.V. and CooperVision Manufacturing Costa Rica, S.R.L.,
as the Joining Borrowers
KeyBank National Association, as the Administrative Agent,
and the Lenders party thereto


Name of Institution:
U.S. BANK NATIONAL ASSOCIATION


By:_______/s/ Tom Priedman___________
   Name: Tom Priedman
   Title: Vice President






NAI-1506002948



Signature Page to
Joinder and Amendment No. 1 to Revolving Credit and Term Loan Agreement,
dated as of the date first above written,
among The Cooper Companies, Inc. and CooperVision International Holding Company, LP,
as the Existing Borrowers,
CooperSurgical Netherlands B.V. and CooperVision Manufacturing Costa Rica, S.R.L.,
as the Joining Borrowers
KeyBank National Association, as the Administrative Agent,
and the Lenders party thereto


Name of Institution:
Wells Fargo Bank, National Association


By:_______/s/ Andrea S Chen__________
   Name: Andrea S Chen
   Title: Managing Director








NAI-1506002948

EX-31.1 3 coo-ex311_2019x01x31x10q.htm EXHIBIT 31.1 Exhibit

Exhibit 31.1

CERTIFICATION PURSUANT TO EXCHANGE ACT RULE 13a-14(a)/15d-14(a)
AS ADOPTED PURSUANT TO SECTION 302
OF THE SARBANES-OXLEY ACT OF 2002

I, Albert G. White III, certify that:

1. I have reviewed this quarterly report on Form 10-Q of The Cooper Companies, Inc. (the “registrant”);

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
Date: March 6, 2019
 
 
 
/s/ Albert G. White III
 
 
Albert G. White III
 
 
President and Chief Executive Officer
 

 EX-31.2 4 coo-ex312_2019x01x31x10q.htm EXHIBIT 31.2 Exhibit

Exhibit 31.2


CERTIFICATION PURSUANT TO EXCHANGE ACT RULE 13a-14(a)/15d-14(a)
AS ADOPTED PURSUANT TO SECTION 302
OF THE SARBANES-OXLEY ACT OF 2002
I, Brian G. Andrews, certify that:

1. I have reviewed this quarterly report on Form 10-Q of The Cooper Companies, Inc. (the “registrant”);

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
Date: March 6, 2019
 
 
 
/s/ Brian G. Andrews
 
 
Brian G. Andrews
 
 
Senior Vice President, Chief Financial Officer and Treasurer
 

 EX-32.1 5 coo-ex321_2019x01x31x10q.htm EXHIBIT 32.1 Exhibit
Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002

 

I, Albert G. White III, do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

•
the Quarterly Report on Form 10-Q of The Cooper Companies, Inc. (the "Company") for the quarterly period ended January 31, 2019, as filed with the Securities and Exchange Commission (the “Report”), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

•
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: March 6, 2019
/s/ Albert G. White III
 
Albert G. White III
 
President and Chief Executive Officer


 EX-32.2 6 coo-ex322_2019x01x31x10q.htm EXHIBIT 32.2 Exhibit
Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002


I, Brian G. Andrews, do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

•
the Quarterly Report on Form 10-Q of The Cooper Companies, Inc. (the "Company") for the quarterly period ended January 31, 2019, as filed with the Securities and Exchange Commission (the “Report”), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

•
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: March 6, 2019
/s/ Brian G. Andrews
 
Brian G. Andrews
 
Senior Vice President, Chief Financial Officer and Treasurer


 EX-101.INS 7 coo-20190131.xml XBRL INSTANCE DOCUMENT 0000711404 2018-11-01 2019-01-31 0000711404 2019-02-26 0000711404 2017-11-01 2018-01-31 0000711404 2018-10-31 0000711404 2019-01-31 0000711404 coo:CommonStockExcludingTreasuryStockParNetValueMember 2019-01-31 0000711404 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-11-01 2019-01-31 0000711404 us-gaap:AdditionalPaidInCapitalMember 2018-11-01 2019-01-31 0000711404 us-gaap:AdditionalPaidInCapitalMember 2019-01-31 0000711404 us-gaap:AdditionalPaidInCapitalMember 2017-11-01 2018-01-31 0000711404 coo:CommonStockExcludingTreasuryStockParNetValueMember 2017-11-01 2018-01-31 0000711404 us-gaap:TreasuryStockMember 2018-10-31 0000711404 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-11-01 2018-01-31 0000711404 us-gaap:NoncontrollingInterestMember 2018-01-31 0000711404 2017-10-31 0000711404 us-gaap:TreasuryStockMember 2019-01-31 0000711404 us-gaap:RetainedEarningsMember 2017-10-31 0000711404 us-gaap:TreasuryStockMember 2018-11-01 2019-01-31 0000711404 us-gaap:TreasuryStockMember 2017-10-31 0000711404 us-gaap:NoncontrollingInterestMember 2019-01-31 0000711404 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-10-31 0000711404 us-gaap:RetainedEarningsMember 2017-11-01 2018-01-31 0000711404 coo:CommonStockExcludingTreasuryStockParNetValueMember 2018-01-31 0000711404 coo:CommonStockExcludingTreasuryStockParNetValueMember 2018-10-31 0000711404 us-gaap:RetainedEarningsMember 2018-10-31 0000711404 us-gaap:TreasuryStockMember 2018-01-31 0000711404 us-gaap:AdditionalPaidInCapitalMember 2017-10-31 0000711404 us-gaap:NoncontrollingInterestMember 2017-10-31 0000711404 coo:TreasuryStockParNetValueMember 2017-10-31 0000711404 coo:CommonStockExcludingTreasuryStockParNetValueMember 2017-10-31 0000711404 coo:CommonStockExcludingTreasuryStockParNetValueMember 2018-11-01 2019-01-31 0000711404 coo:TreasuryStockParNetValueMember 2018-01-31 0000711404 coo:TreasuryStockParNetValueMember 2019-01-31 0000711404 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-31 0000711404 2018-01-31 0000711404 coo:TreasuryStockParNetValueMember 2018-10-31 0000711404 us-gaap:AdditionalPaidInCapitalMember 2018-01-31 0000711404 us-gaap:RetainedEarningsMember 2018-11-01 2019-01-31 0000711404 us-gaap:NoncontrollingInterestMember 2018-10-31 0000711404 us-gaap:AccountingStandardsUpdate201616Member us-gaap:RetainedEarningsMember 2018-11-01 0000711404 us-gaap:AdditionalPaidInCapitalMember 2018-10-31 0000711404 2018-11-01 0000711404 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-10-31 0000711404 us-gaap:RetainedEarningsMember 2018-01-31 0000711404 us-gaap:RetainedEarningsMember 2019-01-31 0000711404 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-31 0000711404 coo:ParagardMember coo:AssembledWorkforceMember 2017-11-01 2017-11-01 0000711404 coo:ParagardMember 2017-11-01 2017-11-01 0000711404 coo:ParagardMember coo:CompositeMember 2017-11-01 2017-11-01 0000711404 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember coo:CompositeMember 2018-10-31 0000711404 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember us-gaap:CustomerRelationshipsMember 2018-10-31 0000711404 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember us-gaap:TechnologyBasedIntangibleAssetsMember 2019-01-31 0000711404 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2017-11-01 2018-10-31 0000711404 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2018-10-31 0000711404 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember us-gaap:TrademarksMember 2018-10-31 0000711404 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2019-01-31 0000711404 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember us-gaap:OtherIntangibleAssetsMember 2018-10-31 0000711404 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember us-gaap:CustomerRelationshipsMember 2019-01-31 0000711404 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember coo:CompositeMember 2019-01-31 0000711404 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember us-gaap:TechnologyBasedIntangibleAssetsMember 2018-10-31 0000711404 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember us-gaap:TrademarksMember 2019-01-31 0000711404 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember us-gaap:OtherIntangibleAssetsMember 2019-01-31 0000711404 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2018-11-01 2019-01-31 0000711404 coo:ParagardMember coo:AssembledWorkforceMember 2017-11-01 0000711404 coo:ParagardMember 2017-11-01 0000711404 coo:ParagardMember coo:CompositeMember 2017-11-01 0000711404 2017-11-01 2018-10-31 0000711404 coo:CoopersurgicalMember 2017-10-31 0000711404 coo:CoopervisionMember 2018-10-31 0000711404 coo:CoopervisionMember 2017-11-01 2018-10-31 0000711404 coo:CoopervisionMember 2019-01-31 0000711404 coo:CoopersurgicalMember 2017-11-01 2018-10-31 0000711404 coo:CoopersurgicalMember 2018-11-01 2019-01-31 0000711404 coo:CoopervisionMember 2017-10-31 0000711404 coo:CoopervisionMember 2018-11-01 2019-01-31 0000711404 coo:CoopersurgicalMember 2018-10-31 0000711404 coo:CoopersurgicalMember 2019-01-31 0000711404 2018-05-01 2018-07-31 0000711404 us-gaap:CustomerRelationshipsMember 2018-11-01 2019-01-31 0000711404 us-gaap:TechnologyBasedIntangibleAssetsMember 2019-01-31 0000711404 coo:LicenseAndDistributionRightsAndOtherMember 2018-10-31 0000711404 us-gaap:TrademarksMember 2019-01-31 0000711404 coo:LicenseAndDistributionRightsAndOtherMember 2018-11-01 2019-01-31 0000711404 coo:CompositeMember 2019-01-31 0000711404 us-gaap:TrademarksMember 2018-11-01 2019-01-31 0000711404 us-gaap:TrademarksMember 2018-10-31 0000711404 us-gaap:CustomerRelationshipsMember 2019-01-31 0000711404 us-gaap:TechnologyBasedIntangibleAssetsMember 2018-10-31 0000711404 coo:LicenseAndDistributionRightsAndOtherMember 2019-01-31 0000711404 us-gaap:CustomerRelationshipsMember 2018-10-31 0000711404 coo:CompositeMember 2018-11-01 2019-01-31 0000711404 us-gaap:TechnologyBasedIntangibleAssetsMember 2018-11-01 2019-01-31 0000711404 coo:CompositeMember 2018-10-31 0000711404 2017-05-01 2017-07-31 0000711404 coo:TermLoanAgreement2019Member us-gaap:SeniorNotesMember 2018-11-01 2018-11-01 0000711404 coo:A2016CreditAgreementMember 2016-03-01 2016-03-01 0000711404 coo:SeniorUnsecuredTermLoanAgreementMember us-gaap:SeniorNotesMember 2018-11-01 2019-01-31 0000711404 srt:MaximumMember coo:TwoThousandSeventeenTermLoanAgreementMember us-gaap:LondonInterbankOfferedRateLIBORMember 2017-11-01 2018-10-31 0000711404 srt:MinimumMember coo:TwoThousandSeventeenTermLoanAgreementMember us-gaap:BaseRateMember 2017-11-01 2018-10-31 0000711404 coo:SeniorUnsecuredTermLoanAgreementMember us-gaap:SeniorNotesMember 2017-11-01 0000711404 coo:TermLoanAgreement2019Member us-gaap:SeniorNotesMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-11-01 2018-11-01 0000711404 srt:MinimumMember coo:TwoThousandSeventeenTermLoanAgreementMember us-gaap:LondonInterbankOfferedRateLIBORMember 2017-11-01 2018-10-31 0000711404 us-gaap:LineOfCreditMember 2016-03-01 2016-03-01 0000711404 coo:A2016CreditAgreementMember 2016-03-01 0000711404 coo:TermLoanAgreement2019Member us-gaap:SeniorNotesMember 2019-01-31 0000711404 coo:SeniorUnsecuredTermLoanAgreementMember us-gaap:SeniorNotesMember 2017-11-01 2017-11-01 0000711404 srt:MaximumMember 2016-03-01 2016-03-01 0000711404 coo:A2016CreditAgreementMember 2019-01-31 0000711404 coo:TermLoanAgreement2019Member us-gaap:SeniorNotesMember us-gaap:BaseRateMember 2018-11-01 2018-11-01 0000711404 srt:MinimumMember 2016-03-01 2016-03-01 0000711404 us-gaap:RevolvingCreditFacilityMember 2016-03-01 0000711404 coo:A2016CreditAgreementMember us-gaap:EurodollarMember 2016-03-01 2016-03-01 0000711404 coo:TermLoanAgreement2019Member us-gaap:SeniorNotesMember 2018-11-01 0000711404 coo:A2016CreditAgreementMember coo:FederalFundsRateMember 2016-03-01 2016-03-01 0000711404 coo:A2016CreditAgreementMember 2016-03-01 0000711404 srt:MaximumMember coo:TwoThousandSeventeenTermLoanAgreementMember us-gaap:BaseRateMember 2017-11-01 2018-10-31 0000711404 coo:SeniorUnsecuredTermLoanAgreementMember us-gaap:SeniorNotesMember 2019-01-31 0000711404 us-gaap:RestrictedStockUnitsRSUMember 2017-11-01 2018-01-31 0000711404 us-gaap:RestrictedStockUnitsRSUMember 2018-11-01 2019-01-31 0000711404 us-gaap:EmployeeStockOptionMember 2018-11-01 2019-01-31 0000711404 us-gaap:EmployeeStockOptionMember 2017-11-01 2018-01-31 0000711404 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-11-01 2019-01-31 0000711404 us-gaap:CostOfSalesMember 2017-11-01 2018-01-31 0000711404 us-gaap:CostOfSalesMember 2018-11-01 2019-01-31 0000711404 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2017-11-01 2018-01-31 0000711404 us-gaap:ResearchAndDevelopmentExpenseMember 2018-11-01 2019-01-31 0000711404 us-gaap:ResearchAndDevelopmentExpenseMember 2017-11-01 2018-01-31 0000711404 us-gaap:SubsequentEventMember 2019-02-09 2019-02-09 0000711404 2017-03-01 0000711404 2017-02-28 0000711404 us-gaap:AccumulatedTranslationAdjustmentMember 2017-11-01 0000711404 2017-11-01 0000711404 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2017-11-01 0000711404 2015-03-01 2017-04-30 0000711404 2018-07-31 0000711404 country:US 2018-10-31 0000711404 srt:EuropeMember 2018-10-31 0000711404 country:US 2019-01-31 0000711404 coo:RestOfWorldOtherEliminationsAndCorporateMember 2018-10-31 0000711404 srt:EuropeMember 2019-01-31 0000711404 coo:RestOfWorldOtherEliminationsAndCorporateMember 2019-01-31 0000711404 us-gaap:CorporateMember 2018-10-31 0000711404 us-gaap:CorporateMember 2019-01-31 0000711404 country:US 2017-11-01 2018-01-31 0000711404 country:US 2018-11-01 2019-01-31 0000711404 srt:EuropeMember 2018-11-01 2019-01-31 0000711404 coo:RestOfWorldOtherEliminationsAndCorporateMember 2017-11-01 2018-01-31 0000711404 srt:EuropeMember 2017-11-01 2018-01-31 0000711404 coo:RestOfWorldOtherEliminationsAndCorporateMember 2018-11-01 2019-01-31 0000711404 us-gaap:CorporateMember 2017-11-01 2018-01-31 0000711404 coo:CoopervisionMember coo:NonSingleUseSphereAndOtherEyeCareProductsMember 2017-11-01 2018-01-31 0000711404 coo:CoopervisionMember coo:SingleUseSphereSoftLensMember 2018-11-01 2019-01-31 0000711404 coo:FertilityMember coo:CoopersurgicalMember 2017-11-01 2018-01-31 0000711404 coo:CoopervisionMember 2017-11-01 2018-01-31 0000711404 coo:OfficeAndSurgicalProceduresMember coo:CoopersurgicalMember 2018-11-01 2019-01-31 0000711404 coo:CoopervisionMember coo:ToricSoftLensMember 2018-11-01 2019-01-31 0000711404 coo:OfficeAndSurgicalProceduresMember coo:CoopersurgicalMember 2017-11-01 2018-01-31 0000711404 coo:CoopersurgicalMember 2017-11-01 2018-01-31 0000711404 coo:CoopervisionMember coo:MultifocalSoftLensMember 2017-11-01 2018-01-31 0000711404 coo:CoopervisionMember coo:MultifocalSoftLensMember 2018-11-01 2019-01-31 0000711404 coo:FertilityMember coo:CoopersurgicalMember 2018-11-01 2019-01-31 0000711404 coo:CoopervisionMember coo:ToricSoftLensMember 2017-11-01 2018-01-31 0000711404 coo:CoopervisionMember coo:NonSingleUseSphereAndOtherEyeCareProductsMember 2018-11-01 2019-01-31 0000711404 us-gaap:CorporateMember 2018-11-01 2019-01-31 0000711404 coo:CoopervisionMember coo:SingleUseSphereSoftLensMember 2017-11-01 2018-01-31 0000711404 2018-01-19 2018-01-19 0000711404 us-gaap:SubsequentEventMember 2019-02-01 2019-02-01 0000711404 us-gaap:SubsequentEventMember 2019-02-26 2019-02-26 iso4217:GBP iso4217:USD xbrli:shares iso4217:USD xbrli:shares coo:action xbrli:pure 110300000 88200000 202000000 400000 10.70 0.01 0.0175 750000000 3500000 3300000 31000000 42000000 3.75 3.00 0 100000 -4400000 2.25 false --10-31 Q1 2019 2019-01-31 10-Q 0000711404 49374137 false Large Accelerated Filer COOPER COMPANIES INC false 146400000 129600000 374700000 389700000 141500000 124800000 954300000 985500000 -21600000 -18500000 -18500000 -353700000 -412200000 -379500000 -375300000 -430700000 -398000000 P5Y P15Y 1572100000 1574800000 12700000 12700000 11700000 11700000 12700000 11700000 19000000 19700000 36000000 36600000 1202000 546000 377000 17000 6112800000 2201700000 3746000000 165100000 6298600000 2214600000 3869800000 214200000 1090900000 1193000000 1100000000 1319800000 64300000 45400000 1121800000 1189600000 1061900000 23500000 4200000 0 100000000 27100000 0 7500000 0 9900000 9700000 1200000 1061900000 47300000 16400000 59600000 1400000 1105400000 9400000 2000000 91400000 77700000 146600000 88800000 91700000 80200000 146900000 2900000 66700000 0.03 0.1 0.1 120000000 120000000 52800000 52900000 48800000 3600000 49000000 3600000 49200000 3600000 49300000 3600000 5300000 5300000 -20200000 135900000 12600000 219100000 209600000 4800000 4800000 0 -13300000 -13300000 -13000000 0 0.0075 0 0.006 0.0075 0.0175 0 0.01 1425000000 400000000.0 2021-03-01 P5Y P364D 2022800000 2132400000 0.0299 3100000 58400000 55200000 31000000 34600000 -400000 -200000 0.08 0 10000000 2300000 2400000 1300000 1500000 2100000 1800000 2700000 2500000 66600000 68800000 1400000 1400000 1500000 1500000 2019-01-22 -2.50 2.09 -2.50 2.07 3900000 900000 2.637 0.100 94000000 75900000 2500000 1700000 P14Y P15Y P9Y P13Y P11Y P14Y 499700000 70800000 52700000 168600000 190700000 16900000 537900000 88500000 56200000 175300000 198500000 19400000 861600000 109100000 130700000 132900000 134800000 136100000 2021000000 1061900000 74900000 350000000 395000000 139200000 2052000000 1061900000 76000000 359000000 405800000 149300000 1505200000 21000000 2354800000 619100000 1735700000 2392100000 70600000 649200000 1742900000 2449300000 35800000 672600000 1776700000 -33900000 -4300000 -29600000 21400000 1500000 19900000 0 0 71200000 34400000 36800000 35800000 21900000 13900000 370900000 418500000 74800000 93800000 197300000 -9400000 -18700000 177000000 53300000 0 600000 1521300000 1514100000 18400000 18200000 343700000 353700000 468800000 486200000 112500000 119900000 12600000 12600000 2805000000 2873100000 6112800000 6298600000 536500000 938600000 0.0025 0.00125 2016-03-01 125000000 1000000000.0 859500000 37100000 45600000 0 400000000 1985700000 1686900000 439000000 140000000 3000000 50 200000 200000 1217400000 93200000 -1244600000 -129200000 26200000 101800000 -122500000 -122500000 103200000 103200000 3000000 1100000 90200000 -9300000 112300000 -12800000 -12600000 110900000 7200000 116300000 74100000 63200000 102300000 32700000 -58500000 32700000 0 -47500000 32700000 102300000 102300000 32700000 32700000 11000000 0 3100000 3100000 259000000 287600000 200000 200000 -259100000 16900000 1193200000 50000000 0 6100000 3900000 200000 1500000 51400000 79200000 0.1 0.1 1000000 1000000 0 0 0 0 0 0 169700000 170500000 22100000 29000000 1672800000 261800000 4800000 407500000 -10500000 -9000000 -122500000 103200000 1930300000 2009300000 976000000 118600000 516700000 340700000 1023800000 124000000 550200000 349600000 445800000 560800000 18800000 21000000 300000 300000 2576000000 2664400000 590000000 57000000 88200000 124700000 261500000 203800000 145200000 444800000 46900000 143800000 116300000 137800000 62300000 95700000 139500000 278900000 209700000 49100000 142900000 132100000 146000000 628100000 158000000 470100000 225900000 250000000 1300000 700000 10700000 1500000 900000 9300000 15.83 226.3 229.66 254.77 37100000 445500000 400000000 200000 100000 100000 -10500000 -10600000 -9000000 -9000000 500000000.0 1000000000.0 557400000 3175800000 4900000 300000 -375300000 1526700000 100000 2434200000 -415100000 3156400000 5000000 300000 -273000000 1528800000 100000 2310300000 -415100000 3307800000 5000000 300000 -430700000 1572100000 200000 2576000000 -415100000 3425500000 5000000 300000 -398000000 1574800000 200000 2664400000 -421200000 248.70 3600000 3600000 0 25000 415100000 421200000 6100000 6100000 68900000 47100000 1550000000 1550000000 1425000000 830000000 48900000 49900000 48900000 49300000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Acquisitions</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following is a summary of the allocation of the total purchase consideration for business and asset acquisitions that the Company completed during fiscal 2019 and 2018:</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:98.11320754716981%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:67%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">January 31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31, 2018</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Technology</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer relationships</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trademarks</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Composite intangible asset</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,061.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total identifiable intangible assets</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,189.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">70.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net tangible assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">59.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total purchase price</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">64.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,319.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">All the acquisitions were funded by cash generated from operations or facility borrowings. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For business acquisitions, we recorded the tangible and intangible assets acquired and liabilities assumed at their fair values as of the applicable date of acquisition. For assets acquisitions, we recorded the tangible and intangible assets acquired and liabilities assumed at their estimated and relative fair values as of the applicable date of acquisition. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We believe these acquisitions strengthen CooperSurgical's and CooperVision's businesses through the addition of new or complementary products and services.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fiscal Year 2019</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December 31, 2018, CooperSurgical completed the acquisition of Incisive Surgical Inc., a privately-held U.S. medical device company that develops mechanical surgical solutions for skin closure. The purchase price allocation is preliminary and we are in the process of finalizing information primarily related to property, plant &amp; equipment, inventories, receivables, certain accruals and other liabilities, taxes and the corresponding impact on goodwill.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December 28, 2018, CooperVision completed the acquisition of Blanchard Contact Lenses. Blanchard is a privately-held scleral lens company, which expands CooperVision's specialty and scleral lens portfolio. The purchase price allocation is preliminary and we are in the process of finalizing information primarily related to property, plant &amp; equipment, inventories, receivables, certain accruals and other liabilities, taxes and the corresponding impact on goodwill.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The pro forma results of operations of these acquisitions have not been presented because the effects of the business combinations described above, individually and in the aggregate, were not material to our consolidated results of operations.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fiscal Year 2018</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">PARAGARD</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On&#160;November&#160;1, 2017, CooperSurgical acquired the assets of the PARAGARD Intrauterine Device (IUD) business (PARAGARD) from Teva Pharmaceuticals Industries Limited for&#160;</font><font style="font-family:inherit;font-size:10pt;">$1.1 billion</font><font style="font-family:inherit;font-size:10pt;">. This asset acquisition broadened and strengthened CooperSurgical's product portfolio. PARAGARD</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> is the only hormone-free, long lasting, reversible contraceptive approved by the United States Food and Drug Administration (FDA) available in the United States.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the relative fair values of net assets acquired and liabilities assumed using the cost accumulation and allocation model:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:98.11320754716981%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:84%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Relative Fair Value </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Composite intangible asset </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,061.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assembled workforce intangible asset</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;(2)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Property, plant and equipment</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventory </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total assets acquired</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,121.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: liabilities assumed</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total Purchase Price</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">1,105.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company proportionally allocated the acquisition costs to the net assets acquired. The acquisition-related costs included advisory, legal, valuation and other professional fees.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1) </sup></font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Composite&#160;Intangible asset consists of technology, trade name, New Drug Application (NDA) approval and physician relationships, which have been valued as a single composite intangible asset as they are inextricably linked. The composite asset was identified as the primary asset acquired, was valued using the Multi-Period Excess Earnings Method and will be amortized over </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">15 years</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2) </sup></font><font style="font-family:inherit;font-size:10pt;font-style:italic;">An assembled workforce was recognized as a separate acquired intangible asset, given the purchase of assets and will be amortized over </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">5 years</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3) </sup></font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Inventory relative fair value includes step up of </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">$45.4 million</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Other Acquisitions</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On April 3, 2018, CooperSurgical completed the acquisition of The LifeGlobal Group (LifeGlobal). LifeGlobal was a privately held company that specializes primarily in in-vitro fertilization (IVF) media.&#160;LifeGlobal&#8217;s product categories include media products as well as IVF laboratory air filtration products and dishware. We have completed the purchase price allocation for this acquisition.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On&#160;December&#160;1, 2017, CooperVision acquired Paragon Vision Sciences, a leading provider of orthokeratology (ortho-k) specialty contact lenses and oxygen permeable rigid contact lens materials. Ortho-k contact lenses are overnight lenses which enable corneal topography correction for myopia (nearsightedness) patients. We have completed the purchase price allocation for this acquisition.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On January 4, 2018, CooperVision acquired Blueyes Ltd, a long-standing distribution partner, with a leading position in the distribution of contact lenses to the Optical and Pharmacy sector in Israel. We have completed the purchase price allocation for this acquisition.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Debt</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:95.41284403669725%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:64%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;text-decoration:underline;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">January&#160;31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">October&#160;31, 2018</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Overdraft and other credit facilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Term loans</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">400.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: unamortized debt issuance cost</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Short-term Debt</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">445.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revolving credit</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">140.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">439.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Term loans</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,550.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,550.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: unamortized debt issuance cost</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term Debt</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,686.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,985.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Debt</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,132.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,022.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$400 million Term Loan on November 1, 2018</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On November&#160;1, 2018, the Company entered into a </font><font style="font-family:inherit;font-size:10pt;">364</font><font style="font-family:inherit;font-size:10pt;">-day, </font><font style="font-family:inherit;font-size:10pt;">$400.0 million</font><font style="font-family:inherit;font-size:10pt;">, senior unsecured term loan agreement by and among the Company, the lenders party thereto and PNC Bank, National Association, as administrative agent which matures on October&#160;31, 2019 (the 2018 Term Loan Agreement). The Company used the funds to partially repay outstanding borrowings under the 2016 Revolving Credit Facility. At January&#160;31, 2019, we had </font><font style="font-family:inherit;font-size:10pt;">$400.0 million</font><font style="font-family:inherit;font-size:10pt;"> outstanding under the 2018 Term Loan Agreement.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amounts outstanding under the 2018 Term Loan Agreement will bear interest, at the Company's option, at either the base rate, or the adjusted LIBO rate (each as defined in the 2018 Term Loan Agreement), plus, in each case, an applicable rate of </font><font style="font-family:inherit;font-size:10pt;">0.00%</font><font style="font-family:inherit;font-size:10pt;"> in respect of base rate loans and </font><font style="font-family:inherit;font-size:10pt;">0.60%</font><font style="font-family:inherit;font-size:10pt;"> in respect of adjusted LIBO rate loans. The weighted average interest rate for the three months ended January 31, 2019 was </font><font style="font-family:inherit;font-size:10pt;">2.99%</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The 2018 Term Loan Agreement contains customary restrictive covenants, as well as financial covenants that require the Company to maintain a certain Total Leverage Ratio and Interest Coverage Ratio (each as defined in the 2018 Term Loan Agreement) consistent with the 2016 Credit Agreement discussed below.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$1.425 billion Term Loan on November 1, 2017 </font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On November 1, 2017, in connection with the PARAGARD acquisition, we entered into a </font><font style="font-family:inherit;font-size:10pt;">five</font><font style="font-family:inherit;font-size:10pt;">-year, </font><font style="font-family:inherit;font-size:10pt;">$1.425 billion</font><font style="font-family:inherit;font-size:10pt;">, senior unsecured term loan agreement (the 2017 Term Loan Agreement) by and among the Company, the lenders party thereto and DNB Bank ASA, New York Branch, as administrative agent which matures on November 1, 2022. The Company used part of the facility to fund the PARAGARD acquisition and used the remainder of the funds to partially repay outstanding borrowings under our revolving credit agreement.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amounts outstanding under the 2017 Term Loan Agreement will bear interest, at our option, at either the base rate, or the adjusted LIBO rate (each as defined in the 2017 Term Loan Agreement), plus, in each case, an applicable rate of, between </font><font style="font-family:inherit;font-size:10pt;">0.00%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">0.75%</font><font style="font-family:inherit;font-size:10pt;"> in respect of base rate loans and between </font><font style="font-family:inherit;font-size:10pt;">1.00%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">1.75%</font><font style="font-family:inherit;font-size:10pt;"> in respect of adjusted LIBO rate loans, in each case in accordance with a pricing grid tied to the Total Leverage Ratio as defined in the 2017 Term Loan Agreement.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The 2017 Term Loan Agreement contains customary restrictive covenants, as well as financial covenants that require the Company to maintain a certain Total Leverage Ratio and Interest Coverage Ratio (each as defined in the 2017 Term Loan Agreement) consistent with the 2016 Credit Agreement discussed below. At </font><font style="font-family:inherit;font-size:10pt;">January&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;">, we had </font><font style="font-family:inherit;font-size:10pt;">$1.425 billion</font><font style="font-family:inherit;font-size:10pt;"> outstanding under the 2017 Term Loan Agreement.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Revolving Credit and Term Loan Agreement on March 1, 2016</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On </font><font style="font-family:inherit;font-size:10pt;">March&#160;1, 2016</font><font style="font-family:inherit;font-size:10pt;">, we entered into a Revolving Credit and Term Loan Agreement (the 2016 Credit Agreement), among the Company, CooperVision International Holding Company, LP, the lenders party thereto and KeyBank National Association, as administrative agent. The 2016 Credit Agreement provides for a multicurrency revolving credit facility in an aggregate principal amount of </font><font style="font-family:inherit;font-size:10pt;">$1.0 billion</font><font style="font-family:inherit;font-size:10pt;"> (the 2016 Revolving Credit Facility) and a term loan facility in an aggregate principal amount of </font><font style="font-family:inherit;font-size:10pt;">$830.0 million</font><font style="font-family:inherit;font-size:10pt;"> (the 2016 Term Loan Facility), each of which, unless terminated earlier, mature on </font><font style="font-family:inherit;font-size:10pt;">March&#160;1, 2021</font><font style="font-family:inherit;font-size:10pt;">. In addition, we have the ability from time to time to request an increase to the size of the 2016 Revolving Credit Facility or establish one or more new term loans under the 2016 Term Loan Facility in an aggregate amount up to </font><font style="font-family:inherit;font-size:10pt;">$750.0 million</font><font style="font-family:inherit;font-size:10pt;">, subject to the discretionary participation of the lenders. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amounts outstanding under the 2016 Credit Agreement will bear interest, at our option, at either the base rate, or the adjusted LIBO rate or adjusted foreign currency rate (each as defined in the 2016 Credit Agreement), plus, in each case, an applicable rate of between&#160;</font><font style="font-family:inherit;font-size:10pt;">0.00%</font><font style="font-family:inherit;font-size:10pt;"> and&#160;</font><font style="font-family:inherit;font-size:10pt;">0.75%</font><font style="font-family:inherit;font-size:10pt;"> in respect of base rate loans and between </font><font style="font-family:inherit;font-size:10pt;">1.00%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">1.75%</font><font style="font-family:inherit;font-size:10pt;"> in respect of adjusted LIBO rate or adjusted foreign currency rate loans, in each case in accordance with a pricing grid tied to the Total Leverage Ratio, as defined in the 2016 Credit Agreement.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We pay an annual commitment fee that ranges from </font><font style="font-family:inherit;font-size:10pt;">0.125%</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">0.25%</font><font style="font-family:inherit;font-size:10pt;"> of the unused portion of the 2016 Revolving Credit Facility depending on certain financial ratios. In addition to the annual commitment fee described above, we are also required to pay certain letter of credit and related fronting fees and other administrative fees pursuant to the terms of the 2016 Credit Agreement.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;">January&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;">, we had </font><font style="font-family:inherit;font-size:10pt;">$125.0 million</font><font style="font-family:inherit;font-size:10pt;"> outstanding under the 2016 Term Loan Facility and </font><font style="font-family:inherit;font-size:10pt;">$859.5 million</font><font style="font-family:inherit;font-size:10pt;"> available under the 2016 Revolving Credit Facility.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The 2016 Credit Agreement contains customary restrictive covenants, as well as financial covenants that require us to maintain a certain Total Leverage Ratio and Interest Coverage Ratio (each as defined in the 2016 Credit Agreement):</font></div><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:42px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest Coverage Ratio, as defined, to be at least </font><font style="font-family:inherit;font-size:10pt;">3.00</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">1.00</font><font style="font-family:inherit;font-size:10pt;"> at all times.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:42px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Leverage Ratio, as defined, to be no higher than </font><font style="font-family:inherit;font-size:10pt;">3.75</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">1.00</font><font style="font-family:inherit;font-size:10pt;">. </font></div></td></tr></table><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;">January&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;">, we were in compliance with the Interest Coverage Ratio at </font><font style="font-family:inherit;font-size:10pt;">10.70</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">1.00</font><font style="font-family:inherit;font-size:10pt;"> and the Total Leverage Ratio at </font><font style="font-family:inherit;font-size:10pt;">2.25</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">1.00</font><font style="font-family:inherit;font-size:10pt;"> for 2018 Term Loan Agreement, the 2017 Term Loan Agreement, and the 2016 Credit Agreement.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Refer to our Annual Report on Form 10-K for the fiscal year ended </font><font style="font-family:inherit;font-size:10pt;">October&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> for more details.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Share-Based Compensation Plans</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cooper has several share-based compensation plans that are described in the Company&#8217;s Annual Report on Form 10&#8209;K for the fiscal year ended </font><font style="font-family:inherit;font-size:10pt;">October&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">. The compensation expense and related income tax benefit recognized in our consolidated condensed financial statements for share-based awards were as follows:</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:93.78757515030061%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended January 31,</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Selling, general and administrative expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of sales</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development expense</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total share-based compensation expense</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Related income tax benefit</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Earnings Per Share</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:69%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended January 31,</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">(In millions, except per share amounts)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income (loss)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">103.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(122.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Basic:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average common shares</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic earnings (loss) per share</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.09</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.50</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Diluted:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average common shares</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effect of potential dilutive shares</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted weighted average common shares*</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted earnings (loss) per share attributable to Cooper stockholders</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.07</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.50</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td colspan="8" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-style:italic;">*The number of diluted weighted average common shares used to calculate fiscal 2018 diluted loss per share excludes all potentially dilutive instrument because they would be antidilutive due to the net loss position.</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table sets forth stock options to purchase Cooper&#8217;s common stock and restricted stock units that were not included in the diluted earnings per share calculation because their effect would have been antidilutive for the periods presented:</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:95.72649572649573%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td style="width:63%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended January 31,</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">(In thousands, except exercise prices)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Number of stock option shares excluded</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">377</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,202</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Range of exercise prices</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$226.30-$254.77</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$15.83-$229.66</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Number of restricted stock units excluded</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">546</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Fair Value Measurements</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounting standards define fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value hierarchy prioritizes the inputs to valuation techniques used to measure fair value. An asset&#8217;s or liability&#8217;s level is based on the lowest level of input that is significant to the fair value measurement. Assets and liabilities carried at fair value are valued and disclosed in one of the following three levels of the valuation hierarchy:</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level 1: Quoted market prices in active markets for identical assets or liabilities.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level 3: Unobservable inputs reflecting the reporting entity&#8217;s own assumptions.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;">January&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">October&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, the carrying value of cash and cash equivalents, accounts receivable, prepaid expense and other current assets, lines of credit, accounts payable and other current liabilities approximate fair value due to the short-term nature of such instruments and the ability to obtain financing on similar terms.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The carrying value of our revolving credit facility and term loans approximates fair value estimated based on current market rates (Level 2). The Company did not have any derivative assets or liabilities that may include interest rate swaps, cross currency swaps or foreign currency forward contracts as of </font><font style="font-family:inherit;font-size:10pt;">January&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">October&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Nonrecurring fair value measurements</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company uses fair value measures when determining assets and liabilities acquired in an acquisition as described in Note 3. Acquisitions which are considered a Level 3 measurement.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of January 31, 2019, the estimation of amortization expenses for intangible assets with finite lives is as follows:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:80%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Fiscal years:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Remainder of 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">109.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">136.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">134.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2022</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">132.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2023</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">130.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Thereafter</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">861.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total remaining amortization for intangible assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,505.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Income Taxes</font></div><div style="line-height:174%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Recent Tax Legislation</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The 2017 Act was enacted into law on December 22, 2017 and significantly changes existing U.S. tax law. The 2017 Act adopts a territorial tax system, imposes a mandatory one-time transition tax on earnings of foreign subsidiaries that were previously indefinitely reinvested, and reduces the U.S. federal statutory tax rate from </font><font style="font-family:inherit;font-size:10pt;">35%</font><font style="font-family:inherit;font-size:10pt;"> to</font><font style="font-family:inherit;font-size:10pt;"> 21%.</font><font style="font-family:inherit;font-size:10pt;"> For first quarter of fiscal 2019, the Company has utilized the enacted U.S. federal statutory tax rate of </font><font style="font-family:inherit;font-size:10pt;">21%.</font><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The 2017 Act includes several provisions that are effective for our fiscal 2019: (i) tax on global intangible low-taxed income (GILTI) of foreign subsidiaries, (ii) tax on certain payments between a U.S. corporation and its foreign subsidiaries referred to as the base erosion and anti-abuse tax (BEAT), (iii) limitation on the tax deduction for interest payments, and (iv) expanded limitation on the tax deduction for compensation paid to certain executives.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The 2017 Act was effective in the first quarter of fiscal 2018. As of January 31, 2019, we have completed our accounting for the tax effects of the enactment of the 2017 Act and recorded a final adjustment to our provisional tax expense pursuant to SAB 118. During the first quarter of fiscal 2019, we recorded tax benefit of </font><font style="font-family:inherit;font-size:10pt;">$4.4 million</font><font style="font-family:inherit;font-size:10pt;"> in our financial statements to finalize the tax effects of the 2017 Act. The Company is no longer asserting that earnings from our foreign subsidiaries are indefinitely reinvested. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The 2017 Act imposes a new tax on foreign earnings and profits in excess of a deemed return on tangible assets of foreign subsidiaries referred to as GILTI which is effective in fiscal 2019. In accordance with FASB Staff Q&amp;A, Topic 740, No. 5, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Accounting for Global Intangible Low-Taxed Income</font><font style="font-family:inherit;font-size:10pt;">, the Company is making an accounting policy election to recognize the tax expense related to GILTI in the year the tax is incurred. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Effective Tax Rate</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's effective tax rates were a benefit of </font><font style="font-family:inherit;font-size:10pt;">10.0%</font><font style="font-family:inherit;font-size:10pt;"> and expense of </font><font style="font-family:inherit;font-size:10pt;">263.7%</font><font style="font-family:inherit;font-size:10pt;"> for the first quarters of fiscal 2019 and fiscal 2018, respectively. The decrease in our effective tax rate for the first quarter of fiscal 2019 compared to the first quarter of fiscal 2018 was primarily due to the provisional charge of </font><font style="font-family:inherit;font-size:10pt;">$202.0 million</font><font style="font-family:inherit;font-size:10pt;"> relating to the 2017 Act that was recorded in the first quarter of fiscal 2018. Our effective tax rate for the first quarter of fiscal 2019 was lower than the U.S. statutory rate because of discrete tax benefits which were partially offset by a less favorable mix of income from our foreign jurisdictions with lower tax rates. Total discrete tax benefits for the first quarter of fiscal 2019 were </font><font style="font-family:inherit;font-size:10pt;">$18.7 million</font><font style="font-family:inherit;font-size:10pt;"> primarily relating to settlement of tax audits, revisions to the provisional tax charges relating to the 2017 Act, and excess tax benefits from share-based compensation. Our effective tax rate for the first quarter of fiscal 2018 was higher than the U.S. statutory rate because of the discrete tax expense relating to the 2017 Act, which was partially offset by a favorable mix of income from our foreign jurisdictions with lower tax rates and an excess tax benefit from share-based compensation.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We recognize the benefit from a tax position only if it is more likely than not that the position would be sustained upon audit based solely on the technical merits of the tax position. As of January 31, 2019, and October 31, 2018, Cooper had unrecognized tax benefits of </font><font style="font-family:inherit;font-size:10pt;">$47.1 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$68.9 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. The decrease is primarily related to settling prior year tax audits, partially offset by additions to current period transfer pricing reserves. It is our policy to recognize interest and penalties directly related to income taxes as additional income tax expense. It is reasonably possible that </font><font style="font-family:inherit;font-size:10pt;">$3.1 million</font><font style="font-family:inherit;font-size:10pt;"> of unrecognized tax benefits could be settled during the next twelve months.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is subject to U.S. Federal income tax examinations for fiscal 2015 through 2018 and the Internal Revenue Service is currently auditing our U.S. Consolidated Corporation Income Tax Returns for fiscal 2015 and 2016. The Company remains subject to income tax examinations in other significant tax jurisdictions including the United Kingdom, Japan, France and Australia for the tax years 2015 through 2018.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Intangible Assets</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Goodwill</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:56%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">CooperVision</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">CooperSurgical</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Balance at October 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,735.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">619.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,354.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net additions during the year ended October 31, 2018</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Translation</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(29.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(33.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at October 31, 2018</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,742.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">649.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,392.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Net additions during the three months ended January 31, 2019</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Translation</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Balance at January 31, 2019</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,776.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">672.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,449.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company evaluates goodwill for impairment annually during the fiscal third quarter and when an event occurs or circumstances change such that it is reasonably possible that impairment may exist. The Company accounts for goodwill and evaluates its goodwill balances and tests them for impairment in accordance with related accounting standards. The Company performed its annual impairment assessment in its third quarters of fiscal 2018 and fiscal 2017 respectively, and its analysis indicated that the Company had </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> impairment of goodwill. </font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Other Intangible Assets</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="18" rowspan="1"></td></tr><tr><td style="width:32%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">January 31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross&#160;Carrying</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross&#160;Carrying</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:13px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted Average Amortization Period (In years)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trademarks</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">149.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">139.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Composite intangible asset</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,061.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,061.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">70.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Technology</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">405.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">198.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">395.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">190.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Customer relationships</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">359.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">175.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">350.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">168.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">License and distribution rights and other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">76.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">56.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">74.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">52.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,052.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">537.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,021.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">499.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: accumulated amortization and translation</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">537.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">499.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Other intangible assets, net</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,514.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,521.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balances include foreign currency translation adjustments. </font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of January 31, 2019, the estimation of amortization expenses for intangible assets with finite lives is as follows:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:80%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Fiscal years:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Remainder of 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">109.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">136.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">134.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2022</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">132.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2023</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">130.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Thereafter</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">861.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total remaining amortization for intangible assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,505.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Inventories</font></div><div style="line-height:120%;text-align:justify;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:92.98597194388778%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:59%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">January&#160;31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">October&#160;31, 2018</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Raw materials</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">119.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">112.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Work-in-process</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Finished goods</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">353.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">343.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">486.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">468.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventories are stated at the lower of cost and net realizable value. Cost is computed using standard cost that approximates actual cost, on a first-in, first-out basis.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Contingencies</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Since March 2015, over </font><font style="font-family:inherit;font-size:10pt;">50</font><font style="font-family:inherit;font-size:10pt;"> putative class action complaints were filed by contact lens consumers alleging that contact lens manufacturers, in conjunction with their respective Unilateral Pricing Policy (UPP), conspired to reach agreements between each other and certain distributors and retailers regarding the prices at which certain contact lenses could be sold to consumers. The plaintiffs are seeking damages against CooperVision, Inc., other contact lens manufacturers, distributors and retailers, in various courts around the United States. In June 2015, all of the class action cases were consolidated and transferred to the United States District Court for the Middle District of Florida. In August 2017, CooperVision entered into a settlement agreement with the plaintiffs, without any admission of liability, to settle all claims against CooperVision. In July 2018, the Court approved the plaintiffs&#8217; motion for preliminary approval of the settlement, and the Company paid the </font><font style="font-family:inherit;font-size:10pt;">$3.0 million</font><font style="font-family:inherit;font-size:10pt;"> settlement amount into an escrow account. The settlement remains subject to final Court approval at a future hearing to be set by the Court.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is involved in various lawsuits, claims and other legal matters from time to time that arise in the ordinary course of conducting business, including matters involving our products, intellectual property, supplier relationships, distributors, competitor relationships, employees and other matters. The Company does not believe that the ultimate resolution of these proceedings or claims pending against it could have a material adverse effect on its financial condition or results of operations. At each reporting period, the Company evaluates whether or not a potential loss amount or a potential range of loss is probable and reasonably estimable under ASC 450, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Contingencies</font><font style="font-family:inherit;font-size:10pt;">. Legal fees are expensed as incurred.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accounts Receivable Factoring Program </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We may factor certain designated trade receivables with one or more third party financial institutions pursuant to a factoring agreement.&#160;These are non-recourse factoring arrangements to assist us in managing operating cash flow and meet the requirements to be accounted for as sales in accordance with the &#8220;Transfers and Servicing&#8221; guidance in ASC 860, where the Company&#8217;s continuing involvement subsequent to the transfer is limited to providing certain servicing and collection actions on behalf of the purchasers of the designated trade receivables. Proceeds from amounts factored by the Company are recorded as an increase to cash and a reduction to accounts receivable outstanding in the Company's Consolidated Balance Sheets. Cash flows attributable to factoring are reflected as cash flows from operating activities in the Company&#8217;s Consolidated Statements of Cash Flows. Factoring fees associated with the sale of factored receivables for the three months ended January 31, 2019 were </font><font style="font-family:inherit;font-size:10pt;">$0.4 million</font><font style="font-family:inherit;font-size:10pt;"> and were minimal for the three months ended January 31, 2018.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">General</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The accompanying unaudited interim consolidated condensed financial statements and related notes should be read in conjunction with the audited Consolidated Financial Statements of the Cooper Companies, Inc. and its subsidiaries (the Company) and related notes as contained in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended October 31, 2018. The unaudited interim financial statements include all adjustments (consisting only of normal recurring adjustments) and accruals necessary in the judgment of management for a fair statement of the results for the periods presented. Readers should not assume that the results reported here either indicate or guarantee future performance. The terms "the Company", "we", "us", and "our" are used to refer collectively to the Cooper Companies, Inc. and its subsidiaries.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accounting Pronouncements Recently Adopted</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In March 2017, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2017-07, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Compensation - Retirement Benefits (Topic 715): Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost</font><font style="font-family:inherit;font-size:10pt;">. The ASU requires an entity to disaggregate the service cost component from the other components of net benefit cost. The service cost component is now presented in the same income statement line as other compensation costs arising from services rendered by the pertinent employees during the period and the other components of net benefit costs are presented separately as other income/expense below operating income. The Company adopted this guidance on November 1, 2018, and it did not have a material impact on the Company&#8217;s reported financial results. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In October 2016, the FASB issued ASU 2016-16, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory</font><font style="font-family:inherit;font-size:10pt;">, which requires entities to recognize the income tax consequences on an intra-entity transfer of an asset other than inventory when the transfer occurs. The ASU changes the timing of the recognition of the income tax consequences of non-inventory transfers which under current guidance defers the income tax consequences until the asset is sold to an outside party or otherwise recognized. The guidance for the amendments of ASU 2016-16 requires companies to apply a modified retrospective approach with a cumulative catch-up adjustment to opening retained earnings in the period of adoption. The Company adopted ASU 2016-16 in the first quarter of fiscal 2019 on a modified retrospective basis. The Company recorded the cumulative effect of the change as a decrease to retained earnings of approximately </font><font style="font-family:inherit;font-size:10pt;">$13.3 million</font><font style="font-family:inherit;font-size:10pt;">. The cumulative effect adjustment represents the recognition of unrecognized income tax effects from intra-entity transfers of assets other than inventory that occurred prior to the date of adoption.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2014, the FASB issued ASU 2014-09, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue from Contracts with Customers (Topic 606).</font><font style="font-family:inherit;font-size:10pt;"> The ASU requires revenue recognition to depict the transfer of goods or services to customers at an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The amendments in the ASU can be applied either retrospectively to each prior reporting period presented or alternatively, the modified retrospective transition method whereby the company recognizes the cumulative effect of initially applying the guidance as an opening balance sheet adjustment to equity in the period of initial application. This alternative approach must be supplemented by additional disclosures. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We adopted ASU 2014-09 on November 1, 2018, using the modified retrospective transition method. We did not recognize any cumulative effect of initially applying the new revenue standard as an adjustment to our opening balance of retained earnings due to its immaterial impact. The comparative information has not been restated and continues to be reported under the accounting standards in effect for those periods. There was no material impact of ASC 606 to our financial statements during the three months ended January 31, 2019. We do not expect the adoption of the new revenue standard to have a material impact to our net income on an ongoing basis.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company applies the provisions of Accounting Standards Codification (ASC) 606-10 or ASU 2014-09, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue from Contracts with Customers</font><font style="font-family:inherit;font-size:10pt;">, and all related appropriate guidance. The Company recognizes revenue under the core principle to depict the transfer of control to the Company&#8217;s customers in an amount reflecting the consideration to which the Company expects to be entitled. In order to achieve that core principle, the Company applies the following five step approach: (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when a performance obligation is satisfied. For a complete discussion of accounting for net product revenue, see Note 2. Revenue Recognition. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accounting Pronouncements Issued Not Yet Adopted</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In November 2018, the FASB issued&#160;ASU 2018-18,&#160;</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Collaborative Arrangements (Topic 808), Clarifying the Interaction between Topic 808 and Topic 606</font><font style="font-family:inherit;font-size:10pt;">. This guidance amended ASC 808 and ASC 606 to clarify that transactions in a collaborative arrangement should be accounted for under ASC 606 when the counterparty is a customer for a distinct good or service (i.e., unit of account). The amendments preclude an entity from presenting consideration from a transaction in a collaborative arrangement as revenue from contracts with customers if the counterparty is not a customer for that transaction. We are currently evaluating the impact of ASU 2018-18 which is effective for the Company in our fiscal year and interim periods beginning on November 1, 2020.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2018, the FASB issued&#160;ASU 2018-15,&#160;</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Intangibles-Goodwill and Other - Internal Use Software (Subtopic 350-40): Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That is a Service Contract.</font><font style="font-family:inherit;font-size:10pt;"> This guidance requires companies to apply the internal-use software guidance in&#160;ASC 350-40&#160;to implementation costs incurred in a hosting arrangement that is a service contract to determine whether to capitalize certain implementation costs or expense them as incurred. We are currently evaluating the impact of ASU 2018-15 which is effective for the Company in our fiscal year and interim periods beginning on November 1, 2020.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016, the FASB issued ASU 2016-02,&#160;</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Leases (Topic 842)</font><font style="font-family:inherit;font-size:10pt;">.&#160;ASU 2016-02 requires that a lessee recognize the assets and liabilities that arise from operating leases. A lessee should recognize in the statement of financial position a liability to make lease payments (the lease liability) and a right-of-use (ROU) asset representing its right to use the underlying asset for the lease term. For leases with a term of 12 months or less, a lessee is permitted to make an accounting policy election by class of underlying asset not to recognize lease assets and lease liabilities. In transition, lessees and lessors are required to recognize and measure leases at the beginning of the earliest period presented using a modified retrospective approach. In July 2018, the FASB issued&#160;ASU 2018-10,&#160;</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Codification Improvements to Topic 842, Leases and ASU 2018-11,&#160;Leases Topic 842 Target improvements</font><font style="font-family:inherit;font-size:10pt;">, which provides an additional (and optional) transition method whereby the new lease standard is applied at the adoption date and recognized as an adjustment to retained earnings. This standard is effective for the Company in our fiscal year and interim periods beginning on November 1, 2019.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We anticipate this standard to have a material impact on our Consolidated Balance Sheets and related disclosures due to the recognition of ROU assets and lease liabilities for operating leases. However, we do not expect adoption to have a material impact on our Consolidated Income Statements. We are continuing to assess and evaluate the potential impacts of the standard as well as the election of transition method and certain practical expedients available within the ASU. We are in the process of documenting and analyzing our lease contracts, assessment of business processes and controls, selecting a system solution and completing our analysis of information necessary to determine the impact to the consolidated financial statements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accounts Receivable Factoring Program </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We may factor certain designated trade receivables with one or more third party financial institutions pursuant to a factoring agreement.&#160;These are non-recourse factoring arrangements to assist us in managing operating cash flow and meet the requirements to be accounted for as sales in accordance with the &#8220;Transfers and Servicing&#8221; guidance in ASC 860, where the Company&#8217;s continuing involvement subsequent to the transfer is limited to providing certain servicing and collection actions on behalf of the purchasers of the designated trade receivables. Proceeds from amounts factored by the Company are recorded as an increase to cash and a reduction to accounts receivable outstanding in the Company's Consolidated Balance Sheets. Cash flows attributable to factoring are reflected as cash flows from operating activities in the Company&#8217;s Consolidated Statements of Cash Flows. Factoring fees associated with the sale of factored receivables for the three months ended January 31, 2019 were </font><font style="font-family:inherit;font-size:10pt;">$0.4 million</font><font style="font-family:inherit;font-size:10pt;"> and were minimal for the three months ended January 31, 2018.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Employee Benefits</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cooper&#8217;s Retirement Income Plan (the Plan), a defined benefit plan, covers substantially all full-time United States employees. Our contributions are designed to fund normal cost on a current basis and to fund the estimated prior service cost of benefit improvements. The unit credit actuarial cost method is used to determine the annual cost. Cooper pays the entire cost of the Plan and funds such costs as they accrue. Virtually all of the assets of the Plan are comprised of equities and participation in equity and fixed income funds.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our results of operations for the three months ended </font><font style="font-family:inherit;font-size:10pt;">January&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">, reflect the following components of net periodic pension costs:</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:71%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended January 31,</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Service cost </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest cost</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected return on plan assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Recognized net actuarial loss</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net periodic pension cost</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We did not contribute to the Plan in the first quarter of fiscal 2019 and expect to contribute </font><font style="font-family:inherit;font-size:10pt;">$10.0 million</font><font style="font-family:inherit;font-size:10pt;"> during the remainder of fiscal 2019. We did </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;">t contribute to the Plan in the first quarter of fiscal 2018. The expected rate of return on Plan assets for determining net periodic pension cost is </font><font style="font-family:inherit;font-size:10pt;">8%</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:95.20897043832824%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:61%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">January&#160;31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">October&#160;31, 2018</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total identifiable assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">CooperVision</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,869.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,746.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">CooperSurgical</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,214.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,201.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">214.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">165.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,298.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,112.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Product Revenue, Net </font><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company sells its products principally to a limited number of distributors, group purchasing organizations, eye care or health care professionals including independent practices, corporate retailers, hospitals and clinics or authorized resellers (collectively, its Customers). These Customers subsequently resell the Company&#8217;s products to eye care or health care providers and patients. In addition to product supply and distribution agreements with Customers, the Company enters into arrangements with health care providers and payors that provide for government-mandated and/or privately-negotiated rebates, chargebacks and discounts with respect to the purchase of the Company&#8217;s products. The Company considers customer purchase orders, which in some cases are governed by master sales agreements, to be contracts with a customer. In situations where sales are to a distributor, the Company has concluded that its contracts are with the distributor. As part of its consideration of the contract, the Company evaluates certain factors including the customer&#8217;s ability to pay (or credit risk). For each contract, the Company considers the promise to transfer products, each of which is distinct, to be the identified performance obligations.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues from product sales are recognized when the Customer obtains control of the Company&#8217;s product, which occurs at a point in time, typically upon shipment or delivery to the Customer. When the Company performs shipping and handling activities after the transfer of control to the Customer (e.g., when control transfers prior to delivery), they are considered as fulfillment activities, and accordingly, the costs are accrued for when the related revenue is recognized. Taxes collected from Customers relating to product sales and remitted to governmental authorities are excluded from revenues. The Company does not have any revenue recognized on payment expected to be received more than one year after the transfer of control of the products. The Company expenses incremental costs of obtaining a contract as and when incurred if the expected amortization period of the asset that the Company would have recognized is one year or less. See Note14. Business Segment Information, for disaggregation of revenue.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160; </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Reserves for Variable Consideration </font><font style="font-family:inherit;font-size:10pt;">&#160; </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues from product sales are recorded at the net sales price (transaction price), which includes estimates of variable consideration for which reserves are established and which result from discounts, returns, chargebacks, rebates and other allowances that are offered within contracts between the Company and its Customers, health care providers, payors and other indirect customers relating to the Company&#8217;s sales of its products. These reserves are based on the amounts earned or to be claimed on the related sales and are classified primarily in current liability. Variable consideration is estimated based on the most likely amount or expected value approach, depending on which method the Company expects to better predict the amount of consideration to which it will be entitled. Once the Company elects one of the methods to estimate variable consideration for a particular type of performance obligation, the Company will apply that method consistently.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Where appropriate, these estimates take into consideration a range of possible outcomes which are probability-weighted for relevant factors such as the Company&#8217;s historical experience, current contractual and statutory requirements, specific known market events and trends, industry data and forecasted customer buying and payment patterns. Overall, these reserves reflect the Company&#8217;s best estimates of the amount of consideration to which it is entitled based on the terms of the contract. Actual amounts of consideration ultimately received may differ from the Company&#8217;s estimates. If actual results in the future vary from the Company&#8217;s estimates, the Company adjusts these estimates, which would affect net product revenue and earnings in the period such variances become known.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160; </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Trade Discounts and Allowances</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company generally provides Customers with discounts, which include incentive fees that are stated in the Company&#8217;s contracts and are recorded as a reduction of revenue in the period the related product revenue is recognized. In addition, the Company receives sales order management, data and distribution services from certain Customers. To the extent the services received are distinct from the Company&#8217;s sale of products to the Customer and have readily determinable fair value, these payments are classified in selling, general and administrative expenses in the consolidated statements of income of the Company.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160; </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Product Returns</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Consistent with industry practice, the Company generally offers Customers a limited right of return for a product that has been purchased from the Company. The Company estimates the amount of its product sales that may be returned by its Customers and records this estimate as a reduction of revenue in the period the related product revenue is recognized. There is inherent judgment in estimating future refunds as they are susceptible to factors outside of our influence. However, we have significant experience in estimating the amount of refunds, based primarily on historical data. Our refund liability for product returns was&#160;</font><font style="font-family:inherit;font-size:10pt;">$12.6 million</font><font style="font-family:inherit;font-size:10pt;">&#160;at&#160;</font><font style="font-family:inherit;font-size:10pt;">January&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;"> which is included in Accrued liabilities on our Condensed Consolidated Balance Sheets and represents the expected value of the aggregate refunds that will be due to our customers. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160; </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Rebates and Chargebacks</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Rebates are estimated based on contractual terms, historical experience, customer mix, trend analysis and projected market conditions in the various markets served.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Chargebacks for fees and discounts to providers represent the estimated obligations resulting from contractual commitments to sell products to qualified healthcare providers at prices lower than the list wholesale prices charged to the Company&#8217;s direct customers. For certain office and surgical products in CooperSurgical, customers charge the Company for the difference between what they pay for the product and the ultimate selling price to the qualified healthcare providers. These reserves are established in the same period that the related revenue is recognized, resulting in a reduction of product revenue. Chargeback amounts are generally determined at the time of resale to the qualified healthcare provider by Customers. CooperSurgical rebates are predominately related to the Medicaid rebate provision that is estimated based upon contractual terms, historical experience, and trend analysis.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Contract balances</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The timing of billing and revenue recognition primarily occurs simultaneously. The Company does not have material contract assets or liabilities.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Revenue Recognition</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Product Revenue, Net </font><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company sells its products principally to a limited number of distributors, group purchasing organizations, eye care or health care professionals including independent practices, corporate retailers, hospitals and clinics or authorized resellers (collectively, its Customers). These Customers subsequently resell the Company&#8217;s products to eye care or health care providers and patients. In addition to product supply and distribution agreements with Customers, the Company enters into arrangements with health care providers and payors that provide for government-mandated and/or privately-negotiated rebates, chargebacks and discounts with respect to the purchase of the Company&#8217;s products. The Company considers customer purchase orders, which in some cases are governed by master sales agreements, to be contracts with a customer. In situations where sales are to a distributor, the Company has concluded that its contracts are with the distributor. As part of its consideration of the contract, the Company evaluates certain factors including the customer&#8217;s ability to pay (or credit risk). For each contract, the Company considers the promise to transfer products, each of which is distinct, to be the identified performance obligations.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues from product sales are recognized when the Customer obtains control of the Company&#8217;s product, which occurs at a point in time, typically upon shipment or delivery to the Customer. When the Company performs shipping and handling activities after the transfer of control to the Customer (e.g., when control transfers prior to delivery), they are considered as fulfillment activities, and accordingly, the costs are accrued for when the related revenue is recognized. Taxes collected from Customers relating to product sales and remitted to governmental authorities are excluded from revenues. The Company does not have any revenue recognized on payment expected to be received more than one year after the transfer of control of the products. The Company expenses incremental costs of obtaining a contract as and when incurred if the expected amortization period of the asset that the Company would have recognized is one year or less. See Note14. Business Segment Information, for disaggregation of revenue.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160; </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Reserves for Variable Consideration </font><font style="font-family:inherit;font-size:10pt;">&#160; </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues from product sales are recorded at the net sales price (transaction price), which includes estimates of variable consideration for which reserves are established and which result from discounts, returns, chargebacks, rebates and other allowances that are offered within contracts between the Company and its Customers, health care providers, payors and other indirect customers relating to the Company&#8217;s sales of its products. These reserves are based on the amounts earned or to be claimed on the related sales and are classified primarily in current liability. Variable consideration is estimated based on the most likely amount or expected value approach, depending on which method the Company expects to better predict the amount of consideration to which it will be entitled. Once the Company elects one of the methods to estimate variable consideration for a particular type of performance obligation, the Company will apply that method consistently.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Where appropriate, these estimates take into consideration a range of possible outcomes which are probability-weighted for relevant factors such as the Company&#8217;s historical experience, current contractual and statutory requirements, specific known market events and trends, industry data and forecasted customer buying and payment patterns. Overall, these reserves reflect the Company&#8217;s best estimates of the amount of consideration to which it is entitled based on the terms of the contract. Actual amounts of consideration ultimately received may differ from the Company&#8217;s estimates. If actual results in the future vary from the Company&#8217;s estimates, the Company adjusts these estimates, which would affect net product revenue and earnings in the period such variances become known.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160; </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Trade Discounts and Allowances</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company generally provides Customers with discounts, which include incentive fees that are stated in the Company&#8217;s contracts and are recorded as a reduction of revenue in the period the related product revenue is recognized. In addition, the Company receives sales order management, data and distribution services from certain Customers. To the extent the services received are distinct from the Company&#8217;s sale of products to the Customer and have readily determinable fair value, these payments are classified in selling, general and administrative expenses in the consolidated statements of income of the Company.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160; </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Product Returns</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Consistent with industry practice, the Company generally offers Customers a limited right of return for a product that has been purchased from the Company. The Company estimates the amount of its product sales that may be returned by its Customers and records this estimate as a reduction of revenue in the period the related product revenue is recognized. There is inherent judgment in estimating future refunds as they are susceptible to factors outside of our influence. However, we have significant experience in estimating the amount of refunds, based primarily on historical data. Our refund liability for product returns was&#160;</font><font style="font-family:inherit;font-size:10pt;">$12.6 million</font><font style="font-family:inherit;font-size:10pt;">&#160;at&#160;</font><font style="font-family:inherit;font-size:10pt;">January&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;"> which is included in Accrued liabilities on our Condensed Consolidated Balance Sheets and represents the expected value of the aggregate refunds that will be due to our customers. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160; </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Rebates and Chargebacks</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Rebates are estimated based on contractual terms, historical experience, customer mix, trend analysis and projected market conditions in the various markets served.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Chargebacks for fees and discounts to providers represent the estimated obligations resulting from contractual commitments to sell products to qualified healthcare providers at prices lower than the list wholesale prices charged to the Company&#8217;s direct customers. For certain office and surgical products in CooperSurgical, customers charge the Company for the difference between what they pay for the product and the ultimate selling price to the qualified healthcare providers. These reserves are established in the same period that the related revenue is recognized, resulting in a reduction of product revenue. Chargeback amounts are generally determined at the time of resale to the qualified healthcare provider by Customers. CooperSurgical rebates are predominately related to the Medicaid rebate provision that is estimated based upon contractual terms, historical experience, and trend analysis.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Contract balances</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The timing of billing and revenue recognition primarily occurs simultaneously. The Company does not have material contract assets or liabilities.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Analysis of Changes in Accumulated Other Comprehensive (Loss) Income:</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:93.78757515030061%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:67%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Foreign Currency Translation Adjustment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Minimum Pension Liability</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at October 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(353.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(21.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(375.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross change in value during the year ended October 31, 2018</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(58.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(47.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Tax effect for the period</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ASU 2018-02 adoption</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;background-color:transparent; font-size:7pt">(1)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:normal;">Balance at October 31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(412.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(18.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(430.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross change in value during the three months ended January 31, 2019</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:normal;">Balance at January 31, 2019</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(379.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(18.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(398.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:9pt;padding-left:0px;"><font style="font-family:inherit;font-size:9pt;font-style:italic;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1) </sup></font><font style="font-family:inherit;font-size:9pt;font-style:italic;"> </font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">Represents reclassification to retained earnings from adoption of ASU 2018-02. Refer to our Annual Report on Form 10-K for the fiscal year ended October 31, 2018 for more details.</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table sets forth stock options to purchase Cooper&#8217;s common stock and restricted stock units that were not included in the diluted earnings per share calculation because their effect would have been antidilutive for the periods presented:</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:95.72649572649573%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td style="width:63%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended January 31,</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">(In thousands, except exercise prices)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Number of stock option shares excluded</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">377</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,202</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Range of exercise prices</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$226.30-$254.77</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$15.83-$229.66</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Number of restricted stock units excluded</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">546</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:95.41284403669725%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:64%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;text-decoration:underline;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">January&#160;31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">October&#160;31, 2018</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Overdraft and other credit facilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Term loans</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">400.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: unamortized debt issuance cost</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Short-term Debt</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">445.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revolving credit</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">140.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">439.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Term loans</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,550.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,550.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: unamortized debt issuance cost</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term Debt</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,686.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,985.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Debt</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,132.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,022.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:69%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended January 31,</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">(In millions, except per share amounts)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income (loss)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">103.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(122.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Basic:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average common shares</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic earnings (loss) per share</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.09</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.50</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Diluted:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average common shares</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effect of potential dilutive shares</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted weighted average common shares*</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted earnings (loss) per share attributable to Cooper stockholders</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.07</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.50</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td colspan="8" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-style:italic;">*The number of diluted weighted average common shares used to calculate fiscal 2018 diluted loss per share excludes all potentially dilutive instrument because they would be antidilutive due to the net loss position.</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The compensation expense and related income tax benefit recognized in our consolidated condensed financial statements for share-based awards were as follows:</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:93.78757515030061%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended January 31,</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Selling, general and administrative expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of sales</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development expense</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total share-based compensation expense</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Related income tax benefit</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:95.20897043832824%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:61%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">January&#160;31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">October&#160;31, 2018</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net property, plant and equipment by country of domicile:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">United States</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">550.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">516.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Europe</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">349.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">340.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Rest of world</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">124.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">118.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,023.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">976.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Other Intangible Assets</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="18" rowspan="1"></td></tr><tr><td style="width:32%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">January 31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross&#160;Carrying</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross&#160;Carrying</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:13px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted Average Amortization Period (In years)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trademarks</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">149.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">139.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Composite intangible asset</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,061.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,061.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">70.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Technology</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">405.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">198.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">395.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">190.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Customer relationships</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">359.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">175.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">350.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">168.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">License and distribution rights and other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">76.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">56.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">74.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">52.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,052.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">537.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,021.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">499.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: accumulated amortization and translation</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">537.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">499.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Other intangible assets, net</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,514.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,521.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Goodwill</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:56%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">CooperVision</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">CooperSurgical</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Balance at October 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,735.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">619.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,354.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net additions during the year ended October 31, 2018</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Translation</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(29.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(33.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at October 31, 2018</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,742.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">649.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,392.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Net additions during the three months ended January 31, 2019</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Translation</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Balance at January 31, 2019</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,776.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">672.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,449.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:92.98597194388778%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:59%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">January&#160;31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">October&#160;31, 2018</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Raw materials</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">119.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">112.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Work-in-process</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Finished goods</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">353.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">343.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">486.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">468.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our results of operations for the three months ended </font><font style="font-family:inherit;font-size:10pt;">January&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">, reflect the following components of net periodic pension costs:</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:71%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended January 31,</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Service cost </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest cost</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected return on plan assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Recognized net actuarial loss</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net periodic pension cost</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the relative fair values of net assets acquired and liabilities assumed using the cost accumulation and allocation model:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:98.11320754716981%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:84%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Relative Fair Value </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Composite intangible asset </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,061.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assembled workforce intangible asset</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;(2)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Property, plant and equipment</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventory </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total assets acquired</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,121.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: liabilities assumed</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total Purchase Price</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">1,105.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company proportionally allocated the acquisition costs to the net assets acquired. The acquisition-related costs included advisory, legal, valuation and other professional fees.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1) </sup></font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Composite&#160;Intangible asset consists of technology, trade name, New Drug Application (NDA) approval and physician relationships, which have been valued as a single composite intangible asset as they are inextricably linked. The composite asset was identified as the primary asset acquired, was valued using the Multi-Period Excess Earnings Method and will be amortized over </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">15 years</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2) </sup></font><font style="font-family:inherit;font-size:10pt;font-style:italic;">An assembled workforce was recognized as a separate acquired intangible asset, given the purchase of assets and will be amortized over </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">5 years</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3) </sup></font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Inventory relative fair value includes step up of </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">$45.4 million</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">.</font></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following is a summary of the allocation of the total purchase consideration for business and asset acquisitions that the Company completed during fiscal 2019 and 2018:</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:98.11320754716981%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:67%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">January 31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31, 2018</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Technology</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer relationships</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trademarks</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Composite intangible asset</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,061.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total identifiable intangible assets</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,189.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">70.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net tangible assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">59.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total purchase price</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">64.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,319.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Geographic information:</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:95.20897043832824%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:61%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended January 31,</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net sales to unaffiliated customers by country of domicile:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">United States</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">278.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">261.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Europe</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">209.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">203.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Rest of world</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">139.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">124.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">628.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">590.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Segment information:</font></div><div style="line-height:120%;text-align:justify;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:95.20897043832824%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:61%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended January 31,</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">CooperVision net sales by category:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Toric lens</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">146.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">137.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Multifocal lens</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Single-use sphere lens</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">132.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">116.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non single-use sphere and other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">142.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">143.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:84px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:normal;">Total CooperVision net sales</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">470.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">444.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">CooperSurgical net sales by category:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Office and surgical procedures</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">95.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fertility</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">62.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">57.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:84px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:normal;">Total CooperSurgical net sales</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">158.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">145.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:normal;">Total net sales</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">628.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">590.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating income (loss):</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">CooperVision</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">116.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">112.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">CooperSurgical</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:normal;">Total operating income</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">110.9</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">90.2</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest expense</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other income, net</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:normal;">Income before income taxes</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">74.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Business Segment Information</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cooper uses operating income, as presented in our financial reports, as the primary measure of segment profitability. We do not allocate costs from corporate functions to segment operating income. Items below operating income are not considered when measuring the profitability of a segment. We use the same accounting policies to generate segment results as we do for our consolidated results.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total identifiable assets are those used in continuing operations except cash and cash equivalents, which we include as corporate assets. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Segment information:</font></div><div style="line-height:120%;text-align:justify;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:95.20897043832824%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:61%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended January 31,</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">CooperVision net sales by category:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Toric lens</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">146.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">137.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Multifocal lens</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Single-use sphere lens</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">132.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">116.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non single-use sphere and other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">142.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">143.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:84px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:normal;">Total CooperVision net sales</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">470.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">444.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">CooperSurgical net sales by category:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Office and surgical procedures</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">95.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fertility</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">62.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">57.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:84px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:normal;">Total CooperSurgical net sales</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">158.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">145.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:normal;">Total net sales</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">628.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">590.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating income (loss):</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">CooperVision</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">116.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">112.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">CooperSurgical</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:normal;">Total operating income</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">110.9</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">90.2</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest expense</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other income, net</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:normal;">Income before income taxes</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">74.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:95.20897043832824%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:61%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">January&#160;31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">October&#160;31, 2018</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total identifiable assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">CooperVision</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,869.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,746.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">CooperSurgical</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,214.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,201.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">214.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">165.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,298.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,112.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Geographic information:</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:95.20897043832824%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:61%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended January 31,</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net sales to unaffiliated customers by country of domicile:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">United States</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">278.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">261.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Europe</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">209.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">203.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Rest of world</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">139.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">124.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">628.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">590.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:95.20897043832824%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:61%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">January&#160;31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">October&#160;31, 2018</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net property, plant and equipment by country of domicile:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">United States</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">550.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">516.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Europe</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">349.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">340.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Rest of world</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">124.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">118.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,023.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">976.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Stockholders&#8217; Equity</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Analysis of Changes in Accumulated Other Comprehensive (Loss) Income:</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:93.78757515030061%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:67%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Foreign Currency Translation Adjustment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Minimum Pension Liability</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at October 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(353.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(21.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(375.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross change in value during the year ended October 31, 2018</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(58.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(47.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Tax effect for the period</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ASU 2018-02 adoption</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;background-color:transparent; font-size:7pt">(1)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:normal;">Balance at October 31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(412.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(18.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(430.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross change in value during the three months ended January 31, 2019</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:normal;">Balance at January 31, 2019</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(379.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(18.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(398.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:9pt;padding-left:0px;"><font style="font-family:inherit;font-size:9pt;font-style:italic;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1) </sup></font><font style="font-family:inherit;font-size:9pt;font-style:italic;"> </font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">Represents reclassification to retained earnings from adoption of ASU 2018-02. Refer to our Annual Report on Form 10-K for the fiscal year ended October 31, 2018 for more details.</font></div></td></tr></table><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Share Repurchases</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In December 2011, our Board of Directors authorized the 2012 Share Repurchase Program and through subsequent amendments, the most recent in March 2017, the total repurchase authorization was increased from </font><font style="font-family:inherit;font-size:10pt;">$500.0 million</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">$1.0 billion</font><font style="font-family:inherit;font-size:10pt;"> of the Company's common stock. This program has no expiration date and may be discontinued at any time. Purchases under the 2012 Share Repurchase Program are subject to a review of the circumstances in place at the time and may be made from time to time as permitted by securities laws and other legal requirements. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the fiscal first quarter of 2019, we repurchased </font><font style="font-family:inherit;font-size:10pt;">24.5 thousand</font><font style="font-family:inherit;font-size:10pt;"> shares of the Company's common stock for </font><font style="font-family:inherit;font-size:10pt;">$6.1 million</font><font style="font-family:inherit;font-size:10pt;">, at an average purchase price of </font><font style="font-family:inherit;font-size:10pt;">$248.70</font><font style="font-family:inherit;font-size:10pt;"> per share. We did </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;">t repurchase shares during the fiscal year ended October 31, 2018. At </font><font style="font-family:inherit;font-size:10pt;">January&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$557.4 million</font><font style="font-family:inherit;font-size:10pt;"> remains authorized for repurchase under the program. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Dividends</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We paid a semiannual dividend of approximately </font><font style="font-family:inherit;font-size:10pt;">$1.5 million</font><font style="font-family:inherit;font-size:10pt;"> or </font><font style="font-family:inherit;font-size:10pt;">3 cents</font><font style="font-family:inherit;font-size:10pt;"> per share on February 8, 2019, to stockholders of record on </font><font style="font-family:inherit;font-size:10pt;">January&#160;22, 2019</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Subsequent Event</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Filshie Clip System</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On February 1, 2019, subsequent to the first quarter of fiscal 2019, the Company agreed to the early termination of an exclusive distribution agreement with Femcare Ltd. which had given CooperSurgical the exclusive rights to distribute the Filshie Clip System in the U.S. The Company received consideration of </font><font style="font-family:inherit;font-size:10pt;">$21 million</font><font style="font-family:inherit;font-size:10pt;"> on January 31, 2019, from Utah Medical Products, Inc. (UTMD), the parent company of Femcare Ltd., in exchange for the agreement to terminate the exclusive distribution agreement prior to the end of the contractual term. UTMD has also agreed to buyback resaleable Filshie Clip System inventory.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Diverted Profit Tax</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On February 26, 2019, subsequent to the first quarter of fiscal 2019, the Company received a refund of approximately GBP </font><font style="font-family:inherit;font-size:10pt;">22.1 million</font><font style="font-family:inherit;font-size:10pt;"> (USD </font><font style="font-family:inherit;font-size:10pt;">29.0 million</font><font style="font-family:inherit;font-size:10pt;">) from the GBP </font><font style="font-family:inherit;font-size:10pt;">31 million</font><font style="font-family:inherit;font-size:10pt;"> (USD </font><font style="font-family:inherit;font-size:10pt;">42.0 million</font><font style="font-family:inherit;font-size:10pt;">) payment made on January 19, 2018 to the U.K. Tax Authorities. The payment had been made in regard to the Diverted Profit Tax matter related to the transfer of certain intellectual property rights in connection with the 2014 acquisition of Sauflon Pharmaceutical Ltd.</font></div></div> We adopted ASU 2016-16, Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory in the first quarter of fiscal 2019. Refer to “Note 1. General" for further information. EX-101.SCH 8 coo-20190131.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 2104100 - Disclosure - Acquisitions link:presentationLink link:calculationLink link:definitionLink 2304301 - Disclosure - Acquisitions Acquisitions (Tables) link:presentationLink link:calculationLink link:definitionLink 2404402 - Disclosure - Acquisitions (Details) link:presentationLink link:calculationLink link:definitionLink 2117100 - Disclosure - Business Segment Information link:presentationLink link:calculationLink link:definitionLink 2417403 - Disclosure - Business Segment Information (Schedule of Identifiable Assets By Segment Information) (Details) link:presentationLink link:calculationLink link:definitionLink 2417405 - Disclosure - Business Segment Information (Schedule of Long-Lived Assets By Country Of Domicile) (Details) link:presentationLink link:calculationLink link:definitionLink 2417404 - Disclosure - Business Segment Information (Schedule of Net Sales To External Customers By Country Of Domicile) (Details) link:presentationLink link:calculationLink link:definitionLink 2417402 - Disclosure - Business Segment Information (Schedule of Segment Information) (Details) link:presentationLink link:calculationLink link:definitionLink 2317301 - Disclosure - Business Segment Information (Tables) link:presentationLink link:calculationLink link:definitionLink 1002000 - Statement - Consolidated Condensed Balance Sheets link:presentationLink link:calculationLink link:definitionLink 1002000 - Statement - Consolidated Condensed Balance Sheets link:presentationLink link:calculationLink link:definitionLink 1002501 - Statement - Consolidated Condensed Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1004000 - Statement - Consolidated Condensed Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 1002000 - Statement - Consolidated Statements of Comprehensive Income (Loss) link:presentationLink link:calculationLink link:definitionLink 1001000 - Statement - Consolidated Statements of Income link:presentationLink link:calculationLink link:definitionLink 1003000 - Statement - Consolidated Statements of Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 2116100 - Disclosure - Contingencies link:presentationLink link:calculationLink link:definitionLink 2416401 - Disclosure - Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 2108100 - Disclosure - Debt link:presentationLink link:calculationLink link:definitionLink 2408403 - Disclosure - Debt (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2408402 - Disclosure - Debt (Schedule of Debt) (Details) link:presentationLink link:calculationLink link:definitionLink 2308301 - Disclosure - Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 0001000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 2110100 - Disclosure - Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 2410402 - Disclosure - Earnings Per Share (Schedule of Earnings Per Share) (Details) link:presentationLink link:calculationLink link:definitionLink 2410403 - Disclosure - Earnings Per Share (Schedule of Stock Options to Purchase Common Stock Not Included in Diluted Net Income Per Share Calculation) (Details) link:presentationLink link:calculationLink link:definitionLink 2310301 - Disclosure - Earnings Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 2115100 - Disclosure - Employee Benefits link:presentationLink link:calculationLink link:definitionLink 2415403 - Disclosure - Employee Benefits (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2415402 - Disclosure - Employee Benefits (Schedule of Components of Net Periodic Pension Costs) (Details) link:presentationLink link:calculationLink link:definitionLink 2315301 - Disclosure - Employee Benefits (Tables) link:presentationLink link:calculationLink link:definitionLink 2114100 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 2101100 - Disclosure - General link:presentationLink link:calculationLink link:definitionLink 2401402 - Disclosure - General (Details) link:presentationLink link:calculationLink link:definitionLink 2201201 - Disclosure - General (Policies) link:presentationLink link:calculationLink link:definitionLink 2109100 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 2409401 - Disclosure - Income Taxes (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2107100 - Disclosure - Intangible Assets link:presentationLink link:calculationLink link:definitionLink 2407404 - Disclosure - Intangible Assets (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2407402 - Disclosure - Intangible Assets (Schedule of Goodwill) (Details) link:presentationLink link:calculationLink link:definitionLink 2407403 - Disclosure - Intangible Assets (Schedule of Other Intangible Assets) (Details) link:presentationLink link:calculationLink link:definitionLink 2307301 - Disclosure - Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 2106100 - Disclosure - Inventories link:presentationLink link:calculationLink link:definitionLink 2406402 - Disclosure - Inventories (Schedule of Inventories) (Details) link:presentationLink link:calculationLink link:definitionLink 2306301 - Disclosure - Inventories (Tables) link:presentationLink link:calculationLink link:definitionLink 2103100 - Disclosure - Revenue Recognition link:presentationLink link:calculationLink link:definitionLink 2403401 - Disclosure - Revenue Recognition (Details) link:presentationLink link:calculationLink link:definitionLink 2111100 - Disclosure - Share-Based Compensation Plans link:presentationLink link:calculationLink link:definitionLink 2411402 - Disclosure - Share-Based Compensation Plans - Schedule of Compensation Expense And Related Income Tax Benefit For Share-Based Awards (Details) link:presentationLink link:calculationLink link:definitionLink 2311301 - Disclosure - Share-Based Compensation Plans (Tables) link:presentationLink link:calculationLink link:definitionLink 2113100 - Disclosure - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 2413404 - Disclosure - Stockholders' Equity (Dividends) (Details) link:presentationLink link:calculationLink link:definitionLink 2413402 - Disclosure - Stockholders' Equity - Schedule of Changes in Accumulated Other Comprehensive Income (Loss) (Details) link:presentationLink link:calculationLink link:definitionLink 2413403 - Disclosure - Stockholders' Equity (Share Repurchases) (Details) link:presentationLink link:calculationLink link:definitionLink 2313301 - Disclosure - Stockholders' Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 2418401 - Disclosure - Subsequent Event (Details) link:presentationLink link:calculationLink link:definitionLink 2118100 - Disclosure - Subsequent Event (Notes) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 9 coo-20190131_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 10 coo-20190131_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 11 coo-20190131_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Goodwill and Intangible Assets Disclosure [Abstract] Schedule of Goodwill Schedule of Goodwill [Table Text Block] Schedule of Other Intangible Assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Finite-lived Intangible Assets Amortization Expense Finite-lived Intangible Assets Amortization Expense [Table Text Block] Components of Income Tax Expense (Benefit), Continuing Operations [Abstract] Income Taxes Income Tax Disclosure [Text Block] Commitments and Contingencies Disclosure [Abstract] Contingencies Contingencies Disclosure [Text Block] Equity [Abstract] Stockholders' Equity Stockholders' Equity Note Disclosure [Text Block] Statement of Financial Position [Abstract] ASSETS Assets [Abstract] Current assets: Assets, Current [Abstract] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Trade accounts receivable, net of allowance for doubtful accounts of $19.7 at January 31, 2019 and $19.0 at October 31, 2018 Accounts Receivable, Net, Current Inventories Inventory, Net Prepaid expense and other current assets Prepaid Expense and Other Assets, Current Total current assets Assets, Current Property, plant and equipment, at cost Property, Plant and Equipment, Gross Less: accumulated depreciation and amortization Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Property, plant and equipment, net Property, Plant and Equipment, Net Goodwill Goodwill Other intangibles, net Intangible Assets, Net (Excluding Goodwill) Deferred tax assets Deferred Tax Assets, Net of Valuation Allowance, Noncurrent Other assets Other Assets, Noncurrent Total assets Assets LIABILITIES AND STOCKHOLDERS’ EQUITY Liabilities and Equity [Abstract] Current liabilities: Liabilities, Current [Abstract] Short-term debt Short-term Debt Accounts payable Accounts Payable, Current Employee compensation and benefits Employee-related Liabilities, Current Other current liabilities Other Liabilities, Current Total current liabilities Liabilities, Current Long-term debt Long-term Debt, Excluding Current Maturities Deferred tax liabilities Deferred Tax Liabilities, Net, Noncurrent Long-term tax payable Accrued Income Taxes, Noncurrent Accrued pension liability and other Accrued pension liability and other This represents the noncurrent liability recognized in the balance sheet that is associated with the defined benefit pension plans. (The current liability will be separate, but it will normally be small, if there is even any at all). It also represents aggregate carrying amount, as of the balance sheet date, of noncurrent obligations not separately disclosed in the balance sheet due to materiality considerations. Noncurrent liabilities are expected to be paid after one year (or the normal operating cycle, if longer). Total liabilities Liabilities Commitments and contingencies Commitments and Contingencies Stockholders’ equity: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Preferred stock, 10 cents par value, shares authorized: 1.0; zero shares issued or outstanding Preferred Stock, Value, Issued Common stock, 10 cents par value, shares authorized: 120.0; issued 52.9 at January 31, 2019 and 52.8 at October 31, 2018 Common Stock, Value, Issued Additional paid-in capital Additional Paid in Capital Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Retained earnings Retained Earnings (Accumulated Deficit) Treasury stock at cost: 3.6 shares at January 31, 2019 and 3.6 shares at October 31, 2018 Treasury Stock, Value Noncontrolling interests Stockholders' Equity Attributable to Noncontrolling Interest Stockholders’ equity Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Total liabilities and stockholders' equity Liabilities and Equity Earnings Per Share [Abstract] Net income (loss) attributable to Cooper stockholders Net Income (Loss) Attributable to Parent Basic: Earnings Per Share, Basic [Abstract] Weighted average common shares Weighted Average Number of Shares Outstanding, Basic Basic earnings (loss) per share attributable to Cooper stockholders Earnings Per Share, Basic Diluted: Earnings Per Share, Diluted [Abstract] Effect of potential dilutive shares Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements Diluted weighted average common shares Weighted Average Number of Shares Outstanding, Diluted Diluted earnings (loss) per share attributable to Cooper stockholders Earnings Per Share, Diluted Segment Reporting [Abstract] Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Statement, Geographical [Axis] Geographical [Axis] Segment, Geographical [Domain] Geographical [Domain] United States UNITED STATES Europe Europe [Member] Rest of world Rest Of World Other Eliminations And Corporate [Member] Rest Of World, Other Eliminations And Corporate [Member] Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Total long-lived assets Statement of Cash Flows [Abstract] Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Net income (loss) Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Depreciation and amortization Depreciation, Depletion and Amortization Increase in operating capital Increase (Decrease) in Operating Capital Increase in long-term tax payable Increase (Decrease) in Accrued Taxes Payable Other non-cash items Other Noncash Income (Expense) Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Purchases of property, plant and equipment Payments to Acquire Property, Plant, and Equipment Acquisitions of businesses and assets, net of cash acquired, and other Payments for (Proceeds from) Other Investing Activities Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Proceeds from long-term debt Proceeds from Issuance of Long-term Debt Repayments of long-term debt Repayments of Long-term Debt Net proceeds from short-term debt Proceeds from (Repayments of) Short-term Debt Net payments related to share-based compensation awards Proceeds from (Repurchase of) Equity Repurchase of common stock Payments for Repurchase of Redeemable Noncontrolling Interest Debt acquisition costs Payments of Debt Issuance Costs Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Effect of exchange rate changes on cash, cash equivalents and restricted cash Effect of Exchange Rate on Cash and Cash Equivalents Net increase in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, cash equivalents and restricted cash at beginning of period Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Cash, cash equivalents and restricted cash at end of period Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract] Cash and cash equivalents Restricted cash included in other current assets Restricted Cash and Cash Equivalents, Current Inventory Disclosure [Abstract] Raw materials Inventory, Raw Materials, Net of Reserves Work-in-process Inventory, Work in Process, Net of Reserves Finished goods Inventory, Finished Goods, Net of Reserves Inventories, net Schedule of Accumulated Other Comprehensive Income (Loss) Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Revenue from Contract with Customer [Abstract] Revenue Recognition Revenue from Contract with Customer [Text Block] Schedule of Stock by Class [Table] Schedule of Stock by Class [Table] Equity Components [Axis] Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Foreign Currency Translation Adjustment Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Minimum Pension Liability Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Class of Stock [Line Items] Class of Stock [Line Items] ASU 2016-16 adoption Cumulative Effect of New Accounting Principle in Period of Adoption Foreign Currency Translation Adjustment [Roll Forward] Cumulative Translation Adjustment Summary [Roll Forward] Foreign Currency Translation Adjustment, Beginning Balance Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax Foreign Currency Translation Adjustment, Gross change in value for the period Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss), before Reclassification and Tax Foreign Currency Translation Adjustment, tax effect Other Comprehensive Income (Loss), Foreign Currency Translation Gain (Loss) Arising During Period, Tax Foreign Currency Translation Adjustment, Ending Balance Minimum Pension Liability [Roll Forward] Accumulated Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans [Roll Forward] Accumulated Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans [Roll Forward] Minimum Pension Liability, Beginning Balance Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax Minimum Pension Liability, Gross change in value for the period Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, before Tax Minimum Pension Liability, tax effect Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax Minimum Pension Liability, Ending Balance Accumulated Other Comprehensive Income (Loss) [Roll Forward] AOCI Attributable to Parent, Net of Tax [Roll Forward] Total, Beginning balance Gross change in value for the period Other Comprehensive Income (Loss), before Reclassifications, before Tax Tax effect for the period Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent Total, Ending balance Organization, Consolidation and Presentation of Financial Statements [Abstract] General Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Schedule of Earnings Per Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule of Stock Options to Purchase Common Stock Not Included in Diluted Net Income Per Share Calculation Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Trade accounts receivable, allowance for doubtful accounts Allowance for Doubtful Accounts Receivable, Current Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Preferred stock, shares authorized Preferred Stock, Shares Authorized Preferred stock, shares issued Preferred Stock, Shares Issued Preferred stock, shares outstanding Preferred Stock, Shares Outstanding Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Common stock, shares authorized Common Stock, Shares Authorized Common stock, shares issued Common Stock, Shares, Issued Treasury stock, shares Treasury Stock, Shares Schedule of Inventories Schedule of Inventory, Current [Table Text Block] Product and Service [Axis] Product and Service [Axis] Product and Service [Domain] Product and Service [Domain] Office and surgical procedures Office And Surgical Procedures [Member] Office And Surgical Procedures [Member] Fertility Fertility [Member] Fertility [Member] Statement, Operating Activities Segment [Axis] Operating Activities [Axis] Segment, Operating Activities [Domain] Operating Activities [Domain] Toric lens Toric Soft Lens [Member] Toric Soft Lens [Member]. Multifocal lens Multifocal Soft Lens [Member] Multifocal Soft Lens [Member] Single-use sphere lens Single Use Sphere Soft Lens [Member] Single-Use Sphere Soft Lens [Member] Non single-use sphere and other Non Single Use Sphere And Other Eye Care Products [Member] Non Single-Use Sphere And Other Eye Care Products [Member] Business Segments [Axis] Segments [Axis] Segment [Domain] Segments [Domain] CooperVision Coopervision [Member] CooperVision [Member] CooperSurgical Coopersurgical [Member] CooperSurgical [Member] Corporate Corporate Segment [Member] Net sales Revenues Operating income (loss) Operating Income (Loss) Interest expense Interest Expense Other income, net Nonoperating Income (Expense) Income before income taxes Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest Share Repurchase Program, maximum amount authorized Stock Repurchase Program, Authorized Amount Average purchase price (in usd per share) Treasury Stock Acquired, Average Cost Per Share Number of common stock repurchased, shares Treasury Stock, Shares, Acquired Treasury Stock, Value, Acquired, Cost Method Treasury Stock, Value, Acquired, Cost Method Share Repurchase Program, remaining authorized amount Stock Repurchase Program, Remaining Authorized Repurchase Amount Document And Entity Information [Abstract] Document and Entity Information [Abstract] Document Type Document Type Amendment Flag Amendment Flag Entity Emerging Growth Company Entity Emerging Growth Company Entity Small Business Entity Small Business Document Period End Date Document Period End Date Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Central Index Key Current Fiscal Year End Date Current Fiscal Year End Date Entity Filer Category Entity Filer Category Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Retirement Benefits, Description [Abstract] Defined benefit plan, contributions by employer Defined Benefit Plan, Plan Assets, Contributions by Employer Defined benefit plan, estimated future employer contributions in current fiscal year Defined Benefit Plan, Expected Future Employer Contributions, Remainder of Fiscal Year Expected rate of return on plan assets for determining net periodic pension cost Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets Business Combinations [Abstract] Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Technology Technology-Based Intangible Assets [Member] Customer relationships Customer Relationships [Member] Trademarks Trademarks [Member] Composite intangible asset Composite [Member] Composite [Member] Other Other Intangible Assets [Member] Assembled Workforce Assembled Workforce [Member] Assembled Workforce [Member] Business Acquisition [Axis] Business Acquisition [Axis] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Series of Individually Immaterial Business Acquisitions Series of Individually Immaterial Business Acquisitions [Member] Paragard Paragard [Member] Paragard [Member] Business Acquisition [Line Items] Business Acquisition [Line Items] Business combination, recognized identifiable assets acquired and liabilities assumed, finite-lived intangibles Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles Property, plant and equipment Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment Inventory Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory Other assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets Total assets acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Less: liabilities assumed Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities Net tangible assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Total purchase consideration Business Combination, Consideration Transferred Acquired Finite-lived Intangible Assets, Weighted Average Useful Life Acquired Finite-lived Intangible Assets, Weighted Average Useful Life Inventory step up Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Inventory New Accounting Pronouncements or Change in Accounting Principle [Table] New Accounting Pronouncements or Change in Accounting Principle [Table] Adjustments for New Accounting Pronouncements [Axis] Adjustments for New Accounting Pronouncements [Axis] Type of Adoption [Domain] Type of Adoption [Domain] Accounting Standards Update 2016-16 Accounting Standards Update 2016-16 [Member] Retained Earnings Retained Earnings [Member] New Accounting Pronouncements or Change in Accounting Principle [Line Items] New Accounting Pronouncements or Change in Accounting Principle [Line Items] Cumulative effect, decrease to retained earnings Factoring fees associated with sale of factored receivables Factoring Fees Associated With Sale Of Factored Receivables Factoring Fees Associated With Sale Of Factored Receivables Share-based Compensation [Abstract] Share-Based Compensation Plans Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Earnings Per Share Earnings Per Share [Text Block] Debt Disclosure [Abstract] Line of Credit Facility [Table] Line of Credit Facility [Table] Debt Instrument [Axis] Debt Instrument [Axis] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Term Loan Agreement 2019 Term Loan Agreement 2019 [Member] Term Loan Agreement 2019 [Member] Senior Unsecured Term Loan Agreement Senior Unsecured Term Loan Agreement [Member] Senior Unsecured Term Loan Agreement [Member] Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Senior Notes Senior Notes [Member] 2017 Term Loan Two Thousand Seventeen Term Loan Agreement [Member] Two Thousand Seventeen Term Loan Agreement [Member] 2016 Credit Agreement 2016 Credit Agreement [Member] 2016 Credit Agreement [Member] Line of Credit Line of Credit [Member] Credit Facility [Axis] Credit Facility [Axis] Credit Facility [Domain] Credit Facility [Domain] Revolving Credit Facility Revolving Credit Facility [Member] Short-term Debt, Type [Axis] Short-term Debt, Type [Axis] Short-term Debt, Type [Domain] Short-term Debt, Type [Domain] Variable Rate [Axis] Variable Rate [Axis] Variable Rate [Domain] Variable Rate [Domain] Base Rate Base Rate [Member] Federal Funds Rate Federal Funds Rate [Member] Federal Funds Rate [Member] Eurodollar Eurodollar [Member] London Interbank Offered Rate (LIBOR) London Interbank Offered Rate (LIBOR) [Member] Range [Axis] Range [Axis] Range [Domain] Range [Domain] Minimum Minimum [Member] Maximum Maximum [Member] Line of Credit Facility [Line Items] Line of Credit Facility [Line Items] Debt term Debt Instrument, Term Debt instrument, face amount Debt Instrument, Face Amount Debt instrument, basis spread on variable rate Debt Instrument, Basis Spread on Variable Rate Weighted average interest rate Debt, Weighted Average Interest Rate Line of credit facility, initiation date Line of Credit Facility, Initiation Date Aggregate commitment amount of credit facility Line of Credit Facility, Maximum Borrowing Capacity Term loans Unsecured Long-term Debt, Noncurrent Debt instrument, maturity date Debt Instrument, Maturity Date Line of credit facility, potential additional borrowing capacity Line of Credit Facility, Additional Borrowing Capacity Line of Credit Facility, Additional Borrowing Capacity Line of credit facility interest rate margin on base rate loans percentage Line Of Credit Facility Interest Rate Margin On Base Rate Loans Percentage Line Of Credit Facility Interest Rate Margin On Base Rate Loans Percentage Line of credit facility interest rate margin on foreign currency loans percentage Line Of Credit Facility Interest Rate Margin On Foreign Currency Loans Percentage Line Of Credit Facility Interest Rate Margin On Foreign Currency Loans Percentage Commitment fee percentage Line of Credit Facility, Commitment Fee Percentage Amount outstanding on credit agreement Line of Credit Facility, Maximum Amount Outstanding During Period Amount available under the credit agreement Line of Credit Facility, Remaining Borrowing Capacity Required minimum Interest coverage ratio Required Minimum Interest Coverage Ratio Required minimum interest coverage ratio. Required maximum total leverage ratio Required Maximum Total Leverage Ratio Required maximum total leverage ratio. Interest coverage ratio Interest Coverage Ratio Interest Coverage Ratio Total leverage ratio Total Leverage Ratio Total Leverage Ratio Schedule of Compensation Expense and Related Income Tax Benefit for Share-Based Awards Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block] Statement of Comprehensive Income [Abstract] Statement [Table] Statement [Table] Common Shares Common Stock, Excluding Treasury Stock Par Net Value [Member] Common Stock, Excluding Treasury Stock Par Net Value [Member] Treasury Stock Treasury Stock [Member] Treasury Stock Par Net Value Treasury Stock Par Net Value [Member] Treasury Stock Par Net Value [Member] Additional Paid-In Capital Additional Paid-in Capital [Member] Accumulated Other Comprehensive Income (Loss) AOCI Attributable to Parent [Member] Noncontrolling Interests Noncontrolling Interest [Member] Statement [Line Items] Statement [Line Items] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Beginning Balance (in shares) Common Stock, Shares, Outstanding Beginning Balance Net income (loss) attributable to Cooper stockholders Other comprehensive income (loss), net of tax Other Comprehensive Income (Loss), Net of Tax Issuance of common stock for stock plans (in shares) Stock Issued During Period, Shares, New Issues Issuance of common stock for stock plans Stock Issued During Period, Value, New Issues Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures Dividends on common stock Dividends, Common Stock Share-based compensation expense Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition Treasury stock repurchase Ending Balance (in shares) Ending Balance Number of putative class action complaints filed (over) Loss Contingency, New Claims Filed, Number Litigation Settlement, Amount Loss Contingency Accrual Debt Debt Disclosure [Text Block] Schedule of Goodwill [Table] Schedule of Goodwill [Table] Goodwill [Line Items] Goodwill [Line Items] Goodwill [Roll Forward] Goodwill [Roll Forward] Balance, beginning Net additions during the three months ended January 31, 2019 Goodwill, Period Increase (Decrease) Translation Goodwill, Foreign Currency Translation Gain (Loss) Balance, ending Business Segment Information Segment Reporting Disclosure [Text Block] Employee Benefits Pension and Other Postretirement Benefits Disclosure [Text Block] Income Statement [Abstract] Cost of sales Cost of Goods and Services Sold Gross profit Gross Profit Selling, general and administrative expense Selling, General and Administrative Expense Research and development expense Research and Development Expense Amortization of intangibles Amortization of Intangible Assets Operating income (Benefit) provision for income taxes Income Tax Expense (Benefit) Earnings (loss) per share - basic (in usd per share) Earnings (loss) per share - diluted (in usd per share) Number of shares used to compute earnings (loss) per share: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Basic (shares) Diluted (shares) Accounting Pronouncements Issued Not Yet Adopted and Accounting Pronouncements Recently Adopted New Accounting Pronouncements, Policy [Policy Text Block] Revenue Recognition Revenue from Contract with Customer [Policy Text Block] Total net sales to external customers Fair Value Disclosures [Abstract] Fair Value Measurements Fair Value Disclosures [Text Block] Schedule of Components of Net Periodic Pension Costs Schedule of Net Benefit Costs [Table Text Block] Intangible Assets Intangible Assets Disclosure [Text Block] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Stock Options Employee Stock Option [Member] Restricted Stock Units (RSUs) Restricted Stock Units (RSUs) [Member] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Numbers of stock option shares excluded Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Range of exercise prices, lower limit Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit Range of exercise prices, upper limit Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table] Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table] Income Statement Location [Axis] Income Statement Location [Axis] Income Statement Location [Domain] Income Statement Location [Domain] Selling, general and administrative expense Selling, General and Administrative Expenses [Member] Cost of sales Cost of Sales [Member] Research and development expense Research and Development Expense [Member] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based compensation expense Share-based Compensation Total share-based compensation expense Allocated Share-based Compensation Expense Related income tax benefit Employee Service Share-based Compensation, Tax Benefit from Compensation Expense Other comprehensive income: Other Comprehensive Income (Loss), Net of Tax [Abstract] Foreign currency translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax Comprehensive income (loss) Comprehensive Income (Loss), Net of Tax, Attributable to Parent Schedule of Segment Information Schedule of Segment Reporting Information, by Segment [Table Text Block] Schedule of Identifiable Assets by Segment Reconciliation of Assets from Segment to Consolidated [Table Text Block] Schedule of Net Sales to External Customers by Country of Domicile Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block] Schedule of Long-Lived Assets by Country of Domicile Schedule of Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries by Country [Table Text Block] Service cost Defined Benefit Plan, Service Cost Interest cost Defined Benefit Plan, Interest Cost Expected return on plan assets Defined Benefit Plan, Expected Return (Loss) on Plan Assets Recognized net actuarial loss Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss) Net periodic pension cost Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Goodwill, Impairment Loss Goodwill, Impairment Loss Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract] Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract] Remainder of 2019 Finite-Lived Intangible Assets, Amortization Expense, Remainder of Fiscal Year 2020 Finite-Lived Intangible Assets, Amortization Expense, Year Two 2021 Finite-Lived Intangible Assets, Amortization Expense, Year Three 2022 Finite-Lived Intangible Assets, Amortization Expense, Year Four 2022 Finite-Lived Intangible Assets, Amortization Expense, Year Five Thereafter Finite-Lived Intangible Assets, Amortization Expense, after Year Five Total remaining amortization for intangible assets Finite-Lived Intangible Assets, Net Acquisitions Business Combination Disclosure [Text Block] Short-term: Short-term Debt [Abstract] Overdraft and other credit facilities Line of Credit, Current Term loans Long-term Debt, Current Maturities Less: unamortized debt issuance cost Short Term Unamortized Debt Issuance Expense Short Term Unamortized Debt Issuance Expense Short-term Debt Short-term Debt Long-term Debt, Unclassified [Abstract] Credit Agreement Long-term Line of Credit, Noncurrent Other Other Long-term Debt, Noncurrent Less: unamortized debt issuance cost Long Term Unamortized Debt Issuance Expense Long Term Unamortized Debt Issuance Expense Long-term debt Total Debt Debt, Long-term and Short-term, Combined Amount Schedule of Finite-Lived Intangible Assets by Major Class [Table] Schedule of Finite-Lived Intangible Assets [Table] License and distribution rights and other License And Distribution Rights And Other [Member] License and Distribution Rights and Other [Member] Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Gross Carrying Amount Finite-Lived Intangible Assets, Gross Accumulated Amortization & Translation Finite-Lived Intangible Assets, Accumulated Amortization Other intangible assets, net Finite-Lived Intangible Asset, Useful Life Finite-Lived Intangible Asset, Useful Life Total Identifiable assets Subsequent Events [Abstract] Subsequent Event Subsequent Events [Text Block] Subsequent Event [Table] Subsequent Event [Table] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Subsequent Event Subsequent Event [Member] Subsequent Event [Line Items] Subsequent Event [Line Items] Consideration received on contract termination Gain (Loss) on Contract Termination Refund from U.K. tax authorities Proceeds from Income Tax Refunds Payment for diverted profit tax Payment For Diverted Profit Tax Payment For Diverted Profit Tax Inventories Inventory Disclosure [Text Block] Dividends on common stock Payments of Ordinary Dividends, Common Stock Cash dividend, per share Common Stock, Dividends, Per Share, Cash Paid Dividends payable, date of record Dividends Payable, Date of Record Schedule of Debt Schedule of Debt [Table Text Block] Income tax expense (benefit) to finalize tax effects of 2017 Act Tax Cuts And Jobs Act, Income Tax Expense (Benefit) Tax Cuts And Jobs Act, Income Tax Expense (Benefit) Effective income tax rate Effective Income Tax Rate Reconciliation, Percent Change of provisional tax expenses related to 2017 Act Effective Income Tax Rate Reconciliation, Tax Cuts And Jobs Act, Amount Effective Income Tax Rate Reconciliation, Tax Cuts And Jobs Act, Amount Discrete tax benefits Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount Unrecognized tax benefits Unrecognized Tax Benefits Unrecognized tax benefits that could be settled Decrease in Unrecognized Tax Benefits is Reasonably Possible Schedule of Acquisitions Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Refund liability for product returns Contract with Customer, Refund Liability EX-101.PRE 12 coo-20190131_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 13 chart-3329bf5c849e51cc889.jpg begin 644 chart-3329bf5c849e51cc889.jpg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end GRAPHIC 14 chart-be3681e339bd5b4a896.jpg begin 644 chart-be3681e339bd5b4a896.jpg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end GRAPHIC 15 chart-ca1d8d37f1b85322aaa.jpg begin 644 chart-ca1d8d37f1b85322aaa.jpg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chart-ceb44c91116959d08de.jpg begin 644 chart-ceb44c91116959d08de.jpg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end GRAPHIC 17 netsalesq119.jpg begin 644 netsalesq119.jpg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end     XML 18 R1.htm IDEA: XBRL DOCUMENT v3.10.0.1
    Document and Entity Information - shares
    		 3 Months Ended
    Jan. 31, 2019
    Feb. 26, 2019
    Document And Entity Information [Abstract]    
    Document Type 10-Q  
    Amendment Flag false  
    Entity Emerging Growth Company false  
    Entity Small Business false  
    Document Period End Date Jan. 31, 2019  
    Document Fiscal Year Focus 2019  
    Document Fiscal Period Focus Q1  
    Entity Registrant Name COOPER COMPANIES INC  
    Entity Central Index Key 0000711404  
    Current Fiscal Year End Date --10-31  
    Entity Filer Category Large Accelerated Filer  
    Entity Common Stock, Shares Outstanding   49,374,137
    XML 19 R2.htm IDEA: XBRL DOCUMENT v3.10.0.1
    Consolidated Statements of Income - USD ($)
    shares in Millions, $ in Millions
    		 3 Months Ended
    Jan. 31, 2019
    Jan. 31, 2018
    Income Statement [Abstract]    
    Net sales $ 628.1 $ 590.0
    Cost of sales 209.6 219.1
    Gross profit 418.5 370.9
    Selling, general and administrative expense 250.0 225.9
    Research and development expense 21.0 18.8
    Amortization of intangibles 36.6 36.0
    Operating income 110.9 90.2
    Interest expense 18.2 18.4
    Other income, net 1.1 3.0
    Income before income taxes 93.8 74.8
    (Benefit) provision for income taxes (9.4) 197.3
    Net income (loss) $ 103.2 $ (122.5)
    Earnings (loss) per share - basic (in usd per share) $ 2.09 $ (2.50)
    Earnings (loss) per share - diluted (in usd per share) $ 2.07 $ (2.50)
    Number of shares used to compute earnings (loss) per share:    
    Basic (shares) 49.3 48.9
    Diluted (shares) 49.9 48.9
    XML 20 R3.htm IDEA: XBRL DOCUMENT v3.10.0.1
    Consolidated Condensed Balance Sheets - USD ($)
    $ in Millions
    Jan. 31, 2019
    Oct. 31, 2018
    Current assets:    
    Cash and cash equivalents $ 146.6 $ 77.7
    Trade accounts receivable, net of allowance for doubtful accounts of $19.7 at January 31, 2019 and $19.0 at October 31, 2018 389.7 374.7
    Inventories 486.2 468.8
    Prepaid expense and other current assets 170.5 169.7
    Total current assets 1,193.0 1,090.9
    Property, plant and equipment, at cost 2,009.3 1,930.3
    Less: accumulated depreciation and amortization 985.5 954.3
    Property, plant and equipment, net 1,023.8 976.0
    Goodwill 2,449.3 2,392.1
    Other intangibles, net 1,514.1 1,521.3
    Deferred tax assets 55.2 58.4
    Other assets 63.2 74.1
    Total assets 6,298.6 6,112.8
    Current liabilities:    
    Short-term debt 445.5 37.1
    Accounts payable 129.6 146.4
    Employee compensation and benefits 75.9 94.0
    Other current liabilities 287.6 259.0
    Total current liabilities 938.6 536.5
    Long-term debt 1,686.9 1,985.7
    Deferred tax liabilities 34.6 31.0
    Long-term tax payable 124.8 141.5
    Accrued pension liability and other 88.2 110.3
    Total liabilities 2,873.1 2,805.0
    Commitments and contingencies
    Stockholders’ equity:    
    Preferred stock, 10 cents par value, shares authorized: 1.0; zero shares issued or outstanding 0.0 0.0
    Common stock, 10 cents par value, shares authorized: 120.0; issued 52.9 at January 31, 2019 and 52.8 at October 31, 2018 5.3 5.3
    Additional paid-in capital 1,574.8 1,572.1
    Accumulated other comprehensive loss (398.0) (430.7)
    Retained earnings 2,664.4 2,576.0
    Treasury stock at cost: 3.6 shares at January 31, 2019 and 3.6 shares at October 31, 2018 (421.2) (415.1)
    Noncontrolling interests 0.2 0.2
    Stockholders’ equity 3,425.5 3,307.8
    Total liabilities and stockholders' equity $ 6,298.6 $ 6,112.8
    XML 21 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
    Consolidated Statements of Comprehensive Income (Loss) - USD ($)
    $ in Millions
    		 3 Months Ended
    Jan. 31, 2019
    Jan. 31, 2018
    Statement of Comprehensive Income [Abstract]    
    Net income (loss) $ 103.2 $ (122.5)
    Other comprehensive income:    
    Foreign currency translation adjustment 32.7 102.3
    Comprehensive income (loss) $ 135.9 $ (20.2)
    XML 22 R5.htm IDEA: XBRL DOCUMENT v3.10.0.1
    Consolidated Condensed Balance Sheets (Parenthetical) - USD ($)
    $ in Millions
    Jan. 31, 2019
    Oct. 31, 2018
    Statement of Financial Position [Abstract]    
    Trade accounts receivable, allowance for doubtful accounts $ 19.7 $ 19.0
    Preferred stock, par value (in dollars per share) $ 0.1 $ 0.1
    Preferred stock, shares authorized 1,000,000 1,000,000
    Preferred stock, shares issued 0 0
    Preferred stock, shares outstanding 0 0
    Common stock, par value (in dollars per share) $ 0.1 $ 0.1
    Common stock, shares authorized 120,000,000 120,000,000
    Common stock, shares issued 52,900,000 52,800,000
    Treasury stock, shares 3,600,000 3,600,000
    XML 23 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1
    Consolidated Statements of Stockholders' Equity - USD ($)
    shares in Millions, $ in Millions
    Total
    Common Shares
    Treasury Stock
    Treasury Stock Par Net Value
    Additional Paid-In Capital
    Accumulated Other Comprehensive Income (Loss)
    Retained Earnings
    Noncontrolling Interests
    Beginning Balance (in shares) at Oct. 31, 2017   48.8 3.6          
    Beginning Balance at Oct. 31, 2017 $ 3,175.8 $ 4.9 $ (415.1) $ 0.3 $ 1,526.7 $ (375.3) $ 2,434.2 $ 0.1
    Increase (Decrease) in Stockholders' Equity [Roll Forward]                
    Net income (loss) attributable to Cooper stockholders (122.5)           (122.5)  
    Other comprehensive income (loss), net of tax 102.3         102.3    
    Issuance of common stock for stock plans (in shares)   0.2            
    Issuance of common stock for stock plans   $ 0.1            
    Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures (10.5)       (10.6)      
    Dividends on common stock (1.4)           (1.4)  
    Share-based compensation expense 12.7       12.7      
    Ending Balance (in shares) at Jan. 31, 2018   49.0 3.6          
    Ending Balance at Jan. 31, 2018 3,156.4 $ 5.0 $ (415.1) 0.3 1,528.8 (273.0) 2,310.3 0.1
    Beginning Balance (in shares) at Oct. 31, 2018   49.2 3.6          
    Beginning Balance at Oct. 31, 2018 3,307.8 $ 5.0 $ (415.1) 0.3 1,572.1 (430.7) 2,576.0 0.2
    Increase (Decrease) in Stockholders' Equity [Roll Forward]                
    Net income (loss) attributable to Cooper stockholders 103.2           103.2  
    Other comprehensive income (loss), net of tax 32.7         32.7    
    Issuance of common stock for stock plans (in shares)   0.1            
    Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures (9.0)       (9.0)      
    Dividends on common stock (1.5)           (1.5)  
    Share-based compensation expense 11.7       11.7      
    Treasury stock repurchase (6.1)   $ (6.1)          
    Ending Balance (in shares) at Jan. 31, 2019   49.3 3.6          
    Ending Balance at Jan. 31, 2019 $ 3,425.5 $ 5.0 $ (421.2) $ 0.3 $ 1,574.8 $ (398.0) $ 2,664.4 $ 0.2
    XML 24 R7.htm IDEA: XBRL DOCUMENT v3.10.0.1
    Consolidated Condensed Statements of Cash Flows - USD ($)
    $ in Millions
    		 3 Months Ended
    Jan. 31, 2019
    Jan. 31, 2018
    Cash flows from operating activities:    
    Net income (loss) $ 103.2 $ (122.5)
    Depreciation and amortization 68.8 66.6
    Increase in operating capital (53.3) (177.0)
    Increase in long-term tax payable
    Other non-cash items (16.9) 259.1
    Net cash provided by operating activities 101.8 26.2
    Cash flows from investing activities:    
    Purchases of property, plant and equipment (79.2) (51.4)
    Acquisitions of businesses and assets, net of cash acquired, and other (50.0) (1,193.2)
    Net cash used in investing activities (129.2) (1,244.6)
    Cash flows from financing activities:    
    Proceeds from long-term debt 261.8 1,672.8
    Repayments of long-term debt (560.8) (445.8)
    Net proceeds from short-term debt 407.5 4.8
    Net payments related to share-based compensation awards (9.0) (10.5)
    Repurchase of common stock (6.1) 0.0
    Debt acquisition costs (0.2) (3.9)
    Net cash provided by financing activities 93.2 1,217.4
    Effect of exchange rate changes on cash, cash equivalents and restricted cash 0.9 3.9
    Net increase in cash, cash equivalents and restricted cash 66.7 2.9
    Cash, cash equivalents and restricted cash at beginning of period 80.2 88.8
    Cash, cash equivalents and restricted cash at end of period 146.9 91.7
    Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]    
    Cash and cash equivalents 146.6 91.4
    Restricted cash included in other current assets 0.3 0.3
    Cash, cash equivalents and restricted cash at end of period $ 146.9 $ 91.7
    XML 25 R8.htm IDEA: XBRL DOCUMENT v3.10.0.1
    General
    		 3 Months Ended
    Jan. 31, 2019
    Organization, Consolidation and Presentation of Financial Statements [Abstract]  
    General
    General

    The accompanying unaudited interim consolidated condensed financial statements and related notes should be read in conjunction with the audited Consolidated Financial Statements of the Cooper Companies, Inc. and its subsidiaries (the Company) and related notes as contained in the Company’s Annual Report on Form 10-K for the fiscal year ended October 31, 2018. The unaudited interim financial statements include all adjustments (consisting only of normal recurring adjustments) and accruals necessary in the judgment of management for a fair statement of the results for the periods presented. Readers should not assume that the results reported here either indicate or guarantee future performance. The terms "the Company", "we", "us", and "our" are used to refer collectively to the Cooper Companies, Inc. and its subsidiaries.
    Accounting Pronouncements Recently Adopted

    In March 2017, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2017-07, Compensation - Retirement Benefits (Topic 715): Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost. The ASU requires an entity to disaggregate the service cost component from the other components of net benefit cost. The service cost component is now presented in the same income statement line as other compensation costs arising from services rendered by the pertinent employees during the period and the other components of net benefit costs are presented separately as other income/expense below operating income. The Company adopted this guidance on November 1, 2018, and it did not have a material impact on the Company’s reported financial results.

    In October 2016, the FASB issued ASU 2016-16, Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory, which requires entities to recognize the income tax consequences on an intra-entity transfer of an asset other than inventory when the transfer occurs. The ASU changes the timing of the recognition of the income tax consequences of non-inventory transfers which under current guidance defers the income tax consequences until the asset is sold to an outside party or otherwise recognized. The guidance for the amendments of ASU 2016-16 requires companies to apply a modified retrospective approach with a cumulative catch-up adjustment to opening retained earnings in the period of adoption. The Company adopted ASU 2016-16 in the first quarter of fiscal 2019 on a modified retrospective basis. The Company recorded the cumulative effect of the change as a decrease to retained earnings of approximately $13.3 million. The cumulative effect adjustment represents the recognition of unrecognized income tax effects from intra-entity transfers of assets other than inventory that occurred prior to the date of adoption.

    In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606). The ASU requires revenue recognition to depict the transfer of goods or services to customers at an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The amendments in the ASU can be applied either retrospectively to each prior reporting period presented or alternatively, the modified retrospective transition method whereby the company recognizes the cumulative effect of initially applying the guidance as an opening balance sheet adjustment to equity in the period of initial application. This alternative approach must be supplemented by additional disclosures.

    We adopted ASU 2014-09 on November 1, 2018, using the modified retrospective transition method. We did not recognize any cumulative effect of initially applying the new revenue standard as an adjustment to our opening balance of retained earnings due to its immaterial impact. The comparative information has not been restated and continues to be reported under the accounting standards in effect for those periods. There was no material impact of ASC 606 to our financial statements during the three months ended January 31, 2019. We do not expect the adoption of the new revenue standard to have a material impact to our net income on an ongoing basis.

    The Company applies the provisions of Accounting Standards Codification (ASC) 606-10 or ASU 2014-09, Revenue from Contracts with Customers, and all related appropriate guidance. The Company recognizes revenue under the core principle to depict the transfer of control to the Company’s customers in an amount reflecting the consideration to which the Company expects to be entitled. In order to achieve that core principle, the Company applies the following five step approach: (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when a performance obligation is satisfied. For a complete discussion of accounting for net product revenue, see Note 2. Revenue Recognition.
    Accounting Pronouncements Issued Not Yet Adopted

    In November 2018, the FASB issued ASU 2018-18, Collaborative Arrangements (Topic 808), Clarifying the Interaction between Topic 808 and Topic 606. This guidance amended ASC 808 and ASC 606 to clarify that transactions in a collaborative arrangement should be accounted for under ASC 606 when the counterparty is a customer for a distinct good or service (i.e., unit of account). The amendments preclude an entity from presenting consideration from a transaction in a collaborative arrangement as revenue from contracts with customers if the counterparty is not a customer for that transaction. We are currently evaluating the impact of ASU 2018-18 which is effective for the Company in our fiscal year and interim periods beginning on November 1, 2020.
    In August 2018, the FASB issued ASU 2018-15, Intangibles-Goodwill and Other - Internal Use Software (Subtopic 350-40): Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That is a Service Contract. This guidance requires companies to apply the internal-use software guidance in ASC 350-40 to implementation costs incurred in a hosting arrangement that is a service contract to determine whether to capitalize certain implementation costs or expense them as incurred. We are currently evaluating the impact of ASU 2018-15 which is effective for the Company in our fiscal year and interim periods beginning on November 1, 2020.

    In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842). ASU 2016-02 requires that a lessee recognize the assets and liabilities that arise from operating leases. A lessee should recognize in the statement of financial position a liability to make lease payments (the lease liability) and a right-of-use (ROU) asset representing its right to use the underlying asset for the lease term. For leases with a term of 12 months or less, a lessee is permitted to make an accounting policy election by class of underlying asset not to recognize lease assets and lease liabilities. In transition, lessees and lessors are required to recognize and measure leases at the beginning of the earliest period presented using a modified retrospective approach. In July 2018, the FASB issued ASU 2018-10, Codification Improvements to Topic 842, Leases and ASU 2018-11, Leases Topic 842 Target improvements, which provides an additional (and optional) transition method whereby the new lease standard is applied at the adoption date and recognized as an adjustment to retained earnings. This standard is effective for the Company in our fiscal year and interim periods beginning on November 1, 2019.

    We anticipate this standard to have a material impact on our Consolidated Balance Sheets and related disclosures due to the recognition of ROU assets and lease liabilities for operating leases. However, we do not expect adoption to have a material impact on our Consolidated Income Statements. We are continuing to assess and evaluate the potential impacts of the standard as well as the election of transition method and certain practical expedients available within the ASU. We are in the process of documenting and analyzing our lease contracts, assessment of business processes and controls, selecting a system solution and completing our analysis of information necessary to determine the impact to the consolidated financial statements.

    Accounts Receivable Factoring Program

    We may factor certain designated trade receivables with one or more third party financial institutions pursuant to a factoring agreement. These are non-recourse factoring arrangements to assist us in managing operating cash flow and meet the requirements to be accounted for as sales in accordance with the “Transfers and Servicing” guidance in ASC 860, where the Company’s continuing involvement subsequent to the transfer is limited to providing certain servicing and collection actions on behalf of the purchasers of the designated trade receivables. Proceeds from amounts factored by the Company are recorded as an increase to cash and a reduction to accounts receivable outstanding in the Company's Consolidated Balance Sheets. Cash flows attributable to factoring are reflected as cash flows from operating activities in the Company’s Consolidated Statements of Cash Flows. Factoring fees associated with the sale of factored receivables for the three months ended January 31, 2019 were $0.4 million and were minimal for the three months ended January 31, 2018.
    XML 26 R9.htm IDEA: XBRL DOCUMENT v3.10.0.1
    Revenue Recognition
    		 3 Months Ended
    Jan. 31, 2019
    Revenue from Contract with Customer [Abstract]  
    Revenue Recognition
    Revenue Recognition

    Product Revenue, Net

    The Company sells its products principally to a limited number of distributors, group purchasing organizations, eye care or health care professionals including independent practices, corporate retailers, hospitals and clinics or authorized resellers (collectively, its Customers). These Customers subsequently resell the Company’s products to eye care or health care providers and patients. In addition to product supply and distribution agreements with Customers, the Company enters into arrangements with health care providers and payors that provide for government-mandated and/or privately-negotiated rebates, chargebacks and discounts with respect to the purchase of the Company’s products. The Company considers customer purchase orders, which in some cases are governed by master sales agreements, to be contracts with a customer. In situations where sales are to a distributor, the Company has concluded that its contracts are with the distributor. As part of its consideration of the contract, the Company evaluates certain factors including the customer’s ability to pay (or credit risk). For each contract, the Company considers the promise to transfer products, each of which is distinct, to be the identified performance obligations.

    Revenues from product sales are recognized when the Customer obtains control of the Company’s product, which occurs at a point in time, typically upon shipment or delivery to the Customer. When the Company performs shipping and handling activities after the transfer of control to the Customer (e.g., when control transfers prior to delivery), they are considered as fulfillment activities, and accordingly, the costs are accrued for when the related revenue is recognized. Taxes collected from Customers relating to product sales and remitted to governmental authorities are excluded from revenues. The Company does not have any revenue recognized on payment expected to be received more than one year after the transfer of control of the products. The Company expenses incremental costs of obtaining a contract as and when incurred if the expected amortization period of the asset that the Company would have recognized is one year or less. See Note14. Business Segment Information, for disaggregation of revenue.
     
    Reserves for Variable Consideration  

    Revenues from product sales are recorded at the net sales price (transaction price), which includes estimates of variable consideration for which reserves are established and which result from discounts, returns, chargebacks, rebates and other allowances that are offered within contracts between the Company and its Customers, health care providers, payors and other indirect customers relating to the Company’s sales of its products. These reserves are based on the amounts earned or to be claimed on the related sales and are classified primarily in current liability. Variable consideration is estimated based on the most likely amount or expected value approach, depending on which method the Company expects to better predict the amount of consideration to which it will be entitled. Once the Company elects one of the methods to estimate variable consideration for a particular type of performance obligation, the Company will apply that method consistently.

    Where appropriate, these estimates take into consideration a range of possible outcomes which are probability-weighted for relevant factors such as the Company’s historical experience, current contractual and statutory requirements, specific known market events and trends, industry data and forecasted customer buying and payment patterns. Overall, these reserves reflect the Company’s best estimates of the amount of consideration to which it is entitled based on the terms of the contract. Actual amounts of consideration ultimately received may differ from the Company’s estimates. If actual results in the future vary from the Company’s estimates, the Company adjusts these estimates, which would affect net product revenue and earnings in the period such variances become known.
     
    Trade Discounts and Allowances

    The Company generally provides Customers with discounts, which include incentive fees that are stated in the Company’s contracts and are recorded as a reduction of revenue in the period the related product revenue is recognized. In addition, the Company receives sales order management, data and distribution services from certain Customers. To the extent the services received are distinct from the Company’s sale of products to the Customer and have readily determinable fair value, these payments are classified in selling, general and administrative expenses in the consolidated statements of income of the Company.
     



    Product Returns

    Consistent with industry practice, the Company generally offers Customers a limited right of return for a product that has been purchased from the Company. The Company estimates the amount of its product sales that may be returned by its Customers and records this estimate as a reduction of revenue in the period the related product revenue is recognized. There is inherent judgment in estimating future refunds as they are susceptible to factors outside of our influence. However, we have significant experience in estimating the amount of refunds, based primarily on historical data. Our refund liability for product returns was $12.6 million at January 31, 2019 which is included in Accrued liabilities on our Condensed Consolidated Balance Sheets and represents the expected value of the aggregate refunds that will be due to our customers.
     
    Rebates and Chargebacks

    Rebates are estimated based on contractual terms, historical experience, customer mix, trend analysis and projected market conditions in the various markets served.

    Chargebacks for fees and discounts to providers represent the estimated obligations resulting from contractual commitments to sell products to qualified healthcare providers at prices lower than the list wholesale prices charged to the Company’s direct customers. For certain office and surgical products in CooperSurgical, customers charge the Company for the difference between what they pay for the product and the ultimate selling price to the qualified healthcare providers. These reserves are established in the same period that the related revenue is recognized, resulting in a reduction of product revenue. Chargeback amounts are generally determined at the time of resale to the qualified healthcare provider by Customers. CooperSurgical rebates are predominately related to the Medicaid rebate provision that is estimated based upon contractual terms, historical experience, and trend analysis.

    Contract balances

    The timing of billing and revenue recognition primarily occurs simultaneously. The Company does not have material contract assets or liabilities.
    XML 27 R10.htm IDEA: XBRL DOCUMENT v3.10.0.1
    Acquisitions
    		 3 Months Ended
    Jan. 31, 2019
    Business Combinations [Abstract]  
    Acquisitions
    Acquisitions
    The following is a summary of the allocation of the total purchase consideration for business and asset acquisitions that the Company completed during fiscal 2019 and 2018:
    (In millions)
    January 31, 2019
     
    October 31, 2018
    Technology
    $
    9.9

     
    $
    —

    Customer relationships
    7.5

     
    23.5

    Trademarks
    9.7

     
    100.0

    Composite intangible asset
    —

     
    1,061.9

    Other
    —

     
    4.2

    Total identifiable intangible assets
    $
    27.1

     
    $
    1,189.6

    Goodwill
    35.8

     
    70.6

    Net tangible assets
    1.4

     
    59.6

    Total purchase price
    $
    64.3

     
    $
    1,319.8


    All the acquisitions were funded by cash generated from operations or facility borrowings.
    For business acquisitions, we recorded the tangible and intangible assets acquired and liabilities assumed at their fair values as of the applicable date of acquisition. For assets acquisitions, we recorded the tangible and intangible assets acquired and liabilities assumed at their estimated and relative fair values as of the applicable date of acquisition.

    We believe these acquisitions strengthen CooperSurgical's and CooperVision's businesses through the addition of new or complementary products and services.

    Fiscal Year 2019

    On December 31, 2018, CooperSurgical completed the acquisition of Incisive Surgical Inc., a privately-held U.S. medical device company that develops mechanical surgical solutions for skin closure. The purchase price allocation is preliminary and we are in the process of finalizing information primarily related to property, plant & equipment, inventories, receivables, certain accruals and other liabilities, taxes and the corresponding impact on goodwill.

    On December 28, 2018, CooperVision completed the acquisition of Blanchard Contact Lenses. Blanchard is a privately-held scleral lens company, which expands CooperVision's specialty and scleral lens portfolio. The purchase price allocation is preliminary and we are in the process of finalizing information primarily related to property, plant & equipment, inventories, receivables, certain accruals and other liabilities, taxes and the corresponding impact on goodwill.
    The pro forma results of operations of these acquisitions have not been presented because the effects of the business combinations described above, individually and in the aggregate, were not material to our consolidated results of operations.
    Fiscal Year 2018

    PARAGARD

    On November 1, 2017, CooperSurgical acquired the assets of the PARAGARD Intrauterine Device (IUD) business (PARAGARD) from Teva Pharmaceuticals Industries Limited for $1.1 billion. This asset acquisition broadened and strengthened CooperSurgical's product portfolio. PARAGARD® is the only hormone-free, long lasting, reversible contraceptive approved by the United States Food and Drug Administration (FDA) available in the United States.

    The following table summarizes the relative fair values of net assets acquired and liabilities assumed using the cost accumulation and allocation model:
    (In millions)
    Relative Fair Value
    Composite intangible asset (1)
    $
    1,061.9

    Assembled workforce intangible asset (2)
    1.2

    Property, plant and equipment
    2.0

    Inventory (3)
    47.3

    Other assets
    9.4

    Total assets acquired
    $
    1,121.8

    Less: liabilities assumed
    16.4

    Total Purchase Price
    $
    1,105.4


    The Company proportionally allocated the acquisition costs to the net assets acquired. The acquisition-related costs included advisory, legal, valuation and other professional fees.

    (1) Composite Intangible asset consists of technology, trade name, New Drug Application (NDA) approval and physician relationships, which have been valued as a single composite intangible asset as they are inextricably linked. The composite asset was identified as the primary asset acquired, was valued using the Multi-Period Excess Earnings Method and will be amortized over 15 years.
    (2) An assembled workforce was recognized as a separate acquired intangible asset, given the purchase of assets and will be amortized over 5 years.
    (3) Inventory relative fair value includes step up of $45.4 million.
    Other Acquisitions
    On April 3, 2018, CooperSurgical completed the acquisition of The LifeGlobal Group (LifeGlobal). LifeGlobal was a privately held company that specializes primarily in in-vitro fertilization (IVF) media. LifeGlobal’s product categories include media products as well as IVF laboratory air filtration products and dishware. We have completed the purchase price allocation for this acquisition.
    On December 1, 2017, CooperVision acquired Paragon Vision Sciences, a leading provider of orthokeratology (ortho-k) specialty contact lenses and oxygen permeable rigid contact lens materials. Ortho-k contact lenses are overnight lenses which enable corneal topography correction for myopia (nearsightedness) patients. We have completed the purchase price allocation for this acquisition.
    On January 4, 2018, CooperVision acquired Blueyes Ltd, a long-standing distribution partner, with a leading position in the distribution of contact lenses to the Optical and Pharmacy sector in Israel. We have completed the purchase price allocation for this acquisition.
    XML 28 R11.htm IDEA: XBRL DOCUMENT v3.10.0.1
    Inventories
    		 3 Months Ended
    Jan. 31, 2019
    Inventory Disclosure [Abstract]  
    Inventories
    Inventories
    (In millions)
    January 31, 2019
     
    October 31, 2018
    Raw materials
    $
    119.9

     
    $
    112.5

    Work-in-process
    12.6

     
    12.6

    Finished goods
    353.7

     
    343.7

     
    $
    486.2

     
    $
    468.8


    Inventories are stated at the lower of cost and net realizable value. Cost is computed using standard cost that approximates actual cost, on a first-in, first-out basis.
    XML 29 R12.htm IDEA: XBRL DOCUMENT v3.10.0.1
    Intangible Assets
    		 3 Months Ended
    Jan. 31, 2019
    Goodwill and Intangible Assets Disclosure [Abstract]  
    Intangible Assets
    Intangible Assets

    Goodwill
    (In millions)
    CooperVision
     
    CooperSurgical
     
    Total
    Balance at October 31, 2017
    $
    1,735.7

     
    $
    619.1

     
    $
    2,354.8

    Net additions during the year ended October 31, 2018
    36.8

     
    34.4

     
    71.2

    Translation
    (29.6
    )
     
    (4.3
    )
     
    (33.9
    )
    Balance at October 31, 2018
    1,742.9

     
    649.2

     
    2,392.1

    Net additions during the three months ended January 31, 2019
    13.9

     
    21.9

     
    35.8

    Translation
    19.9

     
    1.5

     
    21.4

    Balance at January 31, 2019
    $
    1,776.7

     
    $
    672.6

     
    $
    2,449.3



    The Company evaluates goodwill for impairment annually during the fiscal third quarter and when an event occurs or circumstances change such that it is reasonably possible that impairment may exist. The Company accounts for goodwill and evaluates its goodwill balances and tests them for impairment in accordance with related accounting standards. The Company performed its annual impairment assessment in its third quarters of fiscal 2018 and fiscal 2017 respectively, and its analysis indicated that the Company had no impairment of goodwill.
    Other Intangible Assets
     
    January 31, 2019
     
    October 31, 2018
     
     
    (In millions)
    Gross Carrying
    Amount
     
    Accumulated
    Amortization
     
    Gross Carrying
    Amount
     
    Accumulated
    Amortization
     
    Weighted Average Amortization Period (In years)
     
     
     
     
     
     
     
     
     
     
    Trademarks
    $
    149.3

     
    $
    19.4

     
    $
    139.2

     
    $
    16.9

     
    14
    Composite intangible asset
    1,061.9

     
    88.5

     
    1,061.9

     
    70.8

     
    15
    Technology
    405.8

     
    198.5

     
    395.0

     
    190.7

     
    11
    Customer relationships
    359.0

     
    175.3

     
    350.0

     
    168.6

     
    13
    License and distribution rights and other
    76.0

     
    56.2

     
    74.9

     
    52.7

     
    9
     
    2,052.0

     
    $
    537.9

     
    2,021.0

     
    $
    499.7

     
    14
    Less: accumulated amortization and translation
    537.9

     
     
     
    499.7

     
     
     
     
    Other intangible assets, net
    $
    1,514.1

     
     
     
    $
    1,521.3

     
     
     
     

    Balances include foreign currency translation adjustments.
    As of January 31, 2019, the estimation of amortization expenses for intangible assets with finite lives is as follows:
    Fiscal years:
    (In millions)
    Remainder of 2019
    $
    109.1

    2020
    136.1

    2021
    134.8

    2022
    132.9

    2023
    130.7

    Thereafter
    861.6

    Total remaining amortization for intangible assets
    $
    1,505.2
    XML 30 R13.htm IDEA: XBRL DOCUMENT v3.10.0.1
    Debt
    		 3 Months Ended
    Jan. 31, 2019
    Debt Disclosure [Abstract]  
    Debt
    Debt
    (In millions)
    January 31, 2019
     
    October 31, 2018
    Overdraft and other credit facilities
    $
    45.6

     
    $
    37.1

    Term loans
    400.0

     
    —

    Less: unamortized debt issuance cost
    (0.1
    )
     
    —

    Short-term Debt
    $
    445.5

     
    $
    37.1

     
     
     
     
    Revolving credit
    $
    140.0

     
    $
    439.0

    Term loans
    1,550.0

     
    1,550.0

    Other
    0.2

     
    0.2

    Less: unamortized debt issuance cost
    (3.3
    )
     
    (3.5
    )
    Long-term Debt
    $
    1,686.9

     
    $
    1,985.7

     
     
     
     
    Total Debt
    $
    2,132.4

     
    $
    2,022.8




    $400 million Term Loan on November 1, 2018
    On November 1, 2018, the Company entered into a 364-day, $400.0 million, senior unsecured term loan agreement by and among the Company, the lenders party thereto and PNC Bank, National Association, as administrative agent which matures on October 31, 2019 (the 2018 Term Loan Agreement). The Company used the funds to partially repay outstanding borrowings under the 2016 Revolving Credit Facility. At January 31, 2019, we had $400.0 million outstanding under the 2018 Term Loan Agreement.
    Amounts outstanding under the 2018 Term Loan Agreement will bear interest, at the Company's option, at either the base rate, or the adjusted LIBO rate (each as defined in the 2018 Term Loan Agreement), plus, in each case, an applicable rate of 0.00% in respect of base rate loans and 0.60% in respect of adjusted LIBO rate loans. The weighted average interest rate for the three months ended January 31, 2019 was 2.99%.

    The 2018 Term Loan Agreement contains customary restrictive covenants, as well as financial covenants that require the Company to maintain a certain Total Leverage Ratio and Interest Coverage Ratio (each as defined in the 2018 Term Loan Agreement) consistent with the 2016 Credit Agreement discussed below.
    $1.425 billion Term Loan on November 1, 2017
    On November 1, 2017, in connection with the PARAGARD acquisition, we entered into a five-year, $1.425 billion, senior unsecured term loan agreement (the 2017 Term Loan Agreement) by and among the Company, the lenders party thereto and DNB Bank ASA, New York Branch, as administrative agent which matures on November 1, 2022. The Company used part of the facility to fund the PARAGARD acquisition and used the remainder of the funds to partially repay outstanding borrowings under our revolving credit agreement.
    Amounts outstanding under the 2017 Term Loan Agreement will bear interest, at our option, at either the base rate, or the adjusted LIBO rate (each as defined in the 2017 Term Loan Agreement), plus, in each case, an applicable rate of, between 0.00% and 0.75% in respect of base rate loans and between 1.00% and 1.75% in respect of adjusted LIBO rate loans, in each case in accordance with a pricing grid tied to the Total Leverage Ratio as defined in the 2017 Term Loan Agreement.

    The 2017 Term Loan Agreement contains customary restrictive covenants, as well as financial covenants that require the Company to maintain a certain Total Leverage Ratio and Interest Coverage Ratio (each as defined in the 2017 Term Loan Agreement) consistent with the 2016 Credit Agreement discussed below. At January 31, 2019, we had $1.425 billion outstanding under the 2017 Term Loan Agreement.
    Revolving Credit and Term Loan Agreement on March 1, 2016
    On March 1, 2016, we entered into a Revolving Credit and Term Loan Agreement (the 2016 Credit Agreement), among the Company, CooperVision International Holding Company, LP, the lenders party thereto and KeyBank National Association, as administrative agent. The 2016 Credit Agreement provides for a multicurrency revolving credit facility in an aggregate principal amount of $1.0 billion (the 2016 Revolving Credit Facility) and a term loan facility in an aggregate principal amount of $830.0 million (the 2016 Term Loan Facility), each of which, unless terminated earlier, mature on March 1, 2021. In addition, we have the ability from time to time to request an increase to the size of the 2016 Revolving Credit Facility or establish one or more new term loans under the 2016 Term Loan Facility in an aggregate amount up to $750.0 million, subject to the discretionary participation of the lenders.

    Amounts outstanding under the 2016 Credit Agreement will bear interest, at our option, at either the base rate, or the adjusted LIBO rate or adjusted foreign currency rate (each as defined in the 2016 Credit Agreement), plus, in each case, an applicable rate of between 0.00% and 0.75% in respect of base rate loans and between 1.00% and 1.75% in respect of adjusted LIBO rate or adjusted foreign currency rate loans, in each case in accordance with a pricing grid tied to the Total Leverage Ratio, as defined in the 2016 Credit Agreement.

    We pay an annual commitment fee that ranges from 0.125% to 0.25% of the unused portion of the 2016 Revolving Credit Facility depending on certain financial ratios. In addition to the annual commitment fee described above, we are also required to pay certain letter of credit and related fronting fees and other administrative fees pursuant to the terms of the 2016 Credit Agreement.

    At January 31, 2019, we had $125.0 million outstanding under the 2016 Term Loan Facility and $859.5 million available under the 2016 Revolving Credit Facility.

    The 2016 Credit Agreement contains customary restrictive covenants, as well as financial covenants that require us to maintain a certain Total Leverage Ratio and Interest Coverage Ratio (each as defined in the 2016 Credit Agreement):
    •
    Interest Coverage Ratio, as defined, to be at least 3.00 to 1.00 at all times.
    •
    Total Leverage Ratio, as defined, to be no higher than 3.75 to 1.00.
    At January 31, 2019, we were in compliance with the Interest Coverage Ratio at 10.70 to 1.00 and the Total Leverage Ratio at 2.25 to 1.00 for 2018 Term Loan Agreement, the 2017 Term Loan Agreement, and the 2016 Credit Agreement.
    Refer to our Annual Report on Form 10-K for the fiscal year ended October 31, 2018 for more details.
    XML 31 R14.htm IDEA: XBRL DOCUMENT v3.10.0.1
    Income Taxes
    		 3 Months Ended
    Jan. 31, 2019
    Components of Income Tax Expense (Benefit), Continuing Operations [Abstract]  
    Income Taxes
    Income Taxes
    Recent Tax Legislation
    The 2017 Act was enacted into law on December 22, 2017 and significantly changes existing U.S. tax law. The 2017 Act adopts a territorial tax system, imposes a mandatory one-time transition tax on earnings of foreign subsidiaries that were previously indefinitely reinvested, and reduces the U.S. federal statutory tax rate from 35% to 21%. For first quarter of fiscal 2019, the Company has utilized the enacted U.S. federal statutory tax rate of 21%.
    The 2017 Act includes several provisions that are effective for our fiscal 2019: (i) tax on global intangible low-taxed income (GILTI) of foreign subsidiaries, (ii) tax on certain payments between a U.S. corporation and its foreign subsidiaries referred to as the base erosion and anti-abuse tax (BEAT), (iii) limitation on the tax deduction for interest payments, and (iv) expanded limitation on the tax deduction for compensation paid to certain executives.
    The 2017 Act was effective in the first quarter of fiscal 2018. As of January 31, 2019, we have completed our accounting for the tax effects of the enactment of the 2017 Act and recorded a final adjustment to our provisional tax expense pursuant to SAB 118. During the first quarter of fiscal 2019, we recorded tax benefit of $4.4 million in our financial statements to finalize the tax effects of the 2017 Act. The Company is no longer asserting that earnings from our foreign subsidiaries are indefinitely reinvested.

    The 2017 Act imposes a new tax on foreign earnings and profits in excess of a deemed return on tangible assets of foreign subsidiaries referred to as GILTI which is effective in fiscal 2019. In accordance with FASB Staff Q&A, Topic 740, No. 5, Accounting for Global Intangible Low-Taxed Income, the Company is making an accounting policy election to recognize the tax expense related to GILTI in the year the tax is incurred.
    Effective Tax Rate
    The Company's effective tax rates were a benefit of 10.0% and expense of 263.7% for the first quarters of fiscal 2019 and fiscal 2018, respectively. The decrease in our effective tax rate for the first quarter of fiscal 2019 compared to the first quarter of fiscal 2018 was primarily due to the provisional charge of $202.0 million relating to the 2017 Act that was recorded in the first quarter of fiscal 2018. Our effective tax rate for the first quarter of fiscal 2019 was lower than the U.S. statutory rate because of discrete tax benefits which were partially offset by a less favorable mix of income from our foreign jurisdictions with lower tax rates. Total discrete tax benefits for the first quarter of fiscal 2019 were $18.7 million primarily relating to settlement of tax audits, revisions to the provisional tax charges relating to the 2017 Act, and excess tax benefits from share-based compensation. Our effective tax rate for the first quarter of fiscal 2018 was higher than the U.S. statutory rate because of the discrete tax expense relating to the 2017 Act, which was partially offset by a favorable mix of income from our foreign jurisdictions with lower tax rates and an excess tax benefit from share-based compensation.

    We recognize the benefit from a tax position only if it is more likely than not that the position would be sustained upon audit based solely on the technical merits of the tax position. As of January 31, 2019, and October 31, 2018, Cooper had unrecognized tax benefits of $47.1 million and $68.9 million, respectively. The decrease is primarily related to settling prior year tax audits, partially offset by additions to current period transfer pricing reserves. It is our policy to recognize interest and penalties directly related to income taxes as additional income tax expense. It is reasonably possible that $3.1 million of unrecognized tax benefits could be settled during the next twelve months.

    The Company is subject to U.S. Federal income tax examinations for fiscal 2015 through 2018 and the Internal Revenue Service is currently auditing our U.S. Consolidated Corporation Income Tax Returns for fiscal 2015 and 2016. The Company remains subject to income tax examinations in other significant tax jurisdictions including the United Kingdom, Japan, France and Australia for the tax years 2015 through 2018.
    XML 32 R15.htm IDEA: XBRL DOCUMENT v3.10.0.1
    Earnings Per Share
    		 3 Months Ended
    Jan. 31, 2019
    Earnings Per Share [Abstract]  
    Earnings Per Share
    Earnings Per Share
    Three Months Ended January 31,
     
    (In millions, except per share amounts)
    2019
     
    2018
    Net income (loss)
    $
    103.2

     
    $
    (122.5
    )
    Basic:
     
     
     
    Weighted average common shares
    49.3

     
    48.9

    Basic earnings (loss) per share
    $
    2.09

     
    $
    (2.50
    )
    Diluted:
     
     
     
    Weighted average common shares
    49.3

     
    48.9

    Effect of potential dilutive shares
    0.6

     
    —

    Diluted weighted average common shares*
    49.9

     
    48.9

    Diluted earnings (loss) per share attributable to Cooper stockholders
    $
    2.07

     
    $
    (2.50
    )
    *The number of diluted weighted average common shares used to calculate fiscal 2018 diluted loss per share excludes all potentially dilutive instrument because they would be antidilutive due to the net loss position.

    The following table sets forth stock options to purchase Cooper’s common stock and restricted stock units that were not included in the diluted earnings per share calculation because their effect would have been antidilutive for the periods presented:
    Three Months Ended January 31,
     
    (In thousands, except exercise prices)
    2019
     
    2018
    Number of stock option shares excluded
    377

     
    1,202

    Range of exercise prices
    $226.30-$254.77

     
    $15.83-$229.66

    Number of restricted stock units excluded
    17

     
    546
    XML 33 R16.htm IDEA: XBRL DOCUMENT v3.10.0.1
    Share-Based Compensation Plans
    		 3 Months Ended
    Jan. 31, 2019
    Share-based Compensation [Abstract]  
    Share-Based Compensation Plans
    Share-Based Compensation Plans
    Cooper has several share-based compensation plans that are described in the Company’s Annual Report on Form 10‑K for the fiscal year ended October 31, 2018. The compensation expense and related income tax benefit recognized in our consolidated condensed financial statements for share-based awards were as follows:
    Three Months Ended January 31,
     
    (In millions)
    2019
     
    2018
    Selling, general and administrative expense
    $
    9.3

     
    $
    10.7

    Cost of sales
    1.5

     
    1.3

    Research and development expense
    0.9

     
    0.7

    Total share-based compensation expense
    $
    11.7

     
    $
    12.7

    Related income tax benefit
    $
    1.7

     
    $
    2.5
    XML 34 R17.htm IDEA: XBRL DOCUMENT v3.10.0.1
    Stockholders' Equity
    		 3 Months Ended
    Jan. 31, 2019
    Equity [Abstract]  
    Stockholders' Equity
    Stockholders’ Equity
    Analysis of Changes in Accumulated Other Comprehensive (Loss) Income:
    (In millions)
    Foreign Currency Translation Adjustment
     
    Minimum Pension Liability
     
    Total
    Balance at October 31, 2017
    $
    (353.7
    )
     
    $
    (21.6
    )
     
    $
    (375.3
    )
    Gross change in value during the year ended October 31, 2018
    (58.5
    )
     
    11.0

     
    (47.5
    )
    Tax effect for the period
    —

     
    (3.1
    )
     
    (3.1
    )
    ASU 2018-02 adoption(1)
    —

     
    (4.8
    )
     
    (4.8
    )
    Balance at October 31, 2018
    $
    (412.2
    )
     
    $
    (18.5
    )
     
    $
    (430.7
    )
    Gross change in value during the three months ended January 31, 2019
    32.7

     
    —

     
    32.7

    Balance at January 31, 2019
    $
    (379.5
    )
     
    $
    (18.5
    )
     
    $
    (398.0
    )

    (1)
    Represents reclassification to retained earnings from adoption of ASU 2018-02. Refer to our Annual Report on Form 10-K for the fiscal year ended October 31, 2018 for more details.
    Share Repurchases
    In December 2011, our Board of Directors authorized the 2012 Share Repurchase Program and through subsequent amendments, the most recent in March 2017, the total repurchase authorization was increased from $500.0 million to $1.0 billion of the Company's common stock. This program has no expiration date and may be discontinued at any time. Purchases under the 2012 Share Repurchase Program are subject to a review of the circumstances in place at the time and may be made from time to time as permitted by securities laws and other legal requirements.
    In the fiscal first quarter of 2019, we repurchased 24.5 thousand shares of the Company's common stock for $6.1 million, at an average purchase price of $248.70 per share. We did not repurchase shares during the fiscal year ended October 31, 2018. At January 31, 2019, $557.4 million remains authorized for repurchase under the program.
    Dividends
    We paid a semiannual dividend of approximately $1.5 million or 3 cents per share on February 8, 2019, to stockholders of record on January 22, 2019.
    XML 35 R18.htm IDEA: XBRL DOCUMENT v3.10.0.1
    Fair Value Measurements
    		 3 Months Ended
    Jan. 31, 2019
    Fair Value Disclosures [Abstract]  
    Fair Value Measurements
    Fair Value Measurements
    Accounting standards define fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value hierarchy prioritizes the inputs to valuation techniques used to measure fair value. An asset’s or liability’s level is based on the lowest level of input that is significant to the fair value measurement. Assets and liabilities carried at fair value are valued and disclosed in one of the following three levels of the valuation hierarchy:
    Level 1: Quoted market prices in active markets for identical assets or liabilities.
    Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.
    Level 3: Unobservable inputs reflecting the reporting entity’s own assumptions.
    At January 31, 2019 and October 31, 2018, the carrying value of cash and cash equivalents, accounts receivable, prepaid expense and other current assets, lines of credit, accounts payable and other current liabilities approximate fair value due to the short-term nature of such instruments and the ability to obtain financing on similar terms.

    The carrying value of our revolving credit facility and term loans approximates fair value estimated based on current market rates (Level 2). The Company did not have any derivative assets or liabilities that may include interest rate swaps, cross currency swaps or foreign currency forward contracts as of January 31, 2019 and October 31, 2018.


    Nonrecurring fair value measurements

    The Company uses fair value measures when determining assets and liabilities acquired in an acquisition as described in Note 3. Acquisitions which are considered a Level 3 measurement.
    XML 36 R19.htm IDEA: XBRL DOCUMENT v3.10.0.1
    Employee Benefits
    		 3 Months Ended
    Jan. 31, 2019
    Retirement Benefits, Description [Abstract]  
    Employee Benefits
    Employee Benefits
    Cooper’s Retirement Income Plan (the Plan), a defined benefit plan, covers substantially all full-time United States employees. Our contributions are designed to fund normal cost on a current basis and to fund the estimated prior service cost of benefit improvements. The unit credit actuarial cost method is used to determine the annual cost. Cooper pays the entire cost of the Plan and funds such costs as they accrue. Virtually all of the assets of the Plan are comprised of equities and participation in equity and fixed income funds.
    Our results of operations for the three months ended January 31, 2019 and 2018, reflect the following components of net periodic pension costs:
    Three Months Ended January 31,
     
    (In millions)
    2019
     
    2018
    Service cost
    $
    2.5

     
    $
    2.7

    Interest cost
    1.5

     
    1.3

    Expected return on plan assets
    (2.4
    )
     
    (2.3
    )
    Recognized net actuarial loss
    0.2

     
    0.4

    Net periodic pension cost
    $
    1.8

     
    $
    2.1


    We did not contribute to the Plan in the first quarter of fiscal 2019 and expect to contribute $10.0 million during the remainder of fiscal 2019. We did not contribute to the Plan in the first quarter of fiscal 2018. The expected rate of return on Plan assets for determining net periodic pension cost is 8%.
    XML 37 R20.htm IDEA: XBRL DOCUMENT v3.10.0.1
    Contingencies
    		 3 Months Ended
    Jan. 31, 2019
    Commitments and Contingencies Disclosure [Abstract]  
    Contingencies
    Contingencies

    Since March 2015, over 50 putative class action complaints were filed by contact lens consumers alleging that contact lens manufacturers, in conjunction with their respective Unilateral Pricing Policy (UPP), conspired to reach agreements between each other and certain distributors and retailers regarding the prices at which certain contact lenses could be sold to consumers. The plaintiffs are seeking damages against CooperVision, Inc., other contact lens manufacturers, distributors and retailers, in various courts around the United States. In June 2015, all of the class action cases were consolidated and transferred to the United States District Court for the Middle District of Florida. In August 2017, CooperVision entered into a settlement agreement with the plaintiffs, without any admission of liability, to settle all claims against CooperVision. In July 2018, the Court approved the plaintiffs’ motion for preliminary approval of the settlement, and the Company paid the $3.0 million settlement amount into an escrow account. The settlement remains subject to final Court approval at a future hearing to be set by the Court.

    The Company is involved in various lawsuits, claims and other legal matters from time to time that arise in the ordinary course of conducting business, including matters involving our products, intellectual property, supplier relationships, distributors, competitor relationships, employees and other matters. The Company does not believe that the ultimate resolution of these proceedings or claims pending against it could have a material adverse effect on its financial condition or results of operations. At each reporting period, the Company evaluates whether or not a potential loss amount or a potential range of loss is probable and reasonably estimable under ASC 450, Contingencies. Legal fees are expensed as incurred.
    XML 38 R21.htm IDEA: XBRL DOCUMENT v3.10.0.1
    Business Segment Information
    		 3 Months Ended
    Jan. 31, 2019
    Segment Reporting [Abstract]  
    Business Segment Information
    Business Segment Information
    Cooper uses operating income, as presented in our financial reports, as the primary measure of segment profitability. We do not allocate costs from corporate functions to segment operating income. Items below operating income are not considered when measuring the profitability of a segment. We use the same accounting policies to generate segment results as we do for our consolidated results.
    Total identifiable assets are those used in continuing operations except cash and cash equivalents, which we include as corporate assets.
    Segment information:
    Three Months Ended January 31,
     
    (In millions)
    2019
     
    2018
    CooperVision net sales by category:
     
     
     
    Toric lens
    $
    146.0

     
    $
    137.8

    Multifocal lens
    49.1

     
    46.9

    Single-use sphere lens
    132.1

     
    116.3

    Non single-use sphere and other
    142.9

     
    143.8

    Total CooperVision net sales
    470.1

     
    444.8

    CooperSurgical net sales by category:
     
     
     
    Office and surgical procedures
    95.7

     
    88.2

    Fertility
    62.3

     
    57.0

    Total CooperSurgical net sales
    158.0

     
    145.2

    Total net sales
    $
    628.1

     
    $
    590.0

    Operating income (loss):
     
     
     
    CooperVision
    $
    116.3

     
    $
    112.3

    CooperSurgical
    7.2

     
    (9.3
    )
    Corporate
    (12.6
    )
     
    (12.8
    )
    Total operating income
    110.9

     
    90.2

    Interest expense
    18.2

     
    18.4

    Other income, net
    1.1

     
    3.0

    Income before income taxes
    $
    93.8

     
    $
    74.8


    (In millions)
    January 31, 2019
     
    October 31, 2018
    Total identifiable assets:
     
     
     
    CooperVision
    $
    3,869.8

     
    $
    3,746.0

    CooperSurgical
    2,214.6

     
    2,201.7

    Corporate
    214.2

     
    165.1

    Total
    $
    6,298.6

     
    $
    6,112.8


    Geographic information:
    Three Months Ended January 31,
     
    (In millions)
    2019
     
    2018
    Net sales to unaffiliated customers by country of domicile:
     
     
     
    United States
    $
    278.9

     
    $
    261.5

    Europe
    209.7

     
    203.8

    Rest of world
    139.5

     
    124.7

    Total
    $
    628.1

     
    $
    590.0



    (In millions)
    January 31, 2019
     
    October 31, 2018
    Net property, plant and equipment by country of domicile:
     
     
     
    United States
    $
    550.2

     
    $
    516.7

    Europe
    349.6

     
    340.7

    Rest of world
    124.0

     
    118.6

    Total
    $
    1,023.8

     
    $
    976.0
    XML 39 R22.htm IDEA: XBRL DOCUMENT v3.10.0.1
    Subsequent Event (Notes)
    		 3 Months Ended
    Jan. 31, 2019
    Subsequent Events [Abstract]  
    Subsequent Event
    Subsequent Event

    Filshie Clip System

    On February 1, 2019, subsequent to the first quarter of fiscal 2019, the Company agreed to the early termination of an exclusive distribution agreement with Femcare Ltd. which had given CooperSurgical the exclusive rights to distribute the Filshie Clip System in the U.S. The Company received consideration of $21 million on January 31, 2019, from Utah Medical Products, Inc. (UTMD), the parent company of Femcare Ltd., in exchange for the agreement to terminate the exclusive distribution agreement prior to the end of the contractual term. UTMD has also agreed to buyback resaleable Filshie Clip System inventory.

    Diverted Profit Tax

    On February 26, 2019, subsequent to the first quarter of fiscal 2019, the Company received a refund of approximately GBP 22.1 million (USD 29.0 million) from the GBP 31 million (USD 42.0 million) payment made on January 19, 2018 to the U.K. Tax Authorities. The payment had been made in regard to the Diverted Profit Tax matter related to the transfer of certain intellectual property rights in connection with the 2014 acquisition of Sauflon Pharmaceutical Ltd.
    XML 40 R23.htm IDEA: XBRL DOCUMENT v3.10.0.1
    General (Policies)
    		 3 Months Ended
    Jan. 31, 2019
    Organization, Consolidation and Presentation of Financial Statements [Abstract]  
    Accounting Pronouncements Issued Not Yet Adopted and Accounting Pronouncements Recently Adopted

    Accounts Receivable Factoring Program

    We may factor certain designated trade receivables with one or more third party financial institutions pursuant to a factoring agreement. These are non-recourse factoring arrangements to assist us in managing operating cash flow and meet the requirements to be accounted for as sales in accordance with the “Transfers and Servicing” guidance in ASC 860, where the Company’s continuing involvement subsequent to the transfer is limited to providing certain servicing and collection actions on behalf of the purchasers of the designated trade receivables. Proceeds from amounts factored by the Company are recorded as an increase to cash and a reduction to accounts receivable outstanding in the Company's Consolidated Balance Sheets. Cash flows attributable to factoring are reflected as cash flows from operating activities in the Company’s Consolidated Statements of Cash Flows. Factoring fees associated with the sale of factored receivables for the three months ended January 31, 2019 were $0.4 million and were minimal for the three months ended January 31, 2018.
    Revenue Recognition
    Product Revenue, Net

    The Company sells its products principally to a limited number of distributors, group purchasing organizations, eye care or health care professionals including independent practices, corporate retailers, hospitals and clinics or authorized resellers (collectively, its Customers). These Customers subsequently resell the Company’s products to eye care or health care providers and patients. In addition to product supply and distribution agreements with Customers, the Company enters into arrangements with health care providers and payors that provide for government-mandated and/or privately-negotiated rebates, chargebacks and discounts with respect to the purchase of the Company’s products. The Company considers customer purchase orders, which in some cases are governed by master sales agreements, to be contracts with a customer. In situations where sales are to a distributor, the Company has concluded that its contracts are with the distributor. As part of its consideration of the contract, the Company evaluates certain factors including the customer’s ability to pay (or credit risk). For each contract, the Company considers the promise to transfer products, each of which is distinct, to be the identified performance obligations.

    Revenues from product sales are recognized when the Customer obtains control of the Company’s product, which occurs at a point in time, typically upon shipment or delivery to the Customer. When the Company performs shipping and handling activities after the transfer of control to the Customer (e.g., when control transfers prior to delivery), they are considered as fulfillment activities, and accordingly, the costs are accrued for when the related revenue is recognized. Taxes collected from Customers relating to product sales and remitted to governmental authorities are excluded from revenues. The Company does not have any revenue recognized on payment expected to be received more than one year after the transfer of control of the products. The Company expenses incremental costs of obtaining a contract as and when incurred if the expected amortization period of the asset that the Company would have recognized is one year or less. See Note14. Business Segment Information, for disaggregation of revenue.
     
    Reserves for Variable Consideration  

    Revenues from product sales are recorded at the net sales price (transaction price), which includes estimates of variable consideration for which reserves are established and which result from discounts, returns, chargebacks, rebates and other allowances that are offered within contracts between the Company and its Customers, health care providers, payors and other indirect customers relating to the Company’s sales of its products. These reserves are based on the amounts earned or to be claimed on the related sales and are classified primarily in current liability. Variable consideration is estimated based on the most likely amount or expected value approach, depending on which method the Company expects to better predict the amount of consideration to which it will be entitled. Once the Company elects one of the methods to estimate variable consideration for a particular type of performance obligation, the Company will apply that method consistently.

    Where appropriate, these estimates take into consideration a range of possible outcomes which are probability-weighted for relevant factors such as the Company’s historical experience, current contractual and statutory requirements, specific known market events and trends, industry data and forecasted customer buying and payment patterns. Overall, these reserves reflect the Company’s best estimates of the amount of consideration to which it is entitled based on the terms of the contract. Actual amounts of consideration ultimately received may differ from the Company’s estimates. If actual results in the future vary from the Company’s estimates, the Company adjusts these estimates, which would affect net product revenue and earnings in the period such variances become known.
     
    Trade Discounts and Allowances

    The Company generally provides Customers with discounts, which include incentive fees that are stated in the Company’s contracts and are recorded as a reduction of revenue in the period the related product revenue is recognized. In addition, the Company receives sales order management, data and distribution services from certain Customers. To the extent the services received are distinct from the Company’s sale of products to the Customer and have readily determinable fair value, these payments are classified in selling, general and administrative expenses in the consolidated statements of income of the Company.
     



    Product Returns

    Consistent with industry practice, the Company generally offers Customers a limited right of return for a product that has been purchased from the Company. The Company estimates the amount of its product sales that may be returned by its Customers and records this estimate as a reduction of revenue in the period the related product revenue is recognized. There is inherent judgment in estimating future refunds as they are susceptible to factors outside of our influence. However, we have significant experience in estimating the amount of refunds, based primarily on historical data. Our refund liability for product returns was $12.6 million at January 31, 2019 which is included in Accrued liabilities on our Condensed Consolidated Balance Sheets and represents the expected value of the aggregate refunds that will be due to our customers.
     
    Rebates and Chargebacks

    Rebates are estimated based on contractual terms, historical experience, customer mix, trend analysis and projected market conditions in the various markets served.

    Chargebacks for fees and discounts to providers represent the estimated obligations resulting from contractual commitments to sell products to qualified healthcare providers at prices lower than the list wholesale prices charged to the Company’s direct customers. For certain office and surgical products in CooperSurgical, customers charge the Company for the difference between what they pay for the product and the ultimate selling price to the qualified healthcare providers. These reserves are established in the same period that the related revenue is recognized, resulting in a reduction of product revenue. Chargeback amounts are generally determined at the time of resale to the qualified healthcare provider by Customers. CooperSurgical rebates are predominately related to the Medicaid rebate provision that is estimated based upon contractual terms, historical experience, and trend analysis.

    Contract balances

    The timing of billing and revenue recognition primarily occurs simultaneously. The Company does not have material contract assets or liabilities.
    XML 41 R24.htm IDEA: XBRL DOCUMENT v3.10.0.1
    Acquisitions Acquisitions (Tables)
    		 3 Months Ended
    Jan. 31, 2019
    Business Combinations [Abstract]  
    Schedule of Acquisitions
    The following table summarizes the relative fair values of net assets acquired and liabilities assumed using the cost accumulation and allocation model:
    (In millions)
    Relative Fair Value
    Composite intangible asset (1)
    $
    1,061.9

    Assembled workforce intangible asset (2)
    1.2

    Property, plant and equipment
    2.0

    Inventory (3)
    47.3

    Other assets
    9.4

    Total assets acquired
    $
    1,121.8

    Less: liabilities assumed
    16.4

    Total Purchase Price
    $
    1,105.4


    The Company proportionally allocated the acquisition costs to the net assets acquired. The acquisition-related costs included advisory, legal, valuation and other professional fees.

    (1) Composite Intangible asset consists of technology, trade name, New Drug Application (NDA) approval and physician relationships, which have been valued as a single composite intangible asset as they are inextricably linked. The composite asset was identified as the primary asset acquired, was valued using the Multi-Period Excess Earnings Method and will be amortized over 15 years.
    (2) An assembled workforce was recognized as a separate acquired intangible asset, given the purchase of assets and will be amortized over 5 years.
    (3) Inventory relative fair value includes step up of $45.4 million.
    The following is a summary of the allocation of the total purchase consideration for business and asset acquisitions that the Company completed during fiscal 2019 and 2018:
    (In millions)
    January 31, 2019
     
    October 31, 2018
    Technology
    $
    9.9

     
    $
    —

    Customer relationships
    7.5

     
    23.5

    Trademarks
    9.7

     
    100.0

    Composite intangible asset
    —

     
    1,061.9

    Other
    —

     
    4.2

    Total identifiable intangible assets
    $
    27.1

     
    $
    1,189.6

    Goodwill
    35.8

     
    70.6

    Net tangible assets
    1.4

     
    59.6

    Total purchase price
    $
    64.3

     
    $
    1,319.8
    XML 42 R25.htm IDEA: XBRL DOCUMENT v3.10.0.1
    Inventories (Tables)
    		 3 Months Ended
    Jan. 31, 2019
    Inventory Disclosure [Abstract]  
    Schedule of Inventories
    (In millions)
    January 31, 2019
     
    October 31, 2018
    Raw materials
    $
    119.9

     
    $
    112.5

    Work-in-process
    12.6

     
    12.6

    Finished goods
    353.7

     
    343.7

     
    $
    486.2

     
    $
    468.8
    XML 43 R26.htm IDEA: XBRL DOCUMENT v3.10.0.1
    Intangible Assets (Tables)
    		 3 Months Ended
    Jan. 31, 2019
    Goodwill and Intangible Assets Disclosure [Abstract]  
    Schedule of Goodwill
    Goodwill
    (In millions)
    CooperVision
     
    CooperSurgical
     
    Total
    Balance at October 31, 2017
    $
    1,735.7

     
    $
    619.1

     
    $
    2,354.8

    Net additions during the year ended October 31, 2018
    36.8

     
    34.4

     
    71.2

    Translation
    (29.6
    )
     
    (4.3
    )
     
    (33.9
    )
    Balance at October 31, 2018
    1,742.9

     
    649.2

     
    2,392.1

    Net additions during the three months ended January 31, 2019
    13.9

     
    21.9

     
    35.8

    Translation
    19.9

     
    1.5

     
    21.4

    Balance at January 31, 2019
    $
    1,776.7

     
    $
    672.6

     
    $
    2,449.3
    Schedule of Other Intangible Assets
    Other Intangible Assets
     
    January 31, 2019
     
    October 31, 2018
     
     
    (In millions)
    Gross Carrying
    Amount
     
    Accumulated
    Amortization
     
    Gross Carrying
    Amount
     
    Accumulated
    Amortization
     
    Weighted Average Amortization Period (In years)
     
     
     
     
     
     
     
     
     
     
    Trademarks
    $
    149.3

     
    $
    19.4

     
    $
    139.2

     
    $
    16.9

     
    14
    Composite intangible asset
    1,061.9

     
    88.5

     
    1,061.9

     
    70.8

     
    15
    Technology
    405.8

     
    198.5

     
    395.0

     
    190.7

     
    11
    Customer relationships
    359.0

     
    175.3

     
    350.0

     
    168.6

     
    13
    License and distribution rights and other
    76.0

     
    56.2

     
    74.9

     
    52.7

     
    9
     
    2,052.0

     
    $
    537.9

     
    2,021.0

     
    $
    499.7

     
    14
    Less: accumulated amortization and translation
    537.9

     
     
     
    499.7

     
     
     
     
    Other intangible assets, net
    $
    1,514.1

     
     
     
    $
    1,521.3

     
     
     
     
    Finite-lived Intangible Assets Amortization Expense
    As of January 31, 2019, the estimation of amortization expenses for intangible assets with finite lives is as follows:
    Fiscal years:
    (In millions)
    Remainder of 2019
    $
    109.1

    2020
    136.1

    2021
    134.8

    2022
    132.9

    2023
    130.7

    Thereafter
    861.6

    Total remaining amortization for intangible assets
    $
    1,505.2
    XML 44 R27.htm IDEA: XBRL DOCUMENT v3.10.0.1
    Debt (Tables)
    		 3 Months Ended
    Jan. 31, 2019
    Debt Disclosure [Abstract]  
    Schedule of Debt
    (In millions)
    January 31, 2019
     
    October 31, 2018
    Overdraft and other credit facilities
    $
    45.6

     
    $
    37.1

    Term loans
    400.0

     
    —

    Less: unamortized debt issuance cost
    (0.1
    )
     
    —

    Short-term Debt
    $
    445.5

     
    $
    37.1

     
     
     
     
    Revolving credit
    $
    140.0

     
    $
    439.0

    Term loans
    1,550.0

     
    1,550.0

    Other
    0.2

     
    0.2

    Less: unamortized debt issuance cost
    (3.3
    )
     
    (3.5
    )
    Long-term Debt
    $
    1,686.9

     
    $
    1,985.7

     
     
     
     
    Total Debt
    $
    2,132.4

     
    $
    2,022.8
    XML 45 R28.htm IDEA: XBRL DOCUMENT v3.10.0.1
    Earnings Per Share (Tables)
    		 3 Months Ended
    Jan. 31, 2019
    Earnings Per Share [Abstract]  
    Schedule of Earnings Per Share
    Three Months Ended January 31,
     
    (In millions, except per share amounts)
    2019
     
    2018
    Net income (loss)
    $
    103.2

     
    $
    (122.5
    )
    Basic:
     
     
     
    Weighted average common shares
    49.3

     
    48.9

    Basic earnings (loss) per share
    $
    2.09

     
    $
    (2.50
    )
    Diluted:
     
     
     
    Weighted average common shares
    49.3

     
    48.9

    Effect of potential dilutive shares
    0.6

     
    —

    Diluted weighted average common shares*
    49.9

     
    48.9

    Diluted earnings (loss) per share attributable to Cooper stockholders
    $
    2.07

     
    $
    (2.50
    )
    *The number of diluted weighted average common shares used to calculate fiscal 2018 diluted loss per share excludes all potentially dilutive instrument because they would be antidilutive due to the net loss position.
    Schedule of Stock Options to Purchase Common Stock Not Included in Diluted Net Income Per Share Calculation
    The following table sets forth stock options to purchase Cooper’s common stock and restricted stock units that were not included in the diluted earnings per share calculation because their effect would have been antidilutive for the periods presented:
    Three Months Ended January 31,
     
    (In thousands, except exercise prices)
    2019
     
    2018
    Number of stock option shares excluded
    377

     
    1,202

    Range of exercise prices
    $226.30-$254.77

     
    $15.83-$229.66

    Number of restricted stock units excluded
    17

     
    546
    XML 46 R29.htm IDEA: XBRL DOCUMENT v3.10.0.1
    Share-Based Compensation Plans (Tables)
    		 3 Months Ended
    Jan. 31, 2019
    Share-based Compensation [Abstract]  
    Schedule of Compensation Expense and Related Income Tax Benefit for Share-Based Awards
    The compensation expense and related income tax benefit recognized in our consolidated condensed financial statements for share-based awards were as follows:
    Three Months Ended January 31,
     
    (In millions)
    2019
     
    2018
    Selling, general and administrative expense
    $
    9.3

     
    $
    10.7

    Cost of sales
    1.5

     
    1.3

    Research and development expense
    0.9

     
    0.7

    Total share-based compensation expense
    $
    11.7

     
    $
    12.7

    Related income tax benefit
    $
    1.7

     
    $
    2.5
    XML 47 R30.htm IDEA: XBRL DOCUMENT v3.10.0.1
    Stockholders' Equity (Tables)
    		 3 Months Ended
    Jan. 31, 2019
    Equity [Abstract]  
    Schedule of Accumulated Other Comprehensive Income (Loss)
    Analysis of Changes in Accumulated Other Comprehensive (Loss) Income:
    (In millions)
    Foreign Currency Translation Adjustment
     
    Minimum Pension Liability
     
    Total
    Balance at October 31, 2017
    $
    (353.7
    )
     
    $
    (21.6
    )
     
    $
    (375.3
    )
    Gross change in value during the year ended October 31, 2018
    (58.5
    )
     
    11.0

     
    (47.5
    )
    Tax effect for the period
    —

     
    (3.1
    )
     
    (3.1
    )
    ASU 2018-02 adoption(1)
    —

     
    (4.8
    )
     
    (4.8
    )
    Balance at October 31, 2018
    $
    (412.2
    )
     
    $
    (18.5
    )
     
    $
    (430.7
    )
    Gross change in value during the three months ended January 31, 2019
    32.7

     
    —

     
    32.7

    Balance at January 31, 2019
    $
    (379.5
    )
     
    $
    (18.5
    )
     
    $
    (398.0
    )

    (1)
    Represents reclassification to retained earnings from adoption of ASU 2018-02. Refer to our Annual Report on Form 10-K for the fiscal year ended October 31, 2018 for more details.
    XML 48 R31.htm IDEA: XBRL DOCUMENT v3.10.0.1
    Employee Benefits (Tables)
    		 3 Months Ended
    Jan. 31, 2019
    Retirement Benefits, Description [Abstract]  
    Schedule of Components of Net Periodic Pension Costs
    Our results of operations for the three months ended January 31, 2019 and 2018, reflect the following components of net periodic pension costs:
    Three Months Ended January 31,
     
    (In millions)
    2019
     
    2018
    Service cost
    $
    2.5

     
    $
    2.7

    Interest cost
    1.5

     
    1.3

    Expected return on plan assets
    (2.4
    )
     
    (2.3
    )
    Recognized net actuarial loss
    0.2

     
    0.4

    Net periodic pension cost
    $
    1.8

     
    $
    2.1
    XML 49 R32.htm IDEA: XBRL DOCUMENT v3.10.0.1
    Business Segment Information (Tables)
    		 3 Months Ended
    Jan. 31, 2019
    Segment Reporting [Abstract]  
    Schedule of Segment Information
    Segment information:
    Three Months Ended January 31,
     
    (In millions)
    2019
     
    2018
    CooperVision net sales by category:
     
     
     
    Toric lens
    $
    146.0

     
    $
    137.8

    Multifocal lens
    49.1

     
    46.9

    Single-use sphere lens
    132.1

     
    116.3

    Non single-use sphere and other
    142.9

     
    143.8

    Total CooperVision net sales
    470.1

     
    444.8

    CooperSurgical net sales by category:
     
     
     
    Office and surgical procedures
    95.7

     
    88.2

    Fertility
    62.3

     
    57.0

    Total CooperSurgical net sales
    158.0

     
    145.2

    Total net sales
    $
    628.1

     
    $
    590.0

    Operating income (loss):
     
     
     
    CooperVision
    $
    116.3

     
    $
    112.3

    CooperSurgical
    7.2

     
    (9.3
    )
    Corporate
    (12.6
    )
     
    (12.8
    )
    Total operating income
    110.9

     
    90.2

    Interest expense
    18.2

     
    18.4

    Other income, net
    1.1

     
    3.0

    Income before income taxes
    $
    93.8

     
    $
    74.8
    Schedule of Identifiable Assets by Segment
    (In millions)
    January 31, 2019
     
    October 31, 2018
    Total identifiable assets:
     
     
     
    CooperVision
    $
    3,869.8

     
    $
    3,746.0

    CooperSurgical
    2,214.6

     
    2,201.7

    Corporate
    214.2

     
    165.1

    Total
    $
    6,298.6

     
    $
    6,112.8
    Schedule of Net Sales to External Customers by Country of Domicile
    Geographic information:
    Three Months Ended January 31,
     
    (In millions)
    2019
     
    2018
    Net sales to unaffiliated customers by country of domicile:
     
     
     
    United States
    $
    278.9

     
    $
    261.5

    Europe
    209.7

     
    203.8

    Rest of world
    139.5

     
    124.7

    Total
    $
    628.1

     
    $
    590.0
    Schedule of Long-Lived Assets by Country of Domicile
    (In millions)
    January 31, 2019
     
    October 31, 2018
    Net property, plant and equipment by country of domicile:
     
     
     
    United States
    $
    550.2

     
    $
    516.7

    Europe
    349.6

     
    340.7

    Rest of world
    124.0

     
    118.6

    Total
    $
    1,023.8

     
    $
    976.0
    XML 50 R33.htm IDEA: XBRL DOCUMENT v3.10.0.1
    General (Details) - USD ($)
    $ in Millions
    		 3 Months Ended
    Jan. 31, 2019
    Nov. 01, 2018
    Nov. 01, 2017
    New Accounting Pronouncements or Change in Accounting Principle [Line Items]      
    Cumulative effect, decrease to retained earnings   $ 13.3 [1] $ (4.8)
    Factoring fees associated with sale of factored receivables $ 0.4    
    Accounting Standards Update 2016-16 | Retained Earnings      
    New Accounting Pronouncements or Change in Accounting Principle [Line Items]      
    Cumulative effect, decrease to retained earnings [1]   $ 13.3  
    [1] We adopted ASU 2016-16, Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory in the first quarter of fiscal 2019. Refer to “Note 1. General" for further information.
    XML 51 R34.htm IDEA: XBRL DOCUMENT v3.10.0.1
    Revenue Recognition (Details)
    $ in Millions
    Jan. 31, 2019
    USD ($)
    Revenue from Contract with Customer [Abstract]  
    Refund liability for product returns $ 12.6
    XML 52 R35.htm IDEA: XBRL DOCUMENT v3.10.0.1
    Acquisitions (Details) - USD ($)
    $ in Millions
    		 3 Months Ended 12 Months Ended
    Nov. 01, 2017
    Jan. 31, 2019
    Oct. 31, 2018
    Oct. 31, 2017
    Business Acquisition [Line Items]        
    Goodwill   $ 2,449.3 $ 2,392.1 $ 2,354.8
    Series of Individually Immaterial Business Acquisitions        
    Business Acquisition [Line Items]        
    Business combination, recognized identifiable assets acquired and liabilities assumed, finite-lived intangibles   27.1 1,189.6  
    Net tangible assets   1.4 59.6  
    Total purchase consideration   64.3 1,319.8  
    Goodwill   35.8 70.6  
    Paragard        
    Business Acquisition [Line Items]        
    Property, plant and equipment $ 2.0      
    Inventory 47.3      
    Other assets 9.4      
    Total assets acquired 1,121.8      
    Less: liabilities assumed 16.4      
    Net tangible assets 1,105.4      
    Total purchase consideration 1,100.0      
    Inventory step up 45.4      
    Technology | Series of Individually Immaterial Business Acquisitions        
    Business Acquisition [Line Items]        
    Business combination, recognized identifiable assets acquired and liabilities assumed, finite-lived intangibles   9.9 0.0  
    Customer relationships | Series of Individually Immaterial Business Acquisitions        
    Business Acquisition [Line Items]        
    Business combination, recognized identifiable assets acquired and liabilities assumed, finite-lived intangibles   7.5 23.5  
    Trademarks | Series of Individually Immaterial Business Acquisitions        
    Business Acquisition [Line Items]        
    Business combination, recognized identifiable assets acquired and liabilities assumed, finite-lived intangibles   9.7 100.0  
    Composite intangible asset | Series of Individually Immaterial Business Acquisitions        
    Business Acquisition [Line Items]        
    Business combination, recognized identifiable assets acquired and liabilities assumed, finite-lived intangibles   0.0 1,061.9  
    Composite intangible asset | Paragard        
    Business Acquisition [Line Items]        
    Business combination, recognized identifiable assets acquired and liabilities assumed, finite-lived intangibles $ 1,061.9      
    Acquired Finite-lived Intangible Assets, Weighted Average Useful Life 15 years      
    Other | Series of Individually Immaterial Business Acquisitions        
    Business Acquisition [Line Items]        
    Business combination, recognized identifiable assets acquired and liabilities assumed, finite-lived intangibles   $ 0.0 $ 4.2  
    Assembled Workforce | Paragard        
    Business Acquisition [Line Items]        
    Business combination, recognized identifiable assets acquired and liabilities assumed, finite-lived intangibles $ 1.2      
    Acquired Finite-lived Intangible Assets, Weighted Average Useful Life 5 years      
    XML 53 R36.htm IDEA: XBRL DOCUMENT v3.10.0.1
    Inventories (Schedule of Inventories) (Details) - USD ($)
    $ in Millions
    Jan. 31, 2019
    Oct. 31, 2018
    Inventory Disclosure [Abstract]    
    Raw materials $ 119.9 $ 112.5
    Work-in-process 12.6 12.6
    Finished goods 353.7 343.7
    Inventories, net $ 486.2 $ 468.8
    XML 54 R37.htm IDEA: XBRL DOCUMENT v3.10.0.1
    Intangible Assets (Schedule of Goodwill) (Details) - USD ($)
    $ in Millions
    		 3 Months Ended 12 Months Ended
    Jan. 31, 2019
    Oct. 31, 2018
    Goodwill [Roll Forward]    
    Balance, beginning $ 2,392.1 $ 2,354.8
    Net additions during the three months ended January 31, 2019 35.8 71.2
    Translation 21.4 (33.9)
    Balance, ending 2,449.3 2,392.1
    CooperVision    
    Goodwill [Roll Forward]    
    Balance, beginning 1,742.9 1,735.7
    Net additions during the three months ended January 31, 2019 13.9 36.8
    Translation 19.9 (29.6)
    Balance, ending 1,776.7 1,742.9
    CooperSurgical    
    Goodwill [Roll Forward]    
    Balance, beginning 649.2 619.1
    Net additions during the three months ended January 31, 2019 21.9 34.4
    Translation 1.5 (4.3)
    Balance, ending $ 672.6 $ 649.2
    XML 55 R38.htm IDEA: XBRL DOCUMENT v3.10.0.1
    Intangible Assets (Schedule of Other Intangible Assets) (Details) - USD ($)
    $ in Millions
    		 3 Months Ended
    Jan. 31, 2019
    Oct. 31, 2018
    Finite-Lived Intangible Assets [Line Items]    
    Gross Carrying Amount $ 2,052.0 $ 2,021.0
    Accumulated Amortization & Translation 537.9 499.7
    Other intangible assets, net $ 1,514.1 1,521.3
    Finite-Lived Intangible Asset, Useful Life 14 years  
    Trademarks    
    Finite-Lived Intangible Assets [Line Items]    
    Gross Carrying Amount $ 149.3 139.2
    Accumulated Amortization & Translation $ 19.4 16.9
    Finite-Lived Intangible Asset, Useful Life 14 years  
    Composite intangible asset    
    Finite-Lived Intangible Assets [Line Items]    
    Gross Carrying Amount $ 1,061.9 1,061.9
    Accumulated Amortization & Translation $ 88.5 70.8
    Finite-Lived Intangible Asset, Useful Life 15 years  
    Technology    
    Finite-Lived Intangible Assets [Line Items]    
    Gross Carrying Amount $ 405.8 395.0
    Accumulated Amortization & Translation $ 198.5 190.7
    Finite-Lived Intangible Asset, Useful Life 11 years  
    Customer relationships    
    Finite-Lived Intangible Assets [Line Items]    
    Gross Carrying Amount $ 359.0 350.0
    Accumulated Amortization & Translation $ 175.3 168.6
    Finite-Lived Intangible Asset, Useful Life 13 years  
    License and distribution rights and other    
    Finite-Lived Intangible Assets [Line Items]    
    Gross Carrying Amount $ 76.0 74.9
    Accumulated Amortization & Translation $ 56.2 $ 52.7
    Finite-Lived Intangible Asset, Useful Life 9 years  
    XML 56 R39.htm IDEA: XBRL DOCUMENT v3.10.0.1
    Intangible Assets (Narrative) (Details) - USD ($)
    		 3 Months Ended
    Jul. 31, 2018
    Jul. 31, 2017
    Jan. 31, 2019
    Goodwill and Intangible Assets Disclosure [Abstract]      
    Goodwill, Impairment Loss $ 0 $ 0  
    Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]      
    Remainder of 2019     $ 109,100,000
    2020     136,100,000
    2021     134,800,000
    2022     132,900,000
    2022     130,700,000
    Thereafter     861,600,000
    Total remaining amortization for intangible assets     $ 1,505,200,000
    XML 57 R40.htm IDEA: XBRL DOCUMENT v3.10.0.1
    Debt (Schedule of Debt) (Details) - USD ($)
    $ in Millions
    Jan. 31, 2019
    Oct. 31, 2018
    Short-term:    
    Overdraft and other credit facilities $ 45.6 $ 37.1
    Term loans 400.0 0.0
    Less: unamortized debt issuance cost 0.1 0.0
    Short-term Debt 445.5 37.1
    Short-term Debt    
    Credit Agreement 140.0 439.0
    Term loans 1,550.0 1,550.0
    Other 0.2 0.2
    Less: unamortized debt issuance cost (3.3) (3.5)
    Long-term debt 1,686.9 1,985.7
    Total Debt $ 2,132.4 $ 2,022.8
    XML 58 R41.htm IDEA: XBRL DOCUMENT v3.10.0.1
    Debt (Narrative) (Details)
    		 3 Months Ended 12 Months Ended
    Nov. 01, 2018
    USD ($)
    Nov. 01, 2017
    USD ($)
    Mar. 01, 2016
    USD ($)
    Jan. 31, 2019
    USD ($)
    Oct. 31, 2018
    USD ($)
    Line of Credit Facility [Line Items]          
    Short-term debt       $ 445,500,000 $ 37,100,000
    Term loans       $ 1,550,000,000 $ 1,550,000,000
    Required minimum Interest coverage ratio       3.00  
    Required maximum total leverage ratio       3.75  
    Interest coverage ratio       10.70  
    Total leverage ratio       2.25  
    Minimum          
    Line of Credit Facility [Line Items]          
    Commitment fee percentage     0.125%    
    Maximum          
    Line of Credit Facility [Line Items]          
    Commitment fee percentage     0.25%    
    2016 Credit Agreement          
    Line of Credit Facility [Line Items]          
    Line of credit facility, potential additional borrowing capacity     $ 750,000,000    
    Revolving Credit Facility          
    Line of Credit Facility [Line Items]          
    Aggregate commitment amount of credit facility     $ 1,000,000,000.0    
    2017 Term Loan | Base Rate | Minimum          
    Line of Credit Facility [Line Items]          
    Debt instrument, basis spread on variable rate         0.00%
    2017 Term Loan | Base Rate | Maximum          
    Line of Credit Facility [Line Items]          
    Debt instrument, basis spread on variable rate         0.75%
    2017 Term Loan | London Interbank Offered Rate (LIBOR) | Minimum          
    Line of Credit Facility [Line Items]          
    Debt instrument, basis spread on variable rate         1.00%
    2017 Term Loan | London Interbank Offered Rate (LIBOR) | Maximum          
    Line of Credit Facility [Line Items]          
    Debt instrument, basis spread on variable rate         1.75%
    2016 Credit Agreement          
    Line of Credit Facility [Line Items]          
    Line of credit facility, initiation date     Mar. 01, 2016    
    Term loans     $ 830,000,000    
    Line of credit facility interest rate margin on base rate loans percentage     1.00%    
    Line of credit facility interest rate margin on foreign currency loans percentage     1.75%    
    Amount available under the credit agreement       $ 859,500,000  
    2016 Credit Agreement | Federal Funds Rate          
    Line of Credit Facility [Line Items]          
    Debt instrument, basis spread on variable rate     0.00%    
    2016 Credit Agreement | Eurodollar          
    Line of Credit Facility [Line Items]          
    Debt instrument, basis spread on variable rate     0.75%    
    Line of Credit          
    Line of Credit Facility [Line Items]          
    Debt instrument, maturity date     Mar. 01, 2021    
    Term Loan Agreement 2019 | Senior Notes          
    Line of Credit Facility [Line Items]          
    Debt term 364 days        
    Debt instrument, face amount $ 400,000,000.0        
    Short-term debt       $ 400,000,000  
    Weighted average interest rate       2.99%  
    Term Loan Agreement 2019 | Senior Notes | Base Rate          
    Line of Credit Facility [Line Items]          
    Debt instrument, basis spread on variable rate 0.00%        
    Term Loan Agreement 2019 | Senior Notes | London Interbank Offered Rate (LIBOR)          
    Line of Credit Facility [Line Items]          
    Debt instrument, basis spread on variable rate 0.60%        
    Senior Unsecured Term Loan Agreement | Senior Notes          
    Line of Credit Facility [Line Items]          
    Debt term   5 years      
    Debt instrument, face amount   $ 1,425,000,000      
    Term loans       $ 1,425,000,000  
    Amount outstanding on credit agreement       $ 125,000,000  
    XML 59 R42.htm IDEA: XBRL DOCUMENT v3.10.0.1
    Income Taxes (Narrative) (Details) - USD ($)
    $ in Millions
    		 3 Months Ended
    Jan. 31, 2019
    Jan. 31, 2018
    Oct. 31, 2018
    Components of Income Tax Expense (Benefit), Continuing Operations [Abstract]      
    Income tax expense (benefit) to finalize tax effects of 2017 Act $ (4.4)    
    Effective income tax rate 10.00% 263.70%  
    Change of provisional tax expenses related to 2017 Act   $ 202.0  
    Discrete tax benefits $ 18.7    
    Unrecognized tax benefits 47.1   $ 68.9
    Unrecognized tax benefits that could be settled $ 3.1    
    XML 60 R43.htm IDEA: XBRL DOCUMENT v3.10.0.1
    Earnings Per Share (Schedule of Earnings Per Share) (Details) - USD ($)
    $ / shares in Units, shares in Millions, $ in Millions
    		 3 Months Ended
    Jan. 31, 2019
    Jan. 31, 2018
    Earnings Per Share [Abstract]    
    Net income (loss) attributable to Cooper stockholders $ 103.2 $ (122.5)
    Basic:    
    Weighted average common shares 49.3 48.9
    Basic earnings (loss) per share attributable to Cooper stockholders $ 2.09 $ (2.50)
    Diluted:    
    Effect of potential dilutive shares 0.6 0.0
    Diluted weighted average common shares 49.9 48.9
    Diluted earnings (loss) per share attributable to Cooper stockholders $ 2.07 $ (2.50)
    XML 61 R44.htm IDEA: XBRL DOCUMENT v3.10.0.1
    Earnings Per Share (Schedule of Stock Options to Purchase Common Stock Not Included in Diluted Net Income Per Share Calculation) (Details) - $ / shares
    shares in Thousands
    		 3 Months Ended
    Jan. 31, 2019
    Jan. 31, 2018
    Stock Options    
    Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
    Numbers of stock option shares excluded 377 1,202
    Range of exercise prices, lower limit $ 226.3 $ 15.83
    Range of exercise prices, upper limit $ 254.77 $ 229.66
    Restricted Stock Units (RSUs)    
    Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
    Numbers of stock option shares excluded 17 546
    XML 62 R45.htm IDEA: XBRL DOCUMENT v3.10.0.1
    Share-Based Compensation Plans - Schedule of Compensation Expense And Related Income Tax Benefit For Share-Based Awards (Details) - USD ($)
    $ in Millions
    		 3 Months Ended
    Jan. 31, 2019
    Jan. 31, 2018
    Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
    Total share-based compensation expense $ 11.7 $ 12.7
    Related income tax benefit 1.7 2.5
    Selling, general and administrative expense    
    Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
    Share-based compensation expense 9.3 10.7
    Cost of sales    
    Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
    Share-based compensation expense 1.5 1.3
    Research and development expense    
    Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
    Share-based compensation expense $ 0.9 $ 0.7
    XML 63 R46.htm IDEA: XBRL DOCUMENT v3.10.0.1
    Stockholders' Equity - Schedule of Changes in Accumulated Other Comprehensive Income (Loss) (Details) - USD ($)
    $ in Millions
    		 3 Months Ended 12 Months Ended
    Jan. 31, 2019
    Oct. 31, 2018
    Nov. 01, 2018
    		 [1]
    Nov. 01, 2017
    Class of Stock [Line Items]        
    ASU 2016-16 adoption     $ (13.3) $ 4.8
    Foreign Currency Translation Adjustment [Roll Forward]        
    Foreign Currency Translation Adjustment, Beginning Balance $ (412.2) $ (353.7)    
    Foreign Currency Translation Adjustment, Gross change in value for the period 32.7 (58.5)    
    Foreign Currency Translation Adjustment, tax effect   0.0    
    Foreign Currency Translation Adjustment, Ending Balance (379.5) (412.2)    
    Minimum Pension Liability [Roll Forward]        
    Minimum Pension Liability, Beginning Balance (18.5) (21.6)    
    Minimum Pension Liability, Gross change in value for the period 0.0 11.0    
    Minimum Pension Liability, tax effect   (3.1)    
    Minimum Pension Liability, Ending Balance (18.5) (18.5)    
    Accumulated Other Comprehensive Income (Loss) [Roll Forward]        
    Total, Beginning balance (430.7) (375.3)    
    Gross change in value for the period 32.7 (47.5)    
    Tax effect for the period   (3.1)    
    Total, Ending balance $ (398.0) $ (430.7)    
    Foreign Currency Translation Adjustment        
    Class of Stock [Line Items]        
    ASU 2016-16 adoption       0.0
    Minimum Pension Liability        
    Class of Stock [Line Items]        
    ASU 2016-16 adoption       $ 4.8
    [1] We adopted ASU 2016-16, Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory in the first quarter of fiscal 2019. Refer to “Note 1. General" for further information.
    XML 64 R47.htm IDEA: XBRL DOCUMENT v3.10.0.1
    Stockholders' Equity (Share Repurchases) (Details) - USD ($)
    		 3 Months Ended 12 Months Ended
    Jan. 31, 2019
    Oct. 31, 2018
    Mar. 01, 2017
    Feb. 28, 2017
    Equity [Abstract]        
    Share Repurchase Program, maximum amount authorized     $ 1,000,000,000.0 $ 500,000,000.0
    Average purchase price (in usd per share) $ 248.70      
    Number of common stock repurchased, shares 25,000 0    
    Treasury Stock, Value, Acquired, Cost Method $ 6,100,000      
    Share Repurchase Program, remaining authorized amount $ 557,400,000      
    XML 65 R48.htm IDEA: XBRL DOCUMENT v3.10.0.1
    Stockholders' Equity (Dividends) (Details) - Subsequent Event
    $ / shares in Units, $ in Millions
    Feb. 09, 2019
    USD ($)
    $ / shares
    Class of Stock [Line Items]  
    Dividends on common stock | $ $ 1.5
    Cash dividend, per share | $ / shares $ 0.03
    Dividends payable, date of record Jan. 22, 2019
    XML 66 R49.htm IDEA: XBRL DOCUMENT v3.10.0.1
    Employee Benefits (Schedule of Components of Net Periodic Pension Costs) (Details) - USD ($)
    $ in Millions
    		 3 Months Ended
    Jan. 31, 2019
    Jan. 31, 2018
    Retirement Benefits, Description [Abstract]    
    Service cost $ 2.5 $ 2.7
    Interest cost 1.5 1.3
    Expected return on plan assets (2.4) (2.3)
    Recognized net actuarial loss 0.2 0.4
    Net periodic pension cost $ 1.8 $ 2.1
    XML 67 R50.htm IDEA: XBRL DOCUMENT v3.10.0.1
    Employee Benefits (Narrative) (Details) - USD ($)
    		 3 Months Ended
    Jan. 31, 2019
    Jan. 31, 2018
    Retirement Benefits, Description [Abstract]    
    Defined benefit plan, contributions by employer   $ 0
    Defined benefit plan, estimated future employer contributions in current fiscal year $ 10,000,000  
    Expected rate of return on plan assets for determining net periodic pension cost 8.00%  
    XML 68 R51.htm IDEA: XBRL DOCUMENT v3.10.0.1
    Contingencies (Details)
    $ in Millions
    		 26 Months Ended
    Apr. 30, 2017
    action
    Jul. 31, 2018
    USD ($)
    Commitments and Contingencies Disclosure [Abstract]    
    Number of putative class action complaints filed (over) | action 50  
    Litigation Settlement, Amount | $   $ 3.0
    XML 69 R52.htm IDEA: XBRL DOCUMENT v3.10.0.1
    Business Segment Information (Schedule of Segment Information) (Details) - USD ($)
    $ in Millions
    		 3 Months Ended
    Jan. 31, 2019
    Jan. 31, 2018
    Segment Reporting Information [Line Items]    
    Net sales $ 628.1 $ 590.0
    Operating income (loss) 110.9 90.2
    Interest expense 18.2 18.4
    Other income, net 1.1 3.0
    Income before income taxes 93.8 74.8
    CooperVision    
    Segment Reporting Information [Line Items]    
    Net sales 470.1 444.8
    Operating income (loss) 116.3 112.3
    CooperSurgical    
    Segment Reporting Information [Line Items]    
    Net sales 158.0 145.2
    Operating income (loss) 7.2 (9.3)
    Corporate    
    Segment Reporting Information [Line Items]    
    Operating income (loss) (12.6) (12.8)
    Toric lens | CooperVision    
    Segment Reporting Information [Line Items]    
    Net sales 146.0 137.8
    Multifocal lens | CooperVision    
    Segment Reporting Information [Line Items]    
    Net sales 49.1 46.9
    Single-use sphere lens | CooperVision    
    Segment Reporting Information [Line Items]    
    Net sales 132.1 116.3
    Non single-use sphere and other | CooperVision    
    Segment Reporting Information [Line Items]    
    Net sales 142.9 143.8
    Office and surgical procedures | CooperSurgical    
    Segment Reporting Information [Line Items]    
    Net sales 95.7 88.2
    Fertility | CooperSurgical    
    Segment Reporting Information [Line Items]    
    Net sales $ 62.3 $ 57.0
    XML 70 R53.htm IDEA: XBRL DOCUMENT v3.10.0.1
    Business Segment Information (Schedule of Identifiable Assets By Segment Information) (Details) - USD ($)
    $ in Millions
    Jan. 31, 2019
    Oct. 31, 2018
    Segment Reporting Information [Line Items]    
    Total Identifiable assets $ 6,298.6 $ 6,112.8
    CooperVision    
    Segment Reporting Information [Line Items]    
    Total Identifiable assets 3,869.8 3,746.0
    CooperSurgical    
    Segment Reporting Information [Line Items]    
    Total Identifiable assets 2,214.6 2,201.7
    Corporate    
    Segment Reporting Information [Line Items]    
    Total Identifiable assets $ 214.2 $ 165.1
    XML 71 R54.htm IDEA: XBRL DOCUMENT v3.10.0.1
    Business Segment Information (Schedule of Net Sales To External Customers By Country Of Domicile) (Details) - USD ($)
    $ in Millions
    		 3 Months Ended
    Jan. 31, 2019
    Jan. 31, 2018
    Segment Reporting Information [Line Items]    
    Total net sales to external customers $ 628.1 $ 590.0
    United States    
    Segment Reporting Information [Line Items]    
    Total net sales to external customers 278.9 261.5
    Europe    
    Segment Reporting Information [Line Items]    
    Total net sales to external customers 209.7 203.8
    Rest of world    
    Segment Reporting Information [Line Items]    
    Total net sales to external customers $ 139.5 $ 124.7
    XML 72 R55.htm IDEA: XBRL DOCUMENT v3.10.0.1
    Business Segment Information (Schedule of Long-Lived Assets By Country Of Domicile) (Details) - USD ($)
    $ in Millions
    Jan. 31, 2019
    Oct. 31, 2018
    Segment Reporting Information [Line Items]    
    Total long-lived assets $ 1,023.8 $ 976.0
    United States    
    Segment Reporting Information [Line Items]    
    Total long-lived assets 550.2 516.7
    Europe    
    Segment Reporting Information [Line Items]    
    Total long-lived assets 349.6 340.7
    Rest of world    
    Segment Reporting Information [Line Items]    
    Total long-lived assets $ 124.0 $ 118.6
    XML 73 R56.htm IDEA: XBRL DOCUMENT v3.10.0.1
    Subsequent Event (Details)
    £ in Millions, $ in Millions
    Feb. 26, 2019
    GBP (£)
    Feb. 26, 2019
    USD ($)
    Feb. 01, 2019
    USD ($)
    Jan. 19, 2018
    GBP (£)
    Jan. 19, 2018
    USD ($)
    Subsequent Event [Line Items]          
    Payment for diverted profit tax       £ 31.0 $ 42.0
    Subsequent Event          
    Subsequent Event [Line Items]          
    Consideration received on contract termination     $ 21.0    
    Refund from U.K. tax authorities £ 22.1 $ 29.0      
    EXCEL 74 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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end XML 75 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 76 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 78 FilingSummary.xml IDEA: XBRL DOCUMENT 3.10.0.1 html 168 227 1 true 52 0 false 6 false false R1.htm 0001000 - Document - Document and Entity Information Sheet http://www.coopercos.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 1001000 - Statement - Consolidated Statements of Income Sheet http://www.coopercos.com/role/ConsolidatedStatementsOfIncome Consolidated Statements of Income Statements 2 false false R3.htm 1002000 - Statement - Consolidated Condensed Balance Sheets Sheet http://www.coopercos.com/role/ConsolidatedCondensedBalanceSheets Consolidated Condensed Balance Sheets Statements 3 false false R4.htm 1002000 - Statement - Consolidated Statements of Comprehensive Income (Loss) Sheet http://www.coopercos.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss Consolidated Statements of Comprehensive Income (Loss) Statements 4 false false R5.htm 1002501 - Statement - Consolidated Condensed Balance Sheets (Parenthetical) Sheet http://www.coopercos.com/role/ConsolidatedCondensedBalanceSheetsParenthetical Consolidated Condensed Balance Sheets (Parenthetical) Statements 5 false false R6.htm 1003000 - Statement - Consolidated Statements of Stockholders' Equity Sheet http://www.coopercos.com/role/ConsolidatedStatementsOfStockholdersEquity Consolidated Statements of Stockholders' Equity Statements 6 false false R7.htm 1004000 - Statement - Consolidated Condensed Statements of Cash Flows Sheet http://www.coopercos.com/role/ConsolidatedCondensedStatementsOfCashFlows Consolidated Condensed Statements of Cash Flows Statements 7 false false R8.htm 2101100 - Disclosure - General Sheet http://www.coopercos.com/role/General General Notes 8 false false R9.htm 2103100 - Disclosure - Revenue Recognition Sheet http://www.coopercos.com/role/RevenueRecognition Revenue Recognition Notes 9 false false R10.htm 2104100 - Disclosure - Acquisitions Sheet http://www.coopercos.com/role/Acquisitions Acquisitions Notes 10 false false R11.htm 2106100 - Disclosure - Inventories Sheet http://www.coopercos.com/role/Inventories Inventories Notes 11 false false R12.htm 2107100 - Disclosure - Intangible Assets Sheet http://www.coopercos.com/role/IntangibleAssets Intangible Assets Notes 12 false false R13.htm 2108100 - Disclosure - Debt Sheet http://www.coopercos.com/role/Debt Debt Notes 13 false false R14.htm 2109100 - Disclosure - Income Taxes Sheet http://www.coopercos.com/role/IncomeTaxes Income Taxes Notes 14 false false R15.htm 2110100 - Disclosure - Earnings Per Share Sheet http://www.coopercos.com/role/EarningsPerShare Earnings Per Share Notes 15 false false R16.htm 2111100 - Disclosure - Share-Based Compensation Plans Sheet http://www.coopercos.com/role/ShareBasedCompensationPlans Share-Based Compensation Plans Notes 16 false false R17.htm 2113100 - Disclosure - Stockholders' Equity Sheet http://www.coopercos.com/role/StockholdersEquity Stockholders' Equity Notes 17 false false R18.htm 2114100 - Disclosure - Fair Value Measurements Sheet http://www.coopercos.com/role/FairValueMeasurements Fair Value Measurements Notes 18 false false R19.htm 2115100 - Disclosure - Employee Benefits Sheet http://www.coopercos.com/role/EmployeeBenefits Employee Benefits Notes 19 false false R20.htm 2116100 - Disclosure - Contingencies Sheet http://www.coopercos.com/role/Contingencies Contingencies Notes 20 false false R21.htm 2117100 - Disclosure - Business Segment Information Sheet http://www.coopercos.com/role/BusinessSegmentInformation Business Segment Information Notes 21 false false R22.htm 2118100 - Disclosure - Subsequent Event (Notes) Notes http://www.coopercos.com/role/SubsequentEventNotes Subsequent Event (Notes) Notes 22 false false R23.htm 2201201 - Disclosure - General (Policies) Sheet http://www.coopercos.com/role/GeneralPolicies General (Policies) Policies 23 false false R24.htm 2304301 - Disclosure - Acquisitions Acquisitions (Tables) Sheet http://www.coopercos.com/role/AcquisitionsAcquisitionsTables Acquisitions Acquisitions (Tables) Tables 24 false false R25.htm 2306301 - Disclosure - Inventories (Tables) Sheet http://www.coopercos.com/role/InventoriesTables Inventories (Tables) Tables http://www.coopercos.com/role/Inventories 25 false false R26.htm 2307301 - Disclosure - Intangible Assets (Tables) Sheet http://www.coopercos.com/role/IntangibleAssetsTables Intangible Assets (Tables) Tables http://www.coopercos.com/role/IntangibleAssets 26 false false R27.htm 2308301 - Disclosure - Debt (Tables) Sheet http://www.coopercos.com/role/DebtTables Debt (Tables) Tables http://www.coopercos.com/role/Debt 27 false false R28.htm 2310301 - Disclosure - Earnings Per Share (Tables) Sheet http://www.coopercos.com/role/EarningsPerShareTables Earnings Per Share (Tables) Tables http://www.coopercos.com/role/EarningsPerShare 28 false false R29.htm 2311301 - Disclosure - Share-Based Compensation Plans (Tables) Sheet http://www.coopercos.com/role/ShareBasedCompensationPlansTables Share-Based Compensation Plans (Tables) Tables http://www.coopercos.com/role/ShareBasedCompensationPlans 29 false false R30.htm 2313301 - Disclosure - Stockholders' Equity (Tables) Sheet http://www.coopercos.com/role/StockholdersEquityTables Stockholders' Equity (Tables) Tables http://www.coopercos.com/role/StockholdersEquity 30 false false R31.htm 2315301 - Disclosure - Employee Benefits (Tables) Sheet http://www.coopercos.com/role/EmployeeBenefitsTables Employee Benefits (Tables) Tables http://www.coopercos.com/role/EmployeeBenefits 31 false false R32.htm 2317301 - Disclosure - Business Segment Information (Tables) Sheet http://www.coopercos.com/role/BusinessSegmentInformationTables Business Segment Information (Tables) Tables http://www.coopercos.com/role/BusinessSegmentInformation 32 false false R33.htm 2401402 - Disclosure - General (Details) Sheet http://www.coopercos.com/role/GeneralDetails General (Details) Details http://www.coopercos.com/role/GeneralPolicies 33 false false R34.htm 2403401 - Disclosure - Revenue Recognition (Details) Sheet http://www.coopercos.com/role/RevenueRecognitionDetails Revenue Recognition (Details) Details http://www.coopercos.com/role/RevenueRecognition 34 false false R35.htm 2404402 - Disclosure - Acquisitions (Details) Sheet http://www.coopercos.com/role/AcquisitionsDetails Acquisitions (Details) Details http://www.coopercos.com/role/AcquisitionsAcquisitionsTables 35 false false R36.htm 2406402 - Disclosure - Inventories (Schedule of Inventories) (Details) Sheet http://www.coopercos.com/role/InventoriesScheduleOfInventoriesDetails Inventories (Schedule of Inventories) (Details) Details http://www.coopercos.com/role/InventoriesTables 36 false false R37.htm 2407402 - Disclosure - Intangible Assets (Schedule of Goodwill) (Details) Sheet http://www.coopercos.com/role/IntangibleAssetsScheduleOfGoodwillDetails Intangible Assets (Schedule of Goodwill) (Details) Details http://www.coopercos.com/role/IntangibleAssetsTables 37 false false R38.htm 2407403 - Disclosure - Intangible Assets (Schedule of Other Intangible Assets) (Details) Sheet http://www.coopercos.com/role/IntangibleAssetsScheduleOfOtherIntangibleAssetsDetails Intangible Assets (Schedule of Other Intangible Assets) (Details) Details http://www.coopercos.com/role/IntangibleAssetsTables 38 false false R39.htm 2407404 - Disclosure - Intangible Assets (Narrative) (Details) Sheet http://www.coopercos.com/role/IntangibleAssetsNarrativeDetails Intangible Assets (Narrative) (Details) Details http://www.coopercos.com/role/IntangibleAssetsTables 39 false false R40.htm 2408402 - Disclosure - Debt (Schedule of Debt) (Details) Sheet http://www.coopercos.com/role/DebtScheduleOfDebtDetails Debt (Schedule of Debt) (Details) Details http://www.coopercos.com/role/DebtTables 40 false false R41.htm 2408403 - Disclosure - Debt (Narrative) (Details) Sheet http://www.coopercos.com/role/DebtNarrativeDetails Debt (Narrative) (Details) Details http://www.coopercos.com/role/DebtTables 41 false false R42.htm 2409401 - Disclosure - Income Taxes (Narrative) (Details) Sheet http://www.coopercos.com/role/IncomeTaxesNarrativeDetails Income Taxes (Narrative) (Details) Details http://www.coopercos.com/role/IncomeTaxes 42 false false R43.htm 2410402 - Disclosure - Earnings Per Share (Schedule of Earnings Per Share) (Details) Sheet http://www.coopercos.com/role/EarningsPerShareScheduleOfEarningsPerShareDetails Earnings Per Share (Schedule of Earnings Per Share) (Details) Details http://www.coopercos.com/role/EarningsPerShareTables 43 false false R44.htm 2410403 - Disclosure - Earnings Per Share (Schedule of Stock Options to Purchase Common Stock Not Included in Diluted Net Income Per Share Calculation) (Details) Sheet http://www.coopercos.com/role/EarningsPerShareScheduleOfStockOptionsToPurchaseCommonStockNotIncludedInDilutedNetIncomePerShareCalculationDetails Earnings Per Share (Schedule of Stock Options to Purchase Common Stock Not Included in Diluted Net Income Per Share Calculation) (Details) Details http://www.coopercos.com/role/EarningsPerShareTables 44 false false R45.htm 2411402 - Disclosure - Share-Based Compensation Plans - Schedule of Compensation Expense And Related Income Tax Benefit For Share-Based Awards (Details) Sheet http://www.coopercos.com/role/ShareBasedCompensationPlansScheduleOfCompensationExpenseAndRelatedIncomeTaxBenefitForShareBasedAwardsDetails Share-Based Compensation Plans - Schedule of Compensation Expense And Related Income Tax Benefit For Share-Based Awards (Details) Details 45 false false R46.htm 2413402 - Disclosure - Stockholders' Equity - Schedule of Changes in Accumulated Other Comprehensive Income (Loss) (Details) Sheet http://www.coopercos.com/role/StockholdersEquityScheduleOfChangesInAccumulatedOtherComprehensiveIncomeLossDetails Stockholders' Equity - Schedule of Changes in Accumulated Other Comprehensive Income (Loss) (Details) Details 46 false false R47.htm 2413403 - Disclosure - Stockholders' Equity (Share Repurchases) (Details) Sheet http://www.coopercos.com/role/StockholdersEquityShareRepurchasesDetails Stockholders' Equity (Share Repurchases) (Details) Details http://www.coopercos.com/role/StockholdersEquityTables 47 false false R48.htm 2413404 - Disclosure - Stockholders' Equity (Dividends) (Details) Sheet http://www.coopercos.com/role/StockholdersEquityDividendsDetails Stockholders' Equity (Dividends) (Details) Details http://www.coopercos.com/role/StockholdersEquityTables 48 false false R49.htm 2415402 - Disclosure - Employee Benefits (Schedule of Components of Net Periodic Pension Costs) (Details) Sheet http://www.coopercos.com/role/EmployeeBenefitsScheduleOfComponentsOfNetPeriodicPensionCostsDetails Employee Benefits (Schedule of Components of Net Periodic Pension Costs) (Details) Details http://www.coopercos.com/role/EmployeeBenefitsTables 49 false false R50.htm 2415403 - Disclosure - Employee Benefits (Narrative) (Details) Sheet http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails Employee Benefits (Narrative) (Details) Details http://www.coopercos.com/role/EmployeeBenefitsTables 50 false false R51.htm 2416401 - Disclosure - Contingencies (Details) Sheet http://www.coopercos.com/role/ContingenciesDetails Contingencies (Details) Details http://www.coopercos.com/role/Contingencies 51 false false R52.htm 2417402 - Disclosure - Business Segment Information (Schedule of Segment Information) (Details) Sheet http://www.coopercos.com/role/BusinessSegmentInformationScheduleOfSegmentInformationDetails Business Segment Information (Schedule of Segment Information) (Details) Details http://www.coopercos.com/role/BusinessSegmentInformationTables 52 false false R53.htm 2417403 - Disclosure - Business Segment Information (Schedule of Identifiable Assets By Segment Information) (Details) Sheet http://www.coopercos.com/role/BusinessSegmentInformationScheduleOfIdentifiableAssetsBySegmentInformationDetails Business Segment Information (Schedule of Identifiable Assets By Segment Information) (Details) Details http://www.coopercos.com/role/BusinessSegmentInformationTables 53 false false R54.htm 2417404 - Disclosure - Business Segment Information (Schedule of Net Sales To External Customers By Country Of Domicile) (Details) Sheet http://www.coopercos.com/role/BusinessSegmentInformationScheduleOfNetSalesToExternalCustomersByCountryOfDomicileDetails Business Segment Information (Schedule of Net Sales To External Customers By Country Of Domicile) (Details) Details http://www.coopercos.com/role/BusinessSegmentInformationTables 54 false false R55.htm 2417405 - Disclosure - Business Segment Information (Schedule of Long-Lived Assets By Country Of Domicile) (Details) Sheet http://www.coopercos.com/role/BusinessSegmentInformationScheduleOfLongLivedAssetsByCountryOfDomicileDetails Business Segment Information (Schedule of Long-Lived Assets By Country Of Domicile) (Details) Details http://www.coopercos.com/role/BusinessSegmentInformationTables 55 false false R56.htm 2418401 - Disclosure - Subsequent Event (Details) Sheet http://www.coopercos.com/role/SubsequentEventDetails Subsequent Event (Details) Details http://www.coopercos.com/role/SubsequentEventNotes 56 false false All Reports Book All Reports coo-20190131.xml coo-20190131.xsd coo-20190131_cal.xml coo-20190131_def.xml coo-20190131_lab.xml coo-20190131_pre.xml http://xbrl.sec.gov/dei/2018-01-31 http://fasb.org/srt/2018-01-31 http://fasb.org/us-gaap/2018-01-31 http://xbrl.sec.gov/country/2017-01-31 true true ZIP 80 0000711404-19-000012-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000711404-19-000012-xbrl.zip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end